Patent Publication Number: US-9422280-B2

Title: N-substituted hetero-bicyclic compounds and derivatives for combating animal pests II

Description:
This application is a National Stage application of International Application No. PCT/EP2013/056285, filed Mar. 25, 2013, which claims the benefit of U.S. Provisional Application No. 61/617,115, filed Mar. 29, 2012, the entire contents of which are hereby incorporated herein by reference. 
    
    
     The present invention relates to N-substituted hetero-bicyclic compounds, to the enantiomers, diastereomers, derivatives and salts thereof and to compositions comprising such compounds. The invention also relates to the use of the N-substituted hetero-bicyclic compounds, of their salts or of compositions comprising them for combating animal pests. Furthermore the invention relates also to methods of applying such compounds. 
     Animal pests destroy growing and harvested crops and attack wooden dwelling and commercial structures, causing large economic loss to the food supply and to property. While a large number of pesticidal agents are known, due to the ability of target pests to develop resistance to said agents, there is an ongoing need for new agents for combating animal pests. In particular, animal pests such as insects and acaridae are difficult to be effectively controlled. 
     It is therefore an object of the present invention to provide compounds having a good pesticidal activity, especially against difficult to control insects and acaridae. 
     It has been found that these objects are solved by N-substituted hetero-bicyclic derivatives of the general formula I: 
     N-substituted hetero-bicyclic compounds of the general formula (I) 
                         
wherein
         X is selected from a group of hydrogen, halogen, C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, C 1 -C 6 -alkoxy, C 1 -C 6 -alkylthio, NH 2 , CN, NO 2 , OC(O)R c , C(O)R c , C(O)SR c , C(S)R c , C(O)OR a , C(O)NR a R b , OC(O)NR a R b , C(S)NR a R b , S(O) m NR a R b  and S(O) m R c , wherein
           the aforementioned alkyl, cycloalkyl, alkenyl, alkynyl, alkoxy and alkylthio radicals are unsubstituted, partly or completely halogenated or may carry any combination of 1, 2 or 3 radicals R d      
           A is N or CR 4 ;   B is N or CR 7 ;   W 1 , W 2 , W 3      and W 4  represent a chain group connected to N and B, and thus forming a saturated or unsaturated 5-, 6- or 7-membered heterocycle,
           wherein   W 1 , W 2 , W 3  and W 4  each individually represent   CR 6 , CR 5a R 5b , N, NR 3 , O, S(O) n  or C═Y, wherein   Y is selected from C(R 6 ) 2 , O, S or NR 3 , and   wherein   W 2  and W 3  may further represent each individually, or both together, a single or double bond;   and under the proviso that   (i) not more than two of W 1 , W 2 , W 3  and W 4  represent   O, NR 3 , S(O) n  or C═Y at the same time,   and/or   (ii) if two of W 1 , W 2 , W 3  and W 4  represent   O or S(O) n , then at least one carbon atom is present between them;   
           Het is a 5 or 6 membered C- or optionally N-bound saturated, unsaturated or aromatic heterocycle, having at least one heteroatom group, selected from O, S, N and N—R 3 , as ring member and optionally 1 or 2 further N atoms as ring member, wherein
           the heterocycle is unsubstituted or carries at its carbon atoms 1 or 2 radicals R 8 , wherein   R 8  is selected from the group consisting of hydrogen, halogen, C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, C 1 -C 6 -alkoxy, C 2 -C 6 -alkenyloxy, C 2 -C 6 -alkynyloxy, C 1 -C 4 -alkylthio, CN, NO 2 , S(O) m R c , C(O)R c , C(O)OR a , C(O)NR a R b  and C(S)NR a R b ,
               wherein the aforementioned alkyl, cycloalkyl, alkenyl, alkynyl, alkoxy, alkylthio, alkenyloxy and alkynyloxy radicals are unsubstituted, partly or completely halogenated or may carry any combination of 1, 2 or 3 radicals R d ;   
               
           R 1 , R 2  are selected independently from one another from the group consisting of hydrogen, halogen, C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, C 1 -C 6 -alkoxy, C 1 -C 6 -alkylthio, CN, NO 2 , C(O)R c , C(O)OR a , C(O)NR a R b , C(S)NR a R b  and S(O) m R c , wherein
           the aforementioned alkyl, cycloalkyl, alkenyl, alkynyl, alkoxy and alkylthio radicals are unsubstituted, partly or completely halogenated or may carry any combination of 1, 2 or 3 radicals R d ; or   R 1  and R 2  from, together with the carbon atom, which they attached to, a 3- to 6-membered saturated carbocycle, wherein each of the carbon atoms of said carbocycle are unsubstituted or may carry any combination of 1 or 2 radicals R d .   
           R 3  is selected, and if more than one R 3  is present, independently from one another, from the group consisting of hydrogen, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 3 -C 6 -cycloalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -haloalkenyl, C 2 -C 6 -alkynyl, C 2 -C 6 -haloalkynyl, C(O)R c , C(S)R c , C(O)OR a , C(O)NR a R b , C(S)NR a R b  and S(O) m R c  and S(O) m NR a R b , and wherein the aforementioned alkyl, cycloalkyl, alkenyl and alkynyl radicals are unsubstituted or may carry any combination of 1, 2 or 3 radicals R d ,   R 4  is selected from the group consisting of hydrogen, halogen, cyano, nitro, formyl, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -haloalkoxy, C 1 -C 6 -alkylthio, C 1 -C 6 -alkylsulfinyl, C 1 -C 6 -alkylsulfonyl, C 1 -C 6 -haloalkylthio, C 3 -C 8 -cycloalkyl, C 3 -C 8 -halocycloalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -haloalkenyl, C 2 -C 6 -alkinyl, C 2 -C 6  haloalkinyl, C(O)R c , C(S)R c , Si(R a ) 2 R b , OR a , OSO 2 R c , S(O) n R c , S(O) n NR a R b , NR c R f , C(═O)NR a R b , C(═S)NR a R b , C(═O)OR a , wherein each of the carbon atoms of the carbon atom chain of the radicals can carry one or more, e.g. 1, 2 or up to 3, substituents R d , selected independently from one another;
           phenyl, optionally substituted with 1, 2, 3, 4 or up to 5 substituents R d , which are independently selected from one another,   a 3-, 4-, 5-, 6- or 7-membered saturated, partly saturated or unsaturated aromatic heterocyclic ring comprising 1, 2 or 3 heteroatoms selected from oxygen, nitrogen and/or sulfur, optionally substituted with one or more, e.g. 1, 2, 3 or 4, substituents R d , selected independently from one another, and wherein the nitrogen and/or the sulfur atom(s) of the heterocyclic ring may optionally be oxidized;   
           R 5a , R 5b  are independently from one another selected from the group consisting of hydrogen, halogen, C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 2 -C 6 -alkenyl and C 2 -C 6 -alkynyl, wherein
           the aforementioned alkyl, cycloalkyl, alkenyl and alkynyl radicals are unsubstituted, partly or completely halogenated or may carry any combination of 1, 2 or 3 radicals R d ;   
           R 6  is selected, and if more than one R 6  is present, independently from one another, from the group consisting of hydrogen, halogen, C 1 -C 6 -alkyl, C 1 -C 6 -alkyoxy and C 1 -C 6 -alkythio, wherein the carbon atoms of the aforementioned radicals are unsubstituted, partly or completely halogenated or may carry any combination of 1, 2 or 3 radicals R d ;   R 7  has one of the meanings given for R 6 ,
           or   R 7  represents a bond to the neighboring atom W 1  such that B and W 1  are connected by a double bond, under the proviso,   that in this case W 1  does not represent CR 4 R 5 , NR 3 , O, S(O) n  or C═Y;   
           R a , R b  are selected independently from one another from the group consisting of hydrogen, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 3 -C 6 -cycloalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -haloalkenyl and C 2 -C 6 -alkynyl;   R c  is selected, and if more than one R c  is present, independently from one another, from the group consisting of C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 3 -C 6 -cycloalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -haloalkenyl and C 2 -C 6 -alkynyl;   R d  is selected, and if more than one R d  is present, independently from one another, from the group consisting of halogen, C 1 -C 4 -alkyl, C 3 -C 6 -cycloalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, C 1 -C 4 -alkoxy, C 2 -C 6 -alkenyloxy, C 2 -C 6 -alkynyloxy, C 1 -C 4 -alkylthio, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, C 1 -C 4 -alkylthio-C 1 -C 4 -alkyl, wherein all carbon atoms of the aforementioned 10 radicals are unsubstituted or may be partially of fully halogenated, NO 2 , CN, NR c R f , C(O)R c , C(S)R c , C(O)OR a , C(O)NR a R b , C(S)NR a R b  or S(O) m R c , S(O) m NR a R b , phenyl, heteroaryl, phenyl-C 1 -C 4 -alkyl and heteroaryl-C 1 -C 4 -alkyl,
           wherein the rings of the four last mentioned radicals may carry 1, 2, 3, 4 or 5 substituents, which, independently from each other are selected from halogen, NO 2 , CN, C 1 -C 4 -alkoxy and C 1 -C 4 -haloalkoxy;   
           R c , R f  are selected independently from one another from the group consisting of hydrogen, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -alkenyl, C 3 -C 6 -haloalkenyl, C 3 -C 6 -alkynyl, C(O)R c , C(O)OR a , C(O)NR a R b  and C(S)NR a R b ;   n, m are each independently from one another integers selected from 0, 1 or 2;   and/or their enantiomers or diastereomers or agriculturally or veterinary acceptable salts.       

     Such N-substituted hetero-bicyclic compounds according to the present invention have not yet been described for combating animal pests. 
     Substituted imidazo-pyrimidinium compounds having insecticidal activity are described in WO2011/017342. Pesticidal Iminoimidazoles are discussed in DE 10119423. 
     Substituted enamino(thio)carbonyl compounds having pesticidal activity are described in DE 10 2006 015 467, DE 10 2006 015 470, WO2007/115647 and WO2009/121507. 
     Substituted bicyclic enamino(thio)carbonyl compounds and their use as insecticides are disclosed in WO2012/136751 and WO 2012/152741. 
     The N-substituted hetero-bicyclic compounds of the formula I, and their agriculturally acceptable salts are highly active against animal pest, i.e. harmful arthropodes and nematodes, especially against difficult to control insects and acaridae. 
     Accordingly, the present invention relates to N-substituted hetero-bicyclic compounds of the general formula I, to their agriculturally or veterinarily useful salts, their enantiomers or diasteromers. 
     Moreover, the present invention relates to and includes the following embodiments:
         agricultural and veterinary compositions comprising an amount of at least one compound of the formula I or an enantiomer, diasteromer or salt thereof;   the use of a compound of formula I or an enantiomer, diasteromer or salt thereof for combating animal pests;   a method of combating animal pests which comprises contacting the animal pests, their habit, breeding ground, food supply, plant, seed, soil, area, material or environment in which the animal pests are growing or may grow, or the materials, plants, seeds, soils, surfaces or spaces to be protected from animal attack or infestation with a pesticidally effective amount of at least one compound of the formula I or an enantiomer, diasteromer or salt thereof;   a method for protecting crops from attack or infestation by animal pests, which comprises contacting a crop with a pesticidally effective amount of at least one compound of the formula I or an enantiomer, diasteromer or salt thereof;   a method for the protection of plant propagation, especially seeds, from soil insects and of the seedlings&#39; roots and shoots from soil and foliar insects comprising contacting the seeds before sowing and/or after pregermination with at least one compound of the formula I, or the enantiomers, diastereomers or salts thereof;   seeds comprising a compound of the formula I or an enantiomer, diasteromer or salt thereof;   the use of compounds of formula I or the enantiomers, diastereomers or veterinary acceptable salts thereof for combating parasites in and on animals.   a method for treating, controlling, preventing or protecting animals against infestation or infection by parasites which comprises orally, topically or parenterally administering or applying to the animals a parasiticidally effective amount of an compound of formula I or the enantiomers, diastereomers and/or veterinary acceptable salt thereof;   a process for the preparation of a veterinary composition for treating, controlling, preventing or protecting animals against infestation or infection by parasites which comprises adding a parasiticidally effective amount of an compound of formula I or the enantiomers, diastereomers and/or veterinary acceptable salt thereof to a carrier composition suitable for veterinary use;   the use of a compound of formula I or the enantiomers, diastereomers and/or veterinary acceptable salt thereof for the preparation of a medicament for treating, controlling, preventing or protecting animals against infestation or infection by parasites;       

     The present invention especially relates to plant propagation materials, in particular as mentioned above to seeds, comprising at least one compound of formula I and/or an agriculturally acceptable salt thereof. 
     The present invention relates to every possible stereoisomer of the compounds of formula I, i.e. to single enantiomers or diastereomers, as well as to mixtures thereof. 
     The compounds of the present invention may be amorphous or may exist in one ore more different crystalline states (polymorphs) or modifications which may have a different macroscopic properties such as stability or show different biological properties such as activities. The present invention includes both amorphous and crystalline compounds of the formula I, mixtures of different crystalline states or modifications of the respective compound I, as well as amorphous or crystalline salts thereof. 
     Salts of the compounds of the formula I are preferably agriculturally and/or veterinary acceptable salts. They can be formed in a customary method, e.g. by reacting the compound with an acid of the anion in question if the compound of formula I has a basic functionality or by reacting an acidic compound of formula I with a suitable base. 
     Suitable agriculturally or veterinary useful salts are especially the salts of those cations or the acid addition salts of those acids whose cations and anions, respectively, do not have any adverse effect on the action of the compounds according to the present invention. Suitable cations are in particular the ions of the alkali metals, preferably lithium, sodium and potassium, of the alkaline earth metals, preferably calcium, magnesium and barium, and of the transition metals, preferably manganese, copper, zinc and iron, and also ammonium (NH 4     +   ) and substituted ammonium in which one to four of the hydrogen atoms are replaced by C 1 -C 4 -alkyl, C 1 -C 4 -hydroxyalkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, hydroxy-C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, phenyl or benzyl. Examples of substituted ammonium ions comprise methylammonium, isopropylammonium, dimethylammonium, diisopropylammonium, trimethylammonium, tetramethylammonium, tetraethylammonium, tetrabutylammonium, 2-hydroxyethylammonium, 2-(2-hydroxyethoxy)ethyl-ammonium, bis(2-hydroxyethyl)ammonium, benzyltrimethylammonium and benzyltriethylammonium, furthermore phosphonium ions, sulfonium ions, preferably tri(C 1 -C 4 -alkyl)sulfonium, and sulfoxonium ions, preferably tri(C 1 -C 4 -alkyl)sulfoxonium. 
     Anions of useful acid addition salts are primarily chloride, bromide, fluoride, hydrogen sulfate, sulfate, dihydrogen phosphate, hydrogen phosphate, phosphate, nitrate, hydrogen carbonate, carbonate, hexafluorosilicate, hexafluorophosphate, benzoate, and the anions of C 1 -C 4 -alkanoic acids, preferably formate, acetate, propionate and butyrate. They can be formed by reacting the compounds of the formulae I with an acid of the corresponding anion, preferably of hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid or nitric acid. 
     The organic moieties mentioned in the above definitions of the variables are—like the term halogen—collective terms for individual listings of the individual group members. The prefix C n -C m  indicates in each case the possible number of carbon atoms in the group. 
     “Halogen” will be taken to mean fluoro, chloro, bromo and iodo. 
     The term “partially or fully halogenated” will be taken to mean that 1 or more, e.g. 1, 2, 3, 4 or 5 or all of the hydrogen atoms of a given radical have been replaced by a halogen atom, in particular by fluorine or chlorine. 
     The term “C n -C m -alkyl” as used herein (and also in C n -C m -alkylamino, di-C n -C m -alkylamino, C n -C m -alkylaminocarbonyl, di-(C n -C m -alkylamino)carbonyl, C n -C m -alkylthio, C n -C m -alkylsulfinyl and C n -C m -alkylsulfonyl) refers to a branched or unbranched saturated hydrocarbon group having n to m, e.g. 1 to 10 carbon atoms, preferably 1 to 6 carbon atoms, for example methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, 1,1-dimethylethyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, hexyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1,1,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethyl-1-methylpropyl, 1-ethyl-2-methylpropyl, heptyl, octyl, 2-ethylhexyl, nonyl and decyl and their isomers. C 1 -C 4 -alkyl means for example methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl or 1,1-dimethylethyl. 
     The term “C n -C m -haloalkyl” as used herein (and also in C n -C m -haloalkylsulfinyl and C n -C m -haloalkylsulfonyl) refers to a straight-chain or branched alkyl group having n to m carbon atoms, e.g. 1 to 10 in particular 1 to 6 carbon atoms (as mentioned above), where some or all of the hydrogen atoms in these groups may be replaced by halogen atoms as mentioned above, for example C 1 -C 4 -haloalkyl, such as chloromethyl, bromomethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoromethyl, chlorofluoromethyl, dichlorofluoromethyl, chlorodifluoromethyl, 1-chloroethyl, 1-bromoethyl, 1-fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 2-chloro-2-fluoroethyl, 2-chloro-2,2-difluoroethyl, 2,2-dichloro-2-fluoroethyl, 2,2,2-trichloroethyl, pentafluoroethyl and the like. The term C 1 -C 10 -haloalkyl in particular comprises C 1 -C 2 -fluoroalkyl, which is synonym with methyl or ethyl, wherein 1, 2, 3, 4 or 5 hydrogen atoms are substituted by fluorine atoms, such as fluoromethyl, difluoromethyl, trifluoromethyl, 1-fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl and pentafluoromethyl. 
     Similarly, “C n -C m -alkoxy” and “C n -C m -alkylthio” (or C n -C m -alkylsulfenyl, respectively) refer to straight-chain or branched alkyl groups having n to m carbon atoms, e.g. 1 to 10, in particular 1 to 6 or 1 to 4 carbon atoms (as mentioned above) bonded through oxygen or sulfur linkages, respectively, at any bond in the alkyl group. Examples include C 1 -C 4 -alkoxy such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butoxy, isobutoxy and tert-butoxy, further C 1 -C 4 -alkylthio such as methylthio, ethylthio, propylthio, isopropylthio, and n-butylthio. 
     Accordingly, the terms “C n -C m -haloalkoxy” and “C n -C m -haloalkylthio” (or C n -C m -haloalkylsulfenyl, respectively) refer to straight-chain or branched alkyl groups having n to m carbon atoms, e.g. 1 to 10, in particular 1 to 6 or 1 to 4 carbon atoms (as mentioned above) bonded through oxygen or sulfur linkages, respectively, at any bond in the alkyl group, where some or all of the hydrogen atoms in these groups may be replaced by halogen atoms as mentioned above, for example C 1 -C 2 -haloalkoxy, such as chloromethoxy, bromomethoxy, dichloromethoxy, trichloromethoxy, fluoromethoxy, difluoromethoxy, trifluoromethoxy, chlorofluoromethoxy, dichlorofluoromethoxy, chlorodifluoromethoxy, 1-chloroethoxy, 1-bromoethoxy, 1-fluoroethoxy, 2-fluoroethoxy, 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2-fluoroethoxy, 2-chloro-2,2-difluoroethoxy, 2,2-dichloro-2-fluoroethoxy, 2,2,2-trichloroethoxy and pentafluoroethoxy, further C 1 -C 2 -haloalkylthio, such as chloromethylthio, bromomethylthio, dichloromethylthio, trichloromethylthio, fluoromethylthio, difluoromethylthio, trifluoromethylthio, chlorofluoromethylthio, dichlorofluoromethylthio, chlorodifluoromethylthio, 1-chloroethylthio, 1-bromoethylthio, 1-fluoroethylthio, 2-fluoroethylthio, 2,2-difluoroethylthio, 2,2,2-trifluoroethylthio, 2-chloro-2-fluoroethylthio, 2-chloro-2,2-difluoroethylthio, 2,2-dichloro-2-fluoroethylthio, 2,2,2-trichloroethylthio and pentafluoroethylthio and the like. Similarly the terms C 1 -C 2 -fluoroalkoxy and C 1 -C 2 -fluoroalkylthio refer to C 1 -C 2 -fluoroalkyl which is bound to the remainder of the molecule via an oxygen atom or a sulfur atom, respectively. 
     The term “C 2 -C m -alkenyl” as used herein intends a branched or unbranched unsaturated hydrocarbon group having 2 to m, e.g. 2 to 10 or 2 to 6 carbon atoms and a double bond in any position, such as ethenyl, 1-propenyl, 2-propenyl, 1-methyl-ethenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-methyl-1-propenyl, 2-methyl-1-propenyl, 1-methyl-2-propenyl, 2-methyl-2-propenyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 1-methyl-1-butenyl, 2-methyl-1-butenyl, 3-methyl-1-butenyl, 1-methyl-2-butenyl, 2-methyl-2-butenyl, 3-methyl-2-butenyl, 1-methyl-3-butenyl, 2-methyl-3-butenyl, 3-methyl-3-butenyl, 1,1-dimethyl-2-propenyl, 1,2-dimethyl-1-propenyl, 1,2-dimethyl-2-propenyl, 1-ethyl-1-propenyl, 1-ethyl-2-propenyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, 5-hexenyl, 1-methyl-1-pentenyl, 2-methyl-1-pentenyl, 3-methyl-1-pentenyl, 4-methyl-1-pentenyl, 1-methyl-2-pentenyl, 2-methyl-2-pentenyl, 3-methyl-2-pentenyl, 4-methyl-2-pentenyl, 1-methyl-3-pentenyl, 2-methyl-3-pentenyl, 3-methyl-3-pentenyl, 4-methyl-3-pentenyl, 1-methyl-4-pentenyl, 2-methyl-4-pentenyl, 3-methyl-4-pentenyl, 4-methyl-4-pentenyl, 1,1-dimethyl-2-butenyl, 1,1-dimethyl-3-butenyl, 1,2-dimethyl-1-butenyl, 1,2-dimethyl-2-butenyl, 1,2-dimethyl-3-butenyl, 1,3-dimethyl-1-butenyl, 1,3-dimethyl-2-butenyl, 1,3-dimethyl-3-butenyl, 2,2-dimethyl-3-butenyl, 2,3-dimethyl-1-butenyl, 2,3-dimethyl-2-butenyl, 2,3-dimethyl-3-butenyl, 3,3-dimethyl-1-butenyl, 3,3-dimethyl-2-butenyl, 1-ethyl-1-butenyl, 1-ethyl-2-butenyl, 1-ethyl-3-butenyl, 2-ethyl-1-butenyl, 2-ethyl-2-butenyl, 2-ethyl-3-butenyl, 1,1,2-trimethyl-2-propenyl, 1-ethyl-1-methyl-2-propenyl, 1-ethyl-2-methyl-1-propenyl and 1-ethyl-2-methyl-2-propenyl. 
     The term “C 2 -C m -alkynyl” as used herein refers to a branched or unbranched unsaturated hydrocarbon group having 2 to m, e.g. 2 to 10 or 2 to 6 carbon atoms and containing at least one triple bond, such as ethynyl, propynyl, 1-butynyl, 2-butynyl, and the like. 
     The term “C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl” as used herein refers to alkyl having 1 to 4 carbon atoms, e.g. like specific examples mentioned above, wherein one hydrogen atom of the alkyl radical is replaced by an C 1 -C 4 -alkoxy group. 
     The term “C 3 -C m -cycloalkyl” as used herein refers to a monocyclic 3- to m-membered saturated cycloaliphatic radicals, e.g. cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl and cyclodecyl. 
     The term “aryl” as used herein refers to an aromatic hydrocarbon radical such as naphthyl or in particular phenyl. 
     The term “3- to 6-membered carbocyclic ring” as used herein refers to cyclopropane, cyclobutane, cyclopentane and cyclohexane rings. 
     The term “3-, 4-, 5-, 6- or 7-membered saturated, partially unsaturated or aromatic heterocyclic ring containing 1, 2 or 3 heteroatoms” or “containing heteroatom groups”, wherein those heteroatom(s) (group(s)) are selected from N, O, S, NO, SO and SO 2  and are ring members, as used herein refers to monocyclic radicals, the monocyclic radicals being saturated, partially unsaturated or aromatic. The heterocyclic radical may be attached to the remainder of the molecule via a carbon ring member or via a nitrogen ring member. 
     Examples of 3-, 4-, 5-, 6- or 7-membered saturated heterocyclyl or heterocyclic rings include: Oxiranyl, aziridinyl, azetidinyl, 2 tetrahydrofuranyl, 3-tetrahydrofuranyl, 2 tetrahydrothienyl, 3 tetrahydrothienyl, 2-pyrrolidinyl, 3-pyrrolidinyl, 3 pyrazolidinyl, 4 pyrazolidinyl, 5-pyrazolidinyl, 2 imidazolidinyl, 4 imidazolidinyl, 2-oxazolidinyl, 4-oxazolidinyl, 5 oxazolidinyl, 3-isoxazolidinyl, 4 isoxazolidinyl, 5 isoxazolidinyl, 2 thiazolidinyl, 4-thiazolidinyl, 5-thiazolidinyl, 3 isothiazolidinyl, 4-isothiazolidinyl, 5 isothiazolidinyl, 1,2,4-oxadiazolidin-3-yl, 1,2,4 oxadiazolidin 5 yl, 1,2,4-thiadiazolidin-3-yl, 1,2,4 thiadiazolidin-5-yl, 1,2,4 triazolidin-3-yl, 1,3,4-oxadiazolidin-2-yl, 1,3,4 thiadiazolidin-2-yl, 1,3,4 triazolidin-2-yl, 2-tetrahydropyranyl, 4 tetrahydropyranyl, 1,3-dioxan-5-yl, 1,4-dioxan-2-yl, 2-piperidinyl, 3-piperidinyl, 4-piperidinyl, 3-hexahydropyridazinyl, 4 hexahydropyridazinyl, 2-hexahydropyrimidinyl, 4-hexahydropyrimidinyl, 5 hexahydropyrimidinyl, 2-piperazinyl, 1,3,5-hexahydrotriazin-2-yl and 1,2,4 hexahydrotriazin-3-yl, 2-morpholinyl, 3-morpholinyl, 2-thiomorpholinyl, 3-thiomorpholinyl, 1-oxothiomorpholin-2-yl, 1-oxothiomorpholin-3-yl, 1,1-dioxothiomorpholin-2-yl, 1,1-dioxothiomorpholin-3-yl, hexahydroazepin-1-, -2-, -3- or -4-yl, hexahydrooxepinyl, hexahydro-1,3-diazepinyl, hexahydro-1,4-diazepinyl, hexahydro-1,3-oxazepinyl, hexahydro-1,4-oxazepinyl, hexahydro-1,3-dioxepinyl, hexahydro-1,4-dioxepinyl and the like. 
     Examples of 3-, 4-, 5-, 6- or 7-membered partially unsaturated heterocyclyl or heterocyclic rings include: 2,3-dihydrofur-2-yl, 2,3-dihydrofur-3-yl, 2,4-dihydrofur-2-yl, 2,4-dihydrofur-3-yl, 2,3-dihydrothien-2-yl, 2,3 dihydrothien-3-yl, 2,4 dihydrothien-2-yl, 2,4-dihydrothien-3-yl, 2-pyrrolin-2-yl, 2-pyrrolin-3-yl, 3 pyrrolin-2-yl, 3-pyrrolin-3-yl, 2-isoxazolin-3-yl, 3-isoxazolin-3-yl, 4 isoxazolin 3 yl, 2-isoxazolin-4-yl, 3-isoxazolin-4-yl, 4-isoxazolin-4-yl, 2 isoxazolin-5-yl, 3-isoxazolin-5-yl, 4-isoxazolin-5-yl, 2-isothiazolin-3-yl, 3 isothiazolin-3-yl, 4-isothiazolin-3-yl, 2-isothiazolin-4-yl, 3-isothiazolin-4-yl, 4 isothiazolin-4-yl, 2-isothiazolin-5-yl, 3-isothiazolin-5-yl, 4-isothiazolin-5-yl, 2,3 dihydropyrazol-1-yl, 2,3-dihydropyrazol-2-yl, 2,3-dihydropyrazol-3-yl, 2,3 dihydropyrazol-4-yl, 2,3-dihydropyrazol-5-yl, 3,4-dihydropyrazol-1-yl, 3,4 dihydropyrazol-3-yl, 3,4-dihydropyrazol-4-yl, 3,4-dihydropyrazol-5-yl, 4,5 dihydropyrazol-1-yl, 4,5-dihydropyrazol-3-yl, 4,5-dihydropyrazol-4-yl, 4,5 dihydropyrazol-5-yl, 2,3-dihydrooxazol-2-yl, 2,3-dihydrooxazol-3-yl, 2,3 dihydrooxazol-4-yl, 2,3-dihydrooxazol-5-yl, 3,4-dihydrooxazol-2-yl, 3,4 dihydrooxazol-3-yl, 3,4-dihydrooxazol-4-yl, 3,4-dihydrooxazol-5-yl, 3,4 dihydrooxazol-2-yl, 3,4-dihydrooxazol-3-yl, 3,4-dihydrooxazol-4-yl, 2-, 3-, 4-, 5- or 6-di- or tetrahydropyridinyl, 3-di- or tetrahydropyridazinyl, 4 di- or tetrahydropyridazinyl, 2-di- or tetrahydropyrimidinyl, 4-di- or tetrahydropyrimidinyl, 5 di- or tetrahydropyrimidinyl, di- or tetrahydropyrazinyl, 1,3,5-di- or tetrahydrotriazin-2-yl, 1,2,4-di- or tetrahydrotriazin-3-yl, 2,3,4,5-tetrahydro[1H]azepin-1-, -2-, -3-, -4-, -5-, -6- or -7-yl, 3,4,5,6-tetrahydro[2H]azepin-2-, -3-, -4-, -5-, -6- or -7-yl, 2,3,4,7 tetrahydro[1H]azepin-1-, -2-, -3-, -4-, -5-, -6- or -7-yl, 2,3,6,7 tetrahydro[1H]azepin-1-, -2-, -3-, -4-, -5-, -6- or -7-yl, tetrahydrooxepinyl, such as 2,3,4,5-tetrahydro[1H]oxepin-2-, -3-, -4-, -5-, -6- or -7-yl, 2,3,4,7 tetrahydro[1H]oxepin-2-, -3-, -4-, -5-, -6- or -7-yl, 2,3,6,7 tetrahydro[1H]oxepin-2-, -3-, -4-, -5-, -6- or -7-yl, tetrahydro-1,3-diazepinyl, tetrahydro-1,4-diazepinyl, tetrahydro-1,3-oxazepinyl, tetrahydro-1,4-oxazepinyl, tetrahydro-1,3-dioxepinyl and tetrahydro-1,4-dioxepinyl. 
     Examples of 5- or 6-membered aromatic heterocyclyl (hetaryl) or heteroaromatic rings are: 2-furyl, 3-furyl, 2-thienyl, 3-thienyl, 2-pyrrolyl, 3-pyrrolyl, 3-pyrazolyl, 4-pyrazolyl, 5-pyrazolyl, 2-oxazolyl, 4-oxazolyl, 5-oxazolyl, 2-thiazolyl, 4 thiazolyl, 5-thiazolyl, 2-imidazolyl, 4-imidazolyl, 1,3,4-triazol-2-yl, 2-pyridinyl, 3-pyridinyl, 4-pyridinyl, 3-pyridazinyl, 4-pyridazinyl, 2-pyrimidinyl, 4-pyrimidinyl, 5-pyrimidinyl and 2-pyrazinyl. 
     A “C 2 -C m -alkylene” is divalent branched or preferably unbranched saturated aliphatic chain having 2 to m, e.g. 2 to 7 carbon atoms, for example CH 2 CH 2 , —CH(CH 3 )—, CH 2 CH 2 CH 2 , CH(CH 3 )CH 2 , CH 2 CH(CH 3 ), CH 2 CH 2 CH 2 CH 2 , CH 2 CH 2 CH 2 CH 2 CH 2 , CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 , and CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 . 
     Preferences 
     Embodiments and preferred compounds of the present invention are outlined in the following paragraphs. 
     The remarks made below concerning preferred embodiments of the variables of the compounds of formula I, especially with respect to their substituents X, A, B, W 1 , W 2 , W 3 , W 4 , Het, R 1  and R 2  are valid both on their own and, in particular, in every possible combination with each other. When # appears in a formula showing a preferred substructure of a compound of the present invention, it denotes the attachment bond in the remainder molecule. 
     Preferred are compounds of formula (I), wherein Het is selected from the group consisting of radicals of formulae Het-1 to Het-24: 
                                           
and wherein # denotes the bond in formula (I), p is 0, 1 or 2, R 3  and R 8  have the meaning as defined further above.
 
     Especially preferred are compounds of formula (I), wherein Het is selected from the group consisting of radicals of formulae Het-1, Het-11a and Het-24: 
                         
wherein p and R 8  are as defined as further above. Preferably R 8  is selected from hydrogen, halogen, C 1 -C 4 -alkoxy or C 1 -C 4 -alkyl, and wherein the carbon atoms of the latter two radicals may be partially of fully halogenated, and p is 0, 1 or 2.
 
     Especially more preferred are compounds of formula (I), wherein Het is Het-1a: 
                         
and wherein R 8  is as defined as further above. Preferably R 8  is selected from hydrogen, halogen, C 1 -C 4 -alkoxy or C 1 -C 4 -alkyl, and wherein the carbon atoms of the latter two radicals may be partially of fully halogenated.
 
     Especially more preferred are compounds of formula (I), wherein Het is Het-11a: 
                         
and wherein R 8  is as defined as further above. Preferably R 8  is selected from hydrogen, halogen, C 1 -C 4 -alkoxy or C 1 -C 4 -alkyl, and wherein the carbon atoms of the latter two radicals may be partially of fully halogenated.
 
     Preferred are compounds of formula (I), wherein R 1  and R 2  are, independently from one another, selected from the group consisting of hydrogen, halogen, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl and C 3 -C 6 -cycloalkyl. 
     Preferred are compounds of formula (I), wherein X is selected from the group consisting halogen, C 1 -C 4 -haloalkyl, C 1 -C 6 -haloalkoxy and C 1 -C 4 -alkylthio. 
     Especially preferred X is selected from halogen. 
     Especially preferred X is selected from C 1 -C 4 -haloalkyl. 
     Especially preferred X is selected from C 1 -C 4 -alkylthio. 
     Especially preferred X is selected from C 1 -C 4 -haloalkoxy. 
     Preferred are compounds of formula (I), wherein A is selected from N or CH. 
     Especially preferred are compounds of formula (I), wherein A is N. 
     Preferred are compounds of formula (I), wherein B is N or CR 7 , and wherein R 7  is selected from the group consisting of hydrogen, halogen, C 1 -C 4 -alkyl and C 1 -C 4 -haloalkyl. 
     Preferred are compounds of formula (I), wherein B is CR 7 , and wherein R 7  represents a bond to the neighboring atom W 1  such that B and W 1  are connected by a double bond, and wherein W 1  is N or CR 6 , and wherein R 6  is selected from the group consisting of hydrogen, halogen C 1 -C 4 -alkyl and C 1 -C 4 -haloalkyl. 
     Preferred are compounds of formula (I), wherein W 1 , W 2 , W 3  and W 4  form together with N and B they are linked to, a saturated or unsaturated 5- or 6-membered heterocycle, wherein the group B—W 1 —W 2 —W 3 —W 4 —N together with the annulated ring forms a bicycle selected from the group of radicals of formulae II-1 to II-25: 
                                                                               
wherein R 5a , R 5b  and R 6  are selected independently from one another from the group consisting of hydrogen, halogen, C 1 -C 2 -alkyl or C 1 -C 2 -haloalkyl and A, X, Y and R 3  and n are as defined further above and # denotes the bond to the remainder of the molecule.
 
     Especially preferred are compounds of formula (I), wherein the group B—W 1 —W 2 —W 3 —W 4 —N together with the annulated ring forms a bicycle selected from the group of radicals of formulae II-1, II-2, II-5, II-6, II-7, II-10, II-17, II-20 and II-21: 
                                           
wherein # denotes the bond to the remainder of the molecule; and wherein R 5a , R 5b  and R 6  are selected preferably and independently from one another from hydrogen, halogen, C 1 -C 3 -alkyl and C 1 -C 3 -haloalkyl;
 
especially preferred R 5a , R 5b  and R 6  are selected independently from one another from hydrogen, halogen and methyl; and
 
wherein A is selected preferably from CH or N;
 
especially preferred A is N;
 
and
 
wherein X is preferably from selected from the group consisting selected from the group consisting of halogen, C 1 -C-alkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -alkylthio, CN, NO 2  and S(O) m R c , wherein the aforementioned alkyl, alkoxy and alkylthio radicals are unsubstituted, partly or completely halogenated;
 
especially preferred X is selected from the group consisting of halogen, C 1 -C 4 -haloalkyl, C 1 -C 6 -haloalkoxy and C 1 -C 4 -alkylthio;
 
especially more preferred X is selected from halogen;
 
especially more preferred X is selected from C 1 -C 4 -haloalkyl;
 
especially more preferred X is selected from C 1 -C 4 -alkylthio;
 
especially more preferred X is selected from C 1 -C 4 -haloalkoxy;
 
     Especially more preferred are compounds of formula (I), wherein the group B—W 1 —W 2 —W 3 —W 4 —N together with the annulated ring forms a bicycle radical of formulae II-1: 
                         
wherein # denotes the bond to the remainder of the molecule; and
 
wherein R 6  is selected preferably and independently from one another from hydrogen, halogen, C 1 -C 3 -alkyl and C 1 -C 3 -haloalkyl;
 
especially preferred R 6  is selected independently from one another from hydrogen, halogen and methyl; and
 
wherein A is selected preferably from CH or N; especially preferred A is N; and
 
wherein X is selected preferably from the group consisting halogen, C 1 -C 4 -haloalkyl, C 1 -C 6 -haloalkoxy and C 1 -C 4 -alkylthio;
 
especially preferred X is selected from halogen;
 
especially preferred X is selected from C 1 -C 4 -haloalkyl;
 
especially preferred X is selected from C 1 -C 4 -alkylthio.
 
especially preferred X is selected from C 1 -C 4 -haloalkoxy.
 
     Preferred are compounds of formula (I), wherein 
     Het is 
                         
wherein # denotes the bond to the remainder of the molecule; and wherein R 8  is selected from the group consisting of halogen, C 1 -C 4 -alkyl and C 1 -C 4 -haloalkyl, and p is 0, 1 or 2; and
 
wherein A is N, X is halogen or C 1 -C 4 -haloalkyl and R 1  and R 2  are independently from one another selected from the group consisting of hydrogen, methyl, ethyl and trifluoromethyl, or R 1  and R 2  form together with the carbon atom which they are attached to, a cyclopropane ring.
 
     Preferred are compounds of formula (I), wherein 
     Het is 
                         
wherein # denotes the bond to the remainder of the molecule; and wherein R 8  is selected from the group consisting of halogen and C 1 -C 4 -haloalkyl, and p is 1 or 2; and
 
wherein A is N, X is halogen or C 1 -C 4 -haloalkyl, and R 1  and R 2  are both hydrogen.
 
     Examples of especially preferred compounds of formula I are given herein below. 
     Examples of such especially preferred compounds are compounds C.I.1 to C.I.150 of formula (I-A), wherein A, X, R 1 , R 2  and Het have the meanings given in any of lines 1 to 150 of table C. 
     
       
         
         
             
             
         
       
     
     Examples of such especially preferred compounds are compounds C.I.1 to C.I.150 of formula (I-B), wherein A, X, R 1 , R 2  and Het have the meanings given in any of lines 1 to 150 of table C. 
     
       
         
         
             
             
         
       
     
     Examples of such especially preferred compounds are compounds C.I.1 to C.I.150 of formula (I-C), wherein A, X, R 1 , R 2  and Het have the meanings given in any of lines 1 to 150 of table C. 
     
       
         
         
             
             
         
       
     
     Examples of such especially preferred compounds are compounds C.I.1 to C.I.150 of formula (I-D), wherein A, X, R 1 , R 2  and Het have the meanings given in any of lines 1 to 150 of table C. 
     
       
         
         
             
             
         
       
     
     Examples of such especially preferred compounds are compounds C.I.1 to C.I.150 of formula (I-E), wherein A, X, R 1 , R 2  and Het have the meanings given in any of lines 1 to 150 of table C. 
     
       
         
         
             
             
         
       
     
     Examples of such especially preferred compounds are compounds C.I.1 to C.I.150 of formula (I-F), wherein A, X, R 1 , R 2  and Het have the meanings given in any of lines 1 to 150 of table C. 
     
       
         
         
             
             
         
       
     
     Examples of such especially preferred compounds are compounds C.I.1 to C.I.150 of formula (I-G), wherein A, X, R 1 , R 2  and Het have the meanings given in any of lines 1 to 150 of table C. 
     
       
         
         
             
             
         
       
     
     Examples of such especially preferred compounds are compounds C.I.1 to C.I.150 of formula (I-H), wherein A, X, R 1 , R 2  and Het have the meanings given in any of lines 1 to 150 of table C. 
     
       
         
         
             
             
         
       
     
     Examples of such especially preferred compounds are compounds C.I.1 to C.I.150 of formula (I-I), wherein A, X, R 1 , R 2  and Het have the meanings given in any of lines 1 to 150 of table C. 
     
       
         
         
             
             
         
       
     
     Examples of such especially preferred compounds are compounds C.I.1 to C.I.150 of formula (I-J), wherein A, X, R 1 , R 2  and Het have the meanings given in any of lines 1 to 150 of table C. 
     
       
         
         
             
             
         
       
     
     Examples of such especially preferred compounds are compounds C.I.1 to C.I.150 of formula (I-K), wherein A, X, R 1 , R 2  and Het have the meanings given in any of lines 1 to 150 of table C. 
     
       
         
         
             
             
         
       
     
     Examples of such especially preferred compounds are compounds C.I.1 to C.I.150 of formula (I-L), wherein A, X, R 1 , R 2  and Het have the meanings given in any of lines 1 to 150 of table C. 
     
       
         
         
             
             
         
       
     
     Examples of such especially preferred compounds are compounds C.I.1 to C.I.150 of formula (I-M), wherein A, X, R 1 , R 2  and Het have the meanings given in any of lines 1 to 150 of table C. 
     
       
         
         
             
             
         
       
     
     Examples of such especially preferred compounds are compounds C.I.1 to C.I.150 of formula (I-N), wherein A, X, R 1 , R 2  and Het have the meanings given in any of lines 1 to 150 of table C. 
     
       
         
         
             
             
         
       
     
     Examples of such especially preferred compounds are compounds C.I.1 to C.I.150 of formula (I-O), wherein A, X, R 1 , R 2  and Het have the meanings given in any of lines 1 to 150 of table C. 
     
       
         
         
             
             
         
       
     
     Examples of such especially preferred compounds are compounds C.I.1 to C.I.150 of formula (I-P), wherein A, X, R 1 , R 2  and Het have the meanings given in any of lines 1 to 150 of table C. 
     
       
         
         
             
             
         
       
     
     Examples of such especially preferred compounds are compounds C.I.1 to C.I.150 of formula (I-Q), wherein A, X, R 1 , R 2  and Het have the meanings given in any of lines 1 to 150 of table C. 
     
       
         
         
             
             
         
       
     
     Examples of such especially preferred compounds are compounds C.I.1 to C.I.150 of formula (I-R), wherein A, X, R 1 , R 2  and Het have the meanings given in any of lines 1 to 150 of table C. 
     
       
         
         
             
             
         
       
     
     
       
         
           
               
               
               
               
               
               
             
               
                 TABLE C 
               
               
                   
               
               
                 Compound 
                   
                   
                   
                   
                   
               
               
                 no. 
                 Het* )   
                 R 1   
                 R 2   
                 X 
                 A 
               
               
                   
               
             
            
               
                 C.I.1 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 F 
                 N 
               
               
                   
               
               
                 C.I.2 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 F 
                 N 
               
               
                   
               
               
                 C.I.3 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 F 
                 N 
               
               
                   
               
               
                 C.I.4 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 F 
                 N 
               
               
                   
               
               
                 C.I.5 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 F 
                 N 
               
               
                   
               
               
                 C.I.6 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 F 
                 N 
               
               
                   
               
               
                 C.I.7 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 Cl 
                 N 
               
               
                   
               
               
                 C.I.8 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 Cl 
                 N 
               
               
                   
               
               
                 C.I.9 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 Cl 
                 N 
               
               
                   
               
               
                 C.I.10 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 Cl 
                 N 
               
               
                   
               
               
                 C.I.11 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 Cl 
                 N 
               
               
                   
               
               
                 C.I.12 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 Cl 
                 N 
               
               
                   
               
               
                 C.I.13 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 Br 
                 N 
               
               
                   
               
               
                 C.I.14 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 Br 
                 N 
               
               
                   
               
               
                 C.I.15 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 Br 
                 N 
               
               
                   
               
               
                 C.I.16 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 Br 
                 N 
               
               
                   
               
               
                 C.I.17 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 Br 
                 N 
               
               
                   
               
               
                 C.I.18 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 Br 
                 N 
               
               
                   
               
               
                 C.I.19 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 CF 3   
                 N 
               
               
                   
               
               
                 C.I.20 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 CF 3   
                 N 
               
               
                   
               
               
                 C.I.21 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 CF 3   
                 N 
               
               
                   
               
               
                 C.I.22 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 CF 3   
                 N 
               
               
                   
               
               
                 C.I.23 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 CF 3   
                 N 
               
               
                   
               
               
                 C.I.24 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 CF 3   
                 N 
               
               
                   
               
               
                 C.I.25 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 CHF 2   
                 N 
               
               
                   
               
               
                 C.I.26 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 CHF 2   
                 N 
               
               
                   
               
               
                 C.I.27 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 CHF 2   
                 N 
               
               
                   
               
               
                 C.I.28 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 CHF 2   
                 N 
               
               
                   
               
               
                 C.I.29 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 CHF 2   
                 N 
               
               
                   
               
               
                 C.I.30 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 CHF 2   
                 N 
               
               
                   
               
               
                 C.I.31 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 H 
                 F 
                 N 
               
               
                   
               
               
                 C.I.32 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 H 
                 F 
                 N 
               
               
                   
               
               
                 C.I.33 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 H 
                 F 
                 N 
               
               
                   
               
               
                 C.I.34 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 H 
                 F 
                 N 
               
               
                   
               
               
                 C.I.35 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 H 
                 F 
                 N 
               
               
                   
               
               
                 C.I.36 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 H 
                 F 
                 N 
               
               
                   
               
               
                 C.I.37 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 H 
                 Cl 
                 N 
               
               
                   
               
               
                 C.I.38 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 H 
                 Cl 
                 N 
               
               
                   
               
               
                 C.I.39 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 H 
                 Cl 
                 N 
               
               
                   
               
               
                 C.I.40 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 H 
                 Cl 
                 N 
               
               
                   
               
               
                 C.I.41 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 H 
                 Cl 
                 N 
               
               
                   
               
               
                 C.I.42 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 H 
                 Cl 
                 N 
               
               
                   
               
               
                 C.I.43 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 H 
                 Br 
                 N 
               
               
                   
               
               
                 C.I.44 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 H 
                 Br 
                 N 
               
               
                   
               
               
                 C.I.45 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 H 
                 Br 
                 N 
               
               
                   
               
               
                 C.I.46 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 H 
                 Br 
                 N 
               
               
                   
               
               
                 C.I.47 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 H 
                 Br 
                 N 
               
               
                   
               
               
                 C.I.48 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 H 
                 Br 
                 N 
               
               
                   
               
               
                 C.I.49 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 H 
                 CF 3   
                 N 
               
               
                   
               
               
                 C.I.50 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 H 
                 CF 3   
                 N 
               
               
                   
               
               
                 C.I.51 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 H 
                 CF 3   
                 N 
               
               
                   
               
               
                 C.I.52 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 H 
                 CF 3   
                 N 
               
               
                   
               
               
                 C.I.53 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 H 
                 CF 3   
                 N 
               
               
                   
               
               
                 C.I.54 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 H 
                 CF 3   
                 N 
               
               
                   
               
               
                 C.I.55 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 H 
                 CHF 2   
                 N 
               
               
                   
               
               
                 C.I.56 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 H 
                 CHF 2   
                 N 
               
               
                   
               
               
                 C.I.57 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 H 
                 CHF 2   
                 N 
               
               
                   
               
               
                 C.I.58 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 H 
                 CHF 2   
                 N 
               
               
                   
               
               
                 C.I.59 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 H 
                 CHF 2   
                 N 
               
               
                   
               
               
                 C.I.60 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 H 
                 CHF 2   
                 N 
               
               
                   
               
               
                 C.I.61 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 CF 3   
                 F 
                 N 
               
               
                   
               
               
                 C.I.62 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 CF 3   
                 F 
                 N 
               
               
                   
               
               
                 C.I.63 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 CF 3   
                 F 
                 N 
               
               
                   
               
               
                 C.I.64 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 CF 3   
                 F 
                 N 
               
               
                   
               
               
                 C.I.65 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 CF 3   
                 F 
                 N 
               
               
                   
               
               
                 C.I.66 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 CF 3   
                 F 
                 N 
               
               
                   
               
               
                 C.I.67 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 CF 3   
                 Cl 
                 N 
               
               
                   
               
               
                 C.I.68 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 CF 3   
                 Cl 
                 N 
               
               
                   
               
               
                 C.I.69 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 CF 3   
                 Cl 
                 N 
               
               
                   
               
               
                 C.I.70 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 CF 3   
                 Cl 
                 N 
               
               
                   
               
               
                 C.I.71 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 CF 3   
                 Cl 
                 N 
               
               
                   
               
               
                 C.I.72 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 CF 3   
                 Cl 
                 N 
               
               
                   
               
               
                 C.I.73 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 CF 3   
                 Br 
                 N 
               
               
                   
               
               
                 C.I.74 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 CF 3   
                 Br 
                 N 
               
               
                   
               
               
                 C.I.75 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 CF 3   
                 Br 
                 N 
               
               
                   
               
               
                 C.I.76 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 CF 3   
                 Br 
                 N 
               
               
                   
               
               
                 C.I.77 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 CF 3   
                 Br 
                 N 
               
               
                   
               
               
                 C.I.78 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 CF 3   
                 Br 
                 N 
               
               
                   
               
               
                 C.I.79 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 CF 3   
                 CF 3   
                 N 
               
               
                   
               
               
                 C.I.80 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 CF 3   
                 CF 3   
                 N 
               
               
                   
               
               
                 C.I.81 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 CF 3   
                 CF 3   
                 N 
               
               
                   
               
               
                 C.I.82 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 CF 3   
                 CF 3   
                 N 
               
               
                   
               
               
                 C.I.83 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 CF 3   
                 CF 3   
                 N 
               
               
                   
               
               
                 C.I.84 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 CF 3   
                 CF 3   
                 N 
               
               
                   
               
               
                 C.I.85 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 CF 3   
                 CHF 2   
                 N 
               
               
                   
               
               
                 C.I.86 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 CF 3   
                 CHF 2   
                 N 
               
               
                   
               
               
                 C.I.87 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 CF 3   
                 CHF 2   
                 N 
               
               
                   
               
               
                 C.I.88 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 CF 3   
                 CHF 2   
                 N 
               
               
                   
               
               
                 C.I.89 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 CF 3   
                 CHF 2   
                 N 
               
               
                   
               
               
                 C.I.90 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 CF 3   
                 CHF 2   
                 N 
               
               
                   
               
            
           
           
               
               
               
               
               
            
               
                 C.I.91 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 2 —CH 2   
                 F 
                 N 
               
               
                   
               
               
                 C.I.92 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 2 —CH 2   
                 F 
                 N 
               
               
                   
               
               
                 C.I.93 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 2 —CH 2   
                 F 
                 N 
               
               
                   
               
               
                 C.I.94 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 2 —CH 2   
                 F 
                 N 
               
               
                   
               
               
                 C.I.95 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 2 —CH 2   
                 F 
                 N 
               
               
                   
               
               
                 C.I.96 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 2 —CH 2   
                 F 
                 N 
               
               
                   
               
               
                 C.I.97 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 2 —CH 2   
                 Cl 
                 N 
               
               
                   
               
               
                 C.I.98 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 2 —CH 2   
                 Cl 
                 N 
               
               
                   
               
               
                 C.I.99 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 2 —CH 2   
                 Cl 
                 N 
               
               
                   
               
               
                 C.I.100 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 2 —CH 2   
                 Cl 
                 N 
               
               
                   
               
               
                 C.I.101 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 2 —CH 2   
                 Cl 
                 N 
               
               
                   
               
               
                 C.I.102 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 2 —CH 2   
                 Cl 
                 N 
               
               
                   
               
               
                 C.I.103 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 2 —CH 2   
                 Br 
                 N 
               
               
                   
               
               
                 C.I.104 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 2 —CH 2   
                 Br 
                 N 
               
               
                   
               
               
                 C.I.105 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 2 —CH 2   
                 Br 
                 N 
               
               
                   
               
               
                 C.I.106 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 2 —CH 2   
                 Br 
                 N 
               
               
                   
               
               
                 C.I.107 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 2 —CH 2   
                 Br 
                 N 
               
               
                   
               
               
                 C.I.108 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 2 —CH 2   
                 Br 
                 N 
               
               
                   
               
               
                 C.I.109 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 2 —CH 2   
                 CF 3   
                 N 
               
               
                   
               
               
                 C.I.110 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 2 —CH 2   
                 CF 3   
                 N 
               
               
                   
               
               
                 C.I.111 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 2 —CH 2   
                 CF 3   
                 N 
               
               
                   
               
               
                 C.I.112 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 2 —CH 2   
                 CF 3   
                 N 
               
               
                   
               
               
                 C.I.113 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 2 —CH 2   
                 CF 3   
                 N 
               
               
                   
               
               
                 C.I.114 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 2 —CH 2   
                 CF 3   
                 N 
               
               
                   
               
               
                 C.I.115 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 2 —CH 2   
                 CHF 2   
                 N 
               
               
                   
               
               
                 C.I.116 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 2 —CH 2   
                 CHF 2   
                 N 
               
               
                   
               
               
                 C.I.117 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 2 —CH 2   
                 CHF 2   
                 N 
               
               
                   
               
               
                 C.I.118 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 2 —CH 2   
                 CHF 2   
                 N 
               
               
                   
               
               
                 C.I.119 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 2 —CH 2   
                 CHF 2   
                 N 
               
               
                   
               
               
                 C.I.120 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 2 —CH 2   
                 CHF 2   
                 N 
               
               
                   
               
            
           
           
               
               
               
               
               
               
            
               
                 C.I.121 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 CH 3   
                 F 
                 N 
               
               
                   
               
               
                 C.I.122 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 CH 3   
                 F 
                 N 
               
               
                   
               
               
                 C.I.123 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 CH 3   
                 F 
                 N 
               
               
                   
               
               
                 C.I.124 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 CH 3   
                 F 
                 N 
               
               
                   
               
               
                 C.I.125 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 CH 3   
                 F 
                 N 
               
               
                   
               
               
                 C.I.126 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 CH 3   
                 F 
                 N 
               
               
                   
               
               
                 C.I.127 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 CH 3   
                 Cl 
                 N 
               
               
                   
               
               
                 C.I.128 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 CH 3   
                 Cl 
                 N 
               
               
                   
               
               
                 C.I.129 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 CH 3   
                 Cl 
                 N 
               
               
                   
               
               
                 C.I.130 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 CH 3   
                 Cl 
                 N 
               
               
                   
               
               
                 C.I.131 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 CH 3   
                 Cl 
                 N 
               
               
                   
               
               
                 C.I.132 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 CH 3   
                 Cl 
                 N 
               
               
                   
               
               
                 C.I.133 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 CH 3   
                 Br 
                 N 
               
               
                   
               
               
                 C.I.134 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 CH 3   
                 Br 
                 N 
               
               
                   
               
               
                 C.I.135 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 CH 3   
                 Br 
                 N 
               
               
                   
               
               
                 C.I.136 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 CH 3   
                 Br 
                 N 
               
               
                   
               
               
                 C.I.137 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 CH 3   
                 Br 
                 N 
               
               
                   
               
               
                 C.I.138 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 CH 3   
                 Br 
                 N 
               
               
                   
               
               
                 C.I.139 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 CH 3   
                 CF 3   
                 N 
               
               
                   
               
               
                 C.I.140 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 CH 3   
                 CF 3   
                 N 
               
               
                   
               
               
                 C.I.141 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 CH 3   
                 CF 3   
                 N 
               
               
                   
               
               
                 C.I.142 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 CH 3   
                 CF 3   
                 N 
               
               
                   
               
               
                 C.I.143 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 CH 3   
                 CF 3   
                 N 
               
               
                   
               
               
                 C.I.144 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 CH 3   
                 CF 3   
                 N 
               
               
                   
               
               
                 C.I.145 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 CH 3   
                 CHF 2   
                 N 
               
               
                   
               
               
                 C.I.146 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 CH 3   
                 CHF 2   
                 N 
               
               
                   
               
               
                 C.I.147 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 CH 3   
                 CHF 2   
                 N 
               
               
                   
               
               
                 C.I.148 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 CH 3   
                 CHF 2   
                 N 
               
               
                   
               
               
                 C.I.149 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 CH 3   
                 CHF 2   
                 N 
               
               
                   
               
               
                 C.I.150 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 CH 3   
                 CHF 2   
                 N 
               
               
                   
               
               
                 * ) # denotes the bond to the remainder of the molecule 
               
            
           
         
       
     
     Moreover, the meanings mentioned for those individual variables in the tables are per se, independently of the combination in which they are mentioned, a particularly preferred embodiment of the substituents in question. 
     Preparation Methods 
     Compound of formula (I) according to the present invention can be prepared e.g. according the preparation methods and preparation schemes as described below. 
     Compounds of formula (I) according to the present invention can be prepared by standard methods of organic chemistry e.g. by the preparation methods and preparation schemes as described below. The definitions of n, Het, A, B, X, R 1 , R 2 , R 4 , R c , W 1 , W 2 , W 3  and W 4  of the molecular structures given in the schemes are as defined above. Room temperature means a temperature range between about 20 and 25° C. 
     Two examples of general methods for the preparation of compounds of formula (I) are shown below in Scheme A. Thus, construction of the bicyclic structural element present in compounds of formula (I) can be achieved, for example, by intramolecular alkylation of the exocyclic amino group of precursors of formula 1. Examples of suitable leaving groups (LG) in formula 1 include, but are not limited to, halogen, alkyl sulfonate or haloalkyl sulfonate. This transformation is preferably carried out in polar solvents such as acetonitrile, tetrahydrofuran or N,N-dimethylformamide in the presence of a base such as a carbonate or tertiary amine base at temperatures ranging between room temperature and the reflux temperature of the solvent. A second synthetic route to compounds of formula (I) is the intramolecular cyclization of precursors of formula 2. Suitable leaving groups (LG) include, but are not limited to, halogen, O-alkyl or S-alkyl. The reaction is preferably carried out in an inert solvent such as toluene or xylene at temperatures ranging from room temperature to 160° C. 
     
       
         
         
             
             
         
       
     
     
       
         
         
             
             
         
       
     
     Compounds of formula (Ia) containing an unsaturated element within the bicyclic structural motif can also be prepared from precursors of formula 5 by ring closing metathesis (Scheme B). To this end, dienes of formula 5 are incubated with a metathesis catalyst such as, for example, the Grubbs ruthenium or Schrock molybdenum complex catalysts following procedures well known in the art (see, for example, A. Gradillas et al., Angew. Chem. Int. Ed. 2006, 45 (37), 6086-6101 and references cited therein). Intermediates of formula 5 are accessible by incubation of amines of formula 3 with building blocks of formula 4. Suitable leaving groups LG in formula 4 include S-alkyl, O-alkyl or halogen. Amines of formula 3 can be prepared by methods known in the art; see, for example S. Patai “The Chemistry of the Amino Group” Interscience Publishers, New York, 1968. The reaction of compounds 3 and 4 to give intermediate 5 is preferably carried out in a polar solvent such as tetrahydrofuran, acetonitrile or N,N-dimethylformamide in the presence of a tertiary amine or carbonate base (such as triethyl amine or sodium carbonate, respectively) at temperatures ranging from room temperature to the reflux temperature of the solvent. A representative procedure for this transformation in given in: S. Chen et al., Bioorg. Med. Chem. Lett. 2007, 17 (8), 2134-2138. 
     
       
         
         
             
             
         
       
     
     A general method for the preparation of compounds of formula (Ib) is the alkylation of bicycles of formula 7 with an electrophile of formula 6 (Scheme C). Examples of the leaving group (LG) in formula 6 include halogen, alkyl sulfonates or fluoroalkyl sulfonates. Preferably, this transformation is carried out in a polar solvent such as acetonitrile, acetone, dichloromethane or N,N-dimethylformamide in the presence of a base such as a carbonate, a tertiary amine base or an alkali metal hydride (such as triethyl amine, sodium carbonate or sodium hydride, respectively) at temperatures between room temperature and the reflux temperature of the solvent. 
     
       
         
         
             
             
         
       
     
     Compounds of formula (Ic) featuring a structural element representing a subset of bicycles of formulae (II-1), (II-2), (II-3) or (II-4) wherein W 1 , W 2  and W 4  represent CR 6  or N can be prepared by the synthetic sequence outlined in Scheme D. Thus, bicycles of formula 10 can be prepared by N-acylation or analogous reaction of a diamino-substituted heterocycle (e.g. pyridine, pyridazine, pyrimidine, pyrazine or triazine) of formula 8 with a reagent of formula 9, followed by cyclo-condensation. Alkylation of bicycles of formula 10 with an electrophile of formula 6 gives rise to compounds of formula (Ic). Examples of the leaving group (LG) in formula 9 and 6 include halogen, alkyl sulfonates or fluoroalkyl sulfonates. Preferably, both transformation is carried out in a polar solvent such as acetonitrile, acetone, dichloromethane or N,N-dimethylformamide in the presence of a base such as a carbonate, a tertiary amine base or an alkali metal hydride (such as triethyl amine, sodium carbonate or sodium hydride, respectively) at temperatures between room temperature and the reflux temperature of the solvent. For a representative example for the N-acylation/cyclo-condensation reaction, see WO2010135568. 
     
       
         
         
             
             
         
       
     
     A synthetic route for the preparation of compounds of formulae (Ic) and (Ie) via compounds of formula (Id) that takes advantage of the regioselective alkylation of thioethers of formula 11 is shown in Scheme E. For examples of this transformation, as well as of the synthesis of compounds of formula 11, see: L. Bethge et al., Bioorg. Med. Chem. 2008, 16 (1), 114-125; Y. Liu et al., J. Heterocyclic Chem. 2010, 47 (3), 683-686; WO2000/066664. 
     Intermediates of formula 12 can be converted to their S-oxidized analogs (sulfoxides, sulfones) of formula (Ig). Suitable oxidants include, for example, meta-chloroperbenzoic acid, hydrogen peroxide or sodium hypochlorite. Depending on the nature of the sulfur substituent R c , intermediates of formula (Id) wherein X represents halogen, alkoxy, alkylthio, NH 2  or CN can be converted to products of formula (Ic) with a nucleophile HX. Preferably, this transformation is carried out in a polar solvent such as acetonitrile, dichloromethane, tetrahydrofurane or N,N-dimethylformamide in the presence of a base such as a carbonate, a tertiary amine base or an alkali metal hydride (such as triethyl amine, sodium carbonate or sodium hydride, respectively) at temperatures between room temperature and the reflux temperature of the solvent. Alternatively, compounds of formula (Id) can be converted to compounds of formula (Ie) by treatment with Cl 2 . Preferably, this transformation is carried out in an acidic medium, such as acetic acid or aqueous hydrochloric acid. 
     If individual compounds cannot be prepared via the above-described routes, they can be prepared by derivatization of other compounds (I) or by customary modifications of the synthesis routes described. 
     The reaction mixtures are worked up in the customary manner, for example by mixing with water, separating the phases, and, if appropriate, purifying the crude products by chromatography, for example on alumina or silica gel. Some of the intermediates and end products may be obtained in the form of colorless or pale brown viscous oils, which are freed or purified from volatile components under reduced pressure and at moderately elevated temperature. If the intermediates and end products are obtained as solids, they may be purified by recrystallization or digestion. 
     Pests 
     The compounds of the formula I, and their salts are in particular suitable for efficiently controlling arthropodal pests such as arachnids, myriapedes and insects as well as nematodes. 
     The compounds of the formula I are especially suitable for efficiently combating the following pests: 
     Insects from the order of the lepidopterans ( Lepidoptera ), for example  Agrotis ypsilon, Agrotis segetum, Alabama argillacea, Anticarsia gemmatalis, Argyresthia conjugella, Autographa gamma, Bupalus piniarius, Cacoecia murinana, Capua reticulana, Cheimatobia brumata, Choristoneura fumiferana, Choristoneura occidentalis, Cirphis unipuncta, Cydia pomonella, Dendrolimus pini, Diaphania nitidalis, Diatraea grandiosella, Earias insulana, Elasmopalpus lignosellus, Eupoecilia ambiguella, Evetria bouliana, Feltia subterranea, Galleria mellonella, Grapholitha funebrana, Grapholitha molesta, Heliothis armigera, Heliothis virescens, Heliothis zea, Hellula undalis, Hibernia defoliaria, Hyphantria cunea, Hyponomeuta malinellus, Keiferia lycopersicella, Lambdina fiscellana, Laphygma exigua, Leucoptera coffeella, Leucoptera scitella, Lithocolletis blancardella, Lobesia botrana, Loxostege sticticalis, Lymantna dispar, Lymantria monacha, Lyonetia clerkella, Malacosoma neustna, Mamestra brassicae, Orgyia pseudotsugata, Ostrinia nubilalis, Panolis flammea, Pectinophora gossypiella, Pendroma saucia, Phalera bucephala, Phthorimaea operculella, Phyllocnistis citrella, Pieris brassicae, Plathypena scabra, Plutella xylostella, Pseudoplusia includens, Rhyacionia frustrana, Scrobipalpula absoluta, Sitotroga cerealella, Sparganothis pillenana, Spodoptera frugiperda, Spodoptera littoralis, Spodoptera litura, Thaumatopoea pityocampa, Tortrix viridana, Trichoplusia ni  and  Zeiraphera canadensis,    
     beetles ( Coleoptera ), for example  Agrilus sinuatus, Agriotes lineatus, Agriotes obscurus, Amphimallus solstitialis, Anisandrus dispar, Anthonomus grandis, Anthonomus pomorum, Aphthona euphondae, Athous haemorrhoidals, Atomana linearis, Blastophagus piniperda, Blitophaga undata, Bruchus rufimanus, Bruchus pisorum, Bruchus lentis, Byctiscus betulae, Cassida nebulosa, Cerotoma trifurcata, Cetonia aurata, Ceuthorrhynchus assimilis, Ceuthorrhynchus napi, Chaetocnema tibialis, Conoderus vespertinus, Crioceris asparagi, Ctenicera  ssp.,  Diabrotica longicornis, Diabrotica semipunctata, Diabrotica  12- punctata Diabrotica speciosa, Diabrotica virgifera, Epilachna varivestis, Epitrix hirtipennis, Eutinobothrus brasiliensis, Hylobius abietis, Hypera brunneipennis, Hypera postica, Ips typographus, Lema bilineata, Lema melanopus, Leptinotarsa decemlineata, Limonius californicus, Lissorhoptrus oryzophilus, Melanotus communis, Meligethes aeneus, Melolontha hippocastani, Melolontha melolontha, Oulema oryzae, Otiorrhynchus sulcatus, Otiorrhynchus ovatus, Phaedon cochleanae, Phyllobius pyri, Phyllotreta chrysocephala, Phyllophaga  sp.,  Phyllopertha horticola, Phyllotreta nemorum, Phyllotreta striolata, Popilia japonica, Sitona lineatus  and  Sitophilus granaria;    
     flies, mosquitoes (Diptera), e.g.  Aedes aegypti, Aedes albopictus, Aedes vexans, Anastrepha ludens, Anopheles maculipennis, Anopheles crucians, Anopheles albimanus, Anopheles gambiae, Anopheles freeborni, Anopheles leucosphyrus, Anopheles minimus, Anopheles quadrimaculatus, Calliphora vicina, Ceratitis capitata, Chrysomya bezziana, Chrysomya hominivorax, Chrysomya macellaria, Chrysops discalis, Chrysops silacea, Chrysops atlanticus, Cochliomyia hominivorax, Contarinia sorghicola Cordylobia anthropophaga, Culicoides furens, Culex pipiens, Culex nigripalpus, Culex quinquefasciatus, Culex tarsalis, Culiseta inornata, Culiseta melanura, Dacus cucurbitae, Dacus oleae, Dasineura brassicae, Delia antique, Delia coarctata, Delia platura, Delia radicum, Dermatobia hominis, Fannia canicularis, Geomyza Tripunctata, Gasterophilus intestinalis, Glossina morsitans, Glossina palpalis, Glossina fuscipes, Glossina tachinoides, Haematobia irritans, Haplodiplosis equestris, Hippelates  spp.,  Hylemyia platura, Hypoderma lineata, Leptoconops torrens, Liriomyza sativae, Liriomyza trifolii, Lucilia caprina, Lucilia cuprina, Lucilia sericata, Lycoria pectoralis, Mansonia titillanus, Mayetiola destructor, Musca autumnalis, Musca domestica, Muscina stabulans, Oestrus ovis, Opomyza forum, Oscinella frit, Pegomya hysocyami, Phorbia antiqua, Phorbia brassicae, Phorbia coarctata, Phlebotomus argentipes, Psorophora columbiae, Psila rosae, Psorophora discolor, Prosimulium mixtum, Rhagoletis cerasi, Rhagoletis pomonella, Sarcophaga haemorrhoidalis, Sarcophaga  spp.,  Simulium vittatum, Stomoxys calcitrans, Tabanus bovinus, Tabanus atratus, Tabanus lineola , and  Tabanus similis, Tipula oleracea , and  Tipula paludosa;    
     trips (Thysanoptera), e.g.  Dichromothrips corbetti, Dichromothrips  ssp.,  Frankliniella fusca, Frankliniella occidentalis, Frankliniella tritici, Scirtothrips citri, Thrips oryzae, Thrips palmi  and  Thrips tabaci,    
     termites ( Isoptera ), e.g.  Calotermes flavicollis, Leucotermes flavipes, Heterotermes aureus, Reticulitermes flavipes, Reticulitermes virginicus, Reticulitermes lucifugus, Reticulitermes santonensis, Reticulitermes grassei, Termes natalensis , and  Coptotermes formosanus;    
     cockroaches (Blattaria-Blattodea), e.g.  Blattella germanica, Blattella asahinae, Periplaneta americana, Periplaneta japonica, Periplaneta brunnea, Periplaneta fuligginosa, Periplaneta australasiae , and  Blatta orientalis;    
     bugs, aphids, leafhoppers, whiteflies, scale insects, cicadas (Hemiptera), e.g.  Acrosternum hilare, Blissus leucopterus, Cyrtopeltis notatus, Dysdercus cingulatus, Dysdercus intermedius, Eurygaster integriceps, Euschistus impictiventris, Leptoglossus phyllopus, Lygus lineolaris, Lygus pratensis, Nezara viridula, Piesma quadrata, Solubea insularis, Thyanta perditor, Acyrthosiphon onobrychis, Adelges laricis, Aphidula nasturtii, Aphis fabae, Aphis forbesi, Aphis pomi, Aphis gossypii, Aphis grossulanae, Aphis schneideri, Aphis spiraecola, Aphis sambuci, Acyrthosiphon pisum, Aulacorthum solani, Bemisia argentifolii, Brachycaudus cardui, Brachycaudus helichrysi, Brachycaudus persicae, Brachycaudus prunicola, Brevicoryne brassicae, Capitophorus horni, Cerosipha gossypii, Chaetosiphon fragaefolii, Cryptomyzus ribis, Dreyfusia nordmannianae, Dreyfusia piceae, Dysaphis radicola, Dysaulacorthum pseudosolani, Dysaphis plantaginea, Dysaphis pyri, Empoasca fabae, Hyalopterus pruni, Hyperomyzus lactucae, Macrosiphum avenae, Macrosiphum euphorbiae, Macrosiphon rosae, Megoura viciae, Melanaphis pyrarius, Metopolophium dirhodum, Myzus persicae, Myzus ascalonicus, Myzus cerasi, Myzus varians, Nasonovia ribis - nigri, Nilaparvata lugens, Pemphigus bursarius, Perkinsiella saccharicida, Phorodon humuli, Psylla mali, Psylla piri, Rhopalomyzus ascalonicus, Rhopalosiphum maidis, Rhopalosiphum padi, Rhopalosiphum insertum, Sappaphis mala, Sappaphis mali, Schizaphis graminum, Schizoneura lanuginosa, Sitobion avenae, Trialeurodes vaporariorum, Toxoptera aurantiiand, Viteus vitifolii, Cimex lectularius, Cimex hemipterus, Reduvius senilis, Triatoma  spp., and  Arilus critatus;    
     ants, bees, wasps, sawflies ( Hymenoptera ), e.g.  Athalia rosae, Atta cephalotes, Atta capiguara, Atta cephalotes, Atta laevigata, Atta robusta, Atta sexdens, Atta texana, Crematogaster  spp.,  Hoplocampa minuta, Hoplocampa testudinea, Lasius niger, Monomorium pharaonis, Solenopsis geminata, Solenopsis invicta, Solenopsis richteri, Solenopsis xyloni, Pogonomyrmex barbatus, Pogonomyrmex californicus, Pheidole megacephala, Dasymutilla occidentalis, Bombus  spp.,  Vespula squamosa, Paravespula vulgaris, Paravespula pennsylvanica, Paravespula germanica, Dolichovespula maculata, Vespa crabro, Polistes rubiginosa, Camponotus flondanus , and  Linepithema humile;    
     crickets, grasshoppers, locusts ( Orthoptera ), e.g.  Acheta domestica, Gryllotalpa Locusta migratoria, Melanoplus bivittatus, Melanoplus femurrubrum, Melanoplus mexicanus, Melanoplus sanguinipes, Melanoplus spretus, Nomadacris septemfasciata, Schistocerca americana, Schistocerca gregaria, Dociostaurus maroccanus, Tachycines asynamorus, Oedaleus senegalensis, Zonozerus variegatus, Hieroglyphus daganensis, Kraussaria angulifera, Calliptamus italicus, Chortoicetes terminifera , and  Locustana pardalina,    
     arachnoidea, such as arachnids ( Acarina ), e.g. of the families Argasidae, Ixodidae and Sarcoptidae, such as  Amblyomma americanum, Amblyomma variegatum, Ambryomma maculatum, Argas persicus, Boophilus annulatus, Boophilus decoloratus, Boophilus microplus, Dermacentor silvarum, Dermacentor andersoni, Dermacentor variabilis, Hyalomma truncatum, Ixodes ricinus, Ixodes rubicundus, Ixodes scapularis, Ixodes holocyclus, Ixodes pacificus, Ornithodorus moubata, Ornithodorus hermsi, Ornithodorus turicata, Ornithonyssus bacoti, Otobius megnini, Dermanyssus gallinae, Psoroptes ovis, Rhipicephalus sanguineus, Rhipicephalus appendiculatus, Rhipicephalus evertsi, Sarcoptes scabiei , and Eriophyidae spp. such as  Aculus schlechtendali, Phyllocoptrata oleivora  and  Eriophyes sheldoni , Tarsonemidae spp. such as  Phytonemus pallidus  and  Polyphagotarsonemus latus ; Tenuipalpidae spp. such as  Brevipalpus phoenicis ; Tetranychidae spp. such as  Tetranychus cinnabarinus, Tetranychus kanzawai, Tetranychus pacificus, Tetranychus telarius  and  Tetranychus urticae, Panonychus ulmi, Panonychus citri , and  Oligonychus pratensis , Araneida, e.g.  Latrodectus mactans , and  Loxosceles reclusa;    
     fleas (Siphonaptera), e.g.  Ctenocephalides felis, Ctenocephalides canis, Xenopsylla cheopis, Pulex irritans, Tunga penetrans , and  Nosopsyllus fasciatus,    
     silverfish, firebrat ( Thysanura ), e.g.  Lepisma saccharina  and  Thermobia domestica,    
     centipedes ( Chilopoda ), e.g.  Scutigera coleoptrata,    
     millipedes ( Diplopoda ), e.g.  Narceus  spp., 
     Earwigs ( Dermaptera ), e.g.  forficula auricularia,    
     lice (Phthiraptera), e.g.  Pediculus humanus capitis, Pediculus humanus corporis, Pthirus pubis, Haematopinus eurysternus, Haematopinus suis, Linognathus vituli, Bovicola bovis, Menopon gallinae, Menacanthus stramineus  and  Solenopotes capillatus.    
     Collembola (springtails), e.g.  Onychiurus  ssp. 
     They are also suitable for controlling Nematodes: plant parasitic nematodes such as root knot nematodes,  Meloidogyne hapla, Meloidogyne incognita, Meloidogyne javanica , and other  Meloidogyne  species; cyst-forming nematodes,  Globodera rostochiensis  and other  Globodera  species;  Heterodera avenae, Heterodera glycines, Heterodera schachtii, Heterodera trifolii , and other  Heterodera  species; Seed gall nematodes,  Anguina  species; Stem and foliar nematodes,  Aphelenchoides  species; Sting nematodes,  Belonolaimus longicaudatus  and other  Belonolaimus  species; Pine nematodes,  Bursaphelenchus xylophilus  and other  Bursaphelenchus  species; Ring nematodes,  Criconema  species,  Criconemella  species,  Criconemoides  species,  Mesocriconema  species; Stem and bulb nematodes,  Ditylenchus destructor, Ditylenchus dipsaci  and other  Ditylenchus  species; Awl nematodes,  Dolichodorus  species; Spiral nematodes,  Heliocotylenchus multicinctus  and other  Helicotylenchus  species; Sheath and sheathoid nematodes,  Hemicycliophora  species and  Hemicriconemoides  species;  Hirshmanniella  species; Lance nematodes,  Hoploaimus  species; false rootknot nematodes, Nacobbus species; Needle nematodes,  Longidorus elongatus  and other  Longidorus  species; Lesion nematodes,  Pratylenchus neglectus, Pratylenchus penetrans, Pratylenchus curvitatus, Pratylenchus goodeyi  and other  Pratylenchus  species; Burrowing nematodes,  Radopholus similis  and other  Radopholus  species; Reniform nematodes,  Rotylenchus robustus  and other  Rotylenchus  species;  Scutellonema  species; Stubby root nematodes,  Trichodorus primitivus  and other  Trichodorus  species,  Paratrichodorus  species; Stunt nematodes,  Tylenchorhynchus claytoni, Tylenchorhynchus dubius  and other  Tylenchorhynchus  species; Citrus nematodes,  Tylenchulus  species; Dagger nematodes,  Xiphinema  species; and other plant parasitic nematode species. 
     The compounds of the formula I and their salts are also useful for controlling arachnids (Arachnoidea), such as acarians ( Acarina ), e.g. of the families Argasidae, Ixodidae and Sarcoptidae, such as  Amblyomma americanum, Amblyomma variegatum, Argas persicus, Boophilus annulatus, Boophilus decoloratus, Boophilus microplus, Dermacentor silvarum, Hyalomma truncatum, Ixodes ricinus, Ixodes rubicundus, Ornithodorus moubata, Otobius megnini, Dermanyssus gallinae, Psoroptes ovis, Rhipicephalus appendiculatus, Rhipicephalus evertsi, Sarcoptes scabiei , and Eriophyidae spp. such as  Aculus schlechtendali Phyllocoptrata oleivora  and  Eriophyes sheldoni ; Tarsonemidae spp. such as  Phytonemus pallidus  and  Polyphagotarsonemus latus ; Tenuipalpidae spp. such as  Brevipalpus phoenicis ; Tetranychidae spp. such as  Tetranychus cinnabarinus, Tetranychus kanzawai, Tetranychus pacificus, Tetranychus telarius  and  Tetranychus urticae, Panonychus ulmi, Panonychus citri , and  oligonychus pratensis.    
     Compounds of the formula I are particularly useful for controlling insects, preferably sucking or piercing insects such as insects from the genera Thysanoptera, Diptera and Hemiptera, in particular the following species: 
     Thysanoptera:  Frankliniella fusca, Frankliniella occidentalis, Frankliniella tritici, Scirtothrips citri, Thrips oryzae, Thrips palmi  and  Thrips tabaci,    
     Diptera, e.g.  Aedes aegypti, Aedes albopictus, Aedes vexans, Anastrepha ludens, Anopheles maculipennis, Anopheles crucians, Anopheles albimanus, Anopheles gambiae, Anopheles freeborni, Anopheles leucosphyrus, Anopheles minimus, Anopheles quadrimaculatus, Calliphora vicina, Ceratitis capitata, Chrysomya bezziana, Chrysomya hominivorax, Chrysomya macellaria, Chrysops discalis, Chrysops silacea, Chrysops atlanticus, Cochliomyia hominivorax, Contarinia sorghicola Cordylobia anthropophaga, Culicoides furens, Culex pipiens, Culex nigripalpus, Culex quinquefasciatus, Culex tarsalis, Culiseta inornata, Culiseta melanura, Dacus cucurbitae, Dacus oleae, Dasineura brassicae, Delia antique, Delia coarctata, Delia platura, Delia radicum, Dermatobia hominis, Fannia canicularis, Geomyza Tripunctata, Gasterophilus intestinalis, Glossina morsitans, Glossina palpalis, Glossina fuscipes, Glossina tachinoides, Haematobia irritans, Haplodiplosis equestris, Hippelates  spp.,  Hylemyia platura, Hypoderma lineata, Leptoconops torrens, Liriomyza sativae, Liriomyza trifolii, Lucilia caprina, Lucilia cuprina, Lucilia sericata, Lycoria pectoralis, Mansonia titillanus, Mayetiola destructor, Musca autumnalis, Musca domestica, Muscina stabulans, Oestrus ovis, Opomyza florum, Oscinella frit, Pegomya hysocyami, Phorbia antiqua, Phorbia brassicae, Phorbia coarctata, Phlebotomus argentipes, Psorophora columbiae, Psila rosae, Psorophora discolor, Prosimulium mixtum, Rhagoletis cerasi, Rhagoletis pomonella, Sarcophaga haemorrhoidals, Sarcophaga  spp.,  Simulium vittatum, Stomoxys calcitrans, Tabanus bovinus, Tabanus atratus, Tabanus lineola , and  Tabanus similis, Tipula oleracea , and  Tipula paludosa;    
     Hemiptera, in particular aphids:  Acyrthosiphon onobrychis, Adelges laricis, Aphidula nasturtii, Aphis fabae, Aphis forbesi, Aphis porni, Aphis gossypii, Aphis grossulanae, Aphis schneideri, Aphis spiraecola, Aphis sambuci, Acyrthosiphon pisum, Aulacorthum solani, Brachycaudus cardui, Brachycaudus helichrysi, Brachycaudus persicae, Brachycaudus prunicola, Brevicoryne brassicae, Capitophorus horni, Cerosipha gossypii, Chaetosiphon fragaefolii, Cryptomyzus ribis, Dreyfusia nordmannianae, Dreyfusia piceae, Dysaphis radicola, Dysaulacorthum pseudosolani, Dysaphis plantaginea, Dysaphis pyri, Empoasca fabae, Hyalopterus pruni, Hyperomyzus lactucae, Macrosiphum avenae, Macrosiphum euphorbiae, Macrosiphon rosae, Megoura viciae, Melanaphis pyrarius, Metopolophium dirhodum, Myzodes persicae, Myzus ascalonicus, Myzus ceras, Myzus varians, Nasonovia ribis - nigri, Nilaparvata lugens, Pemphigus bursarius, Perkinsiella saccharicida, Phorodon humuli, Psylla mali, Psylla piri, Rhopalomyzus ascalonicus, Rhopalosiphum maidis, Rhopalosiphum padi, Rhopalosiphum insertum, Sappaphis mala, Sappaphis mali, Schizaphis graminum, Schizoneura lanuginosa, Sitobion avenae, Trialeurodes vaporariorum, Toxoptera aurantiiand , and  Viteus vitifolii.    
     Compounds of the formula I are particularly useful for controlling insects of the orders Hemiptera and Thysanoptera. 
     Formulations 
     For use in a method according to the present invention, the compounds I can be converted into the customary formulations, e.g. solutions, emulsions, suspensions, dusts, powders, pastes, granules and directly sprayable solutions. The use form depends on the particular purpose and application method. Formulations and application methods are chosen to ensure in each case a fine and uniform distribution of the compound of the formula I according to the present invention. 
     The formulations are prepared in a known manner (see e.g. for review U.S. Pat. No. 3,060,084, EP-A 707 445 (for liquid concentrates), Browning, “Agglomeration”, Chemical Engineering, Dec. 4, 1967, 147-48, Perry&#39;s Chemical Engineers Handbook, 4th Ed., McGraw-Hill, New York, 1963, pages 8-57 and et seq. WO 91/13546, U.S. Pat. No. 4,172,714, U.S. Pat. No. 4,144,050, U.S. Pat. No. 3,920,442, U.S. Pat. No. 5,180,587, U.S. Pat. No. 5,232,701, U.S. Pat. No. 5,208,030, GB 2,095,558, U.S. Pat. No. 3,299,566, Klingman, Weed Control as a Science, John Wiley and Sons, Inc., New York, 1961, Hance et al., Weed Control Handbook, 8th Ed., Blackwell Scientific Publications, Oxford, 1989 and Mollet, H., Grubemann, A., Formulation technology, Wiley VCH Verlag GmbH, Weinheim (Germany), 2001, 2. D. A. Knowles, Chemistry and Technology of Agrochemical Formulations, Kluwer Academic Publishers, Dordrecht, 1998 (ISBN 0-7514-0443-8), for example by extending the active compound with auxiliaries suitable for the formulation of agrochemicals, such as solvents and/or carriers, if desired emulsifiers, surfactants and dispersants, preservatives, antifoaming agents, anti-freezing agents, for seed treatment formulation also optionally colorants and/or binders and/or gelling agents. 
     Solvents/carriers, which are suitable, are e.g.: 
     
         
         
           
             solvents such as water, aromatic solvents (for example Solvesso products, xylene and the like), paraffins (for example mineral fractions), alcohols (for example methanol, butanol, pentanol, benzyl alcohol), ketones (for example cyclohexanone, gamma-butyrolactone), pyrrolidones (N-metyhl-pyrrolidone (NMP),N-octylpyrrolidone NOP), acetates (glycol diacetate), alkyl lactates, lactones such as g-butyrolactone, glycols, fatty acid dimethylamides, fatty acids and fatty acid esters, triglycerides, oils of vegetable or animal origin and modified oils such as alkylated plant oils. In principle, solvent mixtures may also be used. 
             carriers such as ground natural minerals and ground synthetic minerals, such as silica gels, finely divided silicic acid, silicates, talc, kaolin, attaclay, limestone, lime, chalk, bole, loess, clay, dolomite, diatomaceous earth, calcium sulfate and magnesium sulfate, magnesium oxide, ground synthetic materials, fertilizers, such as, for example, ammonium sulfate, ammonium phosphate, ammonium nitrate, ureas and products of vegetable origin, such as cereal meal, tree bark meal, wood meal and nutshell meal, cellulose powders and other solid carriers. 
           
         
       
    
     Suitable emulsifiers are nonionic and anionic emulsifiers (for example polyoxyethylene fatty alcohol ethers, alkylsulfonates and arylsulfonates). 
     Examples of dispersants are lignin-sulfite waste liquors and methylcellulose. 
     Suitable surfactants are alkali metal, alkaline earth metal and ammonium salts of lignosulfonic acid, naphthalenesulfonic acid, phenolsulfonic acid, dibutylnaphthalenesulfonic acid, alkylarylsulfonates, alkyl sulfates, alkylsulfonates, fatty alcohol sulfates, fatty acids and sulfated fatty alcohol glycol ethers, furthermore condensates of sulfonated naphthalene and naphthalene derivatives with formaldehyde, condensates of naphthalene or of naphthalenesulfonic acid with phenol and formaldehyde, polyoxyethylene octylphenyl ether, ethoxylated isooctylphenol, octylphenol, nonylphenol, alkylphenyl polyglycol ethers, tributylphenyl polyglycol ether, tristearylphenyl polyglycol ether, alkylaryl polyether alcohols, alcohol and fatty alcohol/ethylene oxide condensates, ethoxylated castor oil, polyoxyethylene alkyl ethers, ethoxylated polyoxypropylene, lauryl alcohol polyglycol ether acetal, sorbitol esters, 
     Also anti-freezing agents such as glycerin, ethylene glycol, propylene glycol and bactericides such as can be added to the formulation. 
     Suitable antifoaming agents are for example antifoaming agents based on silicon or magnesium stearate. 
     Suitable preservatives are for example dichlorophen and benzyl alcohol hemiformal 
     Suitable thickeners are compounds which confer a pseudoplastic flow behavior to the formulation, i.e. high viscosity at rest and low viscosity in the agitated stage. Mention may be made, in this context, for example, of commercial thickeners based on polysaccharides, such as Xanthan Gum® (Kelzan® from Kelco), Rhodopol®23 (Rhone Poulenc) or Veegum® (from R. T. Vanderbilt), or organic phyllosilicates, such as Attaclay® (from Engelhardt). Antifoam agents suitable for the dispersions according to the invention are, for example, silicone emulsions (such as, for example, Silikon® SRE, Wacker or Rhodorsil® from Rhodia), long-chain alcohols, fatty acids, organofluorine compounds and mixtures thereof. Biocides can be added to stabilize the compositions according to the invention against attack by microorganisms. Suitable biocides are, for example, based on isothiazolones such as the compounds marketed under the trademarks Proxel® from Avecia (or Arch) or Acticide® RS from Thor Chemie and Kathon® MK from Rohm &amp; Haas. Suitable antifreeze agents are organic polyols, for example ethylene glycol, propylene glycol or glycerol. These are usually employed in amounts of not more than 10% by weight, based on the total weight of the active compound composition. If appropriate, the active compound compositions according to the invention may comprise 1 to 5% by weight of buffer, based on the total amount of the formulation prepared, to regulate the pH, the amount and type of the buffer used depending on the chemical properties of the active compound or the active compounds. Examples of buffers are alkali metal salts of weak inorganic or organic acids, such as, for example, phosphoric acid, boronic acid, acetic acid, propionic acid, citric acid, fumaric acid, tartaric acid, oxalic acid and succinic acid. 
     Substances which are suitable for the preparation of directly sprayable solutions, emulsions, pastes or oil dispersions are mineral oil fractions of medium to high boiling point, such as kerosene or diesel oil, furthermore coal tar oils and oils of vegetable or animal origin, aliphatic, cyclic and aromatic hydrocarbons, for example toluene, xylene, paraffin, tetrahydronaphthalene, alkylated naphthalenes or their derivatives, methanol, ethanol, propanol, butanol, cyclohexanol, cyclohexanone, isophorone, strongly polar solvents, for example dimethyl sulfoxide, N-methylpyrrolidone and water. 
     Powders, materials for spreading and dusts can be prepared by mixing or concomitantly grinding the active substances with a solid carrier. 
     Granules, for example coated granules, impregnated granules and homogeneous granules, can be prepared by binding the active ingredients to solid carriers. Examples of solid carriers are mineral earths such as silica gels, silicates, talc, kaolin, attaclay, limestone, lime, chalk, bole, loess, clay, dolomite, diatomaceous earth, calcium sulfate, magnesium sulfate, magnesium oxide, ground synthetic materials, fertilizers, such as, for example, ammonium sulfate, ammonium phosphate, ammonium nitrate, ureas, and products of vegetable origin, such as cereal meal, tree bark meal, wood meal and nutshell meal, cellulose powders and other solid carriers. 
     In general, the formulations comprise from 0.01 to 95% by weight, preferably from 0.1 to 90% by weight, of the active ingredient. The active ingredients are employed in a purity of from 90% to 100%, preferably 95% to 100% (according to NMR spectrum). 
     For seed treatment purposes, respective formulations can be diluted 2-10 fold leading to concentrations in the ready to use preparations of 0.01 to 60% by weight active compound by weight, preferably 0.1 to 40% by weight. 
     The compound of formula I can be used as such, in the form of their formulations or the use forms prepared therefrom, for example in the form of directly sprayable solutions, powders, suspensions or dispersions, emulsions, oil dispersions, pastes, dustable products, materials for spreading, or granules, by means of spraying, atomizing, dusting, spreading or pouring. The use forms depend entirely on the intended purposes; they are intended to ensure in each case the finest possible distribution of the active compounds according to the invention. 
     The following are examples of formulations:
     1. Products for dilution with water. For seed treatment purposes, such products may be applied to the seed diluted or undiluted.
 
A) Water-soluble concentrates (SL, LS)
   

     10 parts by weight of the active compound is dissolved in 90 parts by weight of water or a water-soluble solvent. As an alternative, wetters or other auxiliaries are added. The active compound dissolves upon dilution with water, whereby a formulation with 10% (w/w) of active compound is obtained. 
     B) Dispersible concentrates (DC) 
     20 parts by weight of the active compound is dissolved in 70 parts by weight of cyclohexanone with addition of 10 parts by weight of a dispersant, for example polyvinylpyrrolidone. Dilution with water gives a dispersion, whereby a formulation with 20% (w/w) of active compounds is obtained. 
     C) Emulsifiable concentrates (EC) 
     15 parts by weight of the active compounds is dissolved in 7 parts by weight of xylene with addition of calcium dodecylbenzenesulfonate and castor oil ethoxylate (in each case 5 parts by weight). Dilution with water gives an emulsion, whereby a formulation with 15% (w/w) of active compounds is obtained. 
     D) Emulsions (EW, EO, ES) 
     25 parts by weight of the active compound is dissolved in 35 parts by weight of xylene with addition of calcium dodecylbenzenesulfonate and castor oil ethoxylate (in each case 5 parts by weight). This mixture is introduced into 30 parts by weight of water by means of an emulsifier machine (e.g. Ultraturrax) and made into a homogeneous emulsion. Dilution with water gives an emulsion, whereby a formulation with 25% (w/w) of active compound is obtained. 
     E) Suspensions (SC, OD, FS) 
     In an agitated ball mill, 20 parts by weight of the active compound is comminuted with addition of 10 parts by weight of dispersants, wetters and 70 parts by weight of water or of an organic solvent to give a fine active compound suspension. Dilution with water gives a stable suspension of the active compound, whereby a formulation with 20% (w/w) of active compound is obtained. 
     F) Water-dispersible granules and water-soluble granules (WG, SG) 
     50 parts by weight of the active compound is ground finely with addition of 50 parts by weight of dispersants and wetters and made as water-dispersible or water-soluble granules by means of technical appliances (for example extrusion, spray tower, fluidized bed). Dilution with water gives a stable dispersion or solution of the active compound, whereby a formulation with 50% (w/w) of active compound is obtained. 
     G) Water-dispersible powders and water-soluble powders (WP, SP, SS, WS) 
     75 parts by weight of the active compound are ground in a rotor-stator mill with addition of 25 parts by weight of dispersants, wetters and silica gel. Dilution with water gives a stable dispersion or solution of the active compound, whereby a formulation with 75% (w/w) of active compound is obtained. 
     H) Gel-Formulation (GF) 
     In an agitated ball mill, 20 parts by weight of the active compound is comminuted with addition of 10 parts by weight of dispersants, 1 part by weight of a gelling agent wetters and 70 parts by weight of water or of an organic solvent to give a fine active compound suspension. Dilution with water gives a stable suspension of the active compound, whereby a formulation with 20% (w/w) of active compound is obtained.
     2. Products to be applied undiluted for foliar applications. For seed treatment purposes, such products may be applied to the seed diluted or undiluted.
 
I) Dustable powders (DP, DS)
   

     5 parts by weight of the active compound are ground finely and mixed intimately with 95 parts by weight of finely divided kaolin. This gives a dustable product having 5% (w/w) of active compound. 
     J) Granules (GR, FG, GG, MG) 
     0.5 part by weight of the active compound is ground finely and associated with 95.5 parts by weight of carriers, whereby a formulation with 0.5% (w/w) of active compound is obtained. Current methods are extrusion, spray-drying or the fluidized bed. This gives granules to be applied undiluted for foliar use. 
     K) ULV solutions (UL) 
     10 parts by weight of the active compound is dissolved in 90 parts by weight of an organic solvent, for example xylene. This gives a product having 10% (w/w) of active compound, which is applied undiluted for foliar use. 
     Aqueous use forms can be prepared from emulsion concentrates, pastes or wettable powders (sprayable powders, oil dispersions) by adding water. To prepare emulsions, pastes or oil dispersions, the substances, as such or dissolved in an oil or solvent, can be homogenized in water by means of a wetter, tackifier, dispersant or emulsifier. Alternatively, it is possible to prepare concentrates composed of active substance, wetter, tackifier, dispersant or emulsifier and, if appropriate, solvent or oil, and such concentrates are suitable for dilution with water. 
     The active ingredient concentrations in the ready-to-use products can be varied within relatively wide ranges. In general, they are from 0.0001 to 10%, preferably from 0.01 to 1%. 
     The active ingredients may also be used successfully in the ultra-low-volume process (ULV), it being possible to apply formulations comprising over 95% by weight of active ingredient, or even to apply the active ingredient without additives. 
     In the method of this invention compounds I may be applied with other active ingredients, for example with other pesticides, insecticides, herbicides, fertilizers such as ammonium nitrate, urea, potash, and superphosphate, phytotoxicants and plant growth regulators, safeners and nematicides. These additional ingredients may be used sequentially or in combination with the above-described compositions, if appropriate also added only immediately prior to use (tank mix). For example, the plant(s) may be sprayed with a composition of this invention either before or after being treated with other active ingredients. 
     The following list M of pesticides, categorized and classified according to the Insecticde Resistance Action Committee (IRAC), together with which the compounds according to the invention can be used and with which potential synergistic effects might be produced, is intended to illustrate the possible combinations, but not to impose any limitation: 
     M.1 Acetylcholine esterase (AChE) inhibitors from the class of 
     M.1A carbamates, for example aldicarb, alanycarb, bendiocarb, benfuracarb, butocarboxim, butoxycarboxim, carbaryl, carbofuran, carbosulfan, ethiofencarb, fenobucarb, formetanate, furathiocarb, isoprocarb, methiocarb, methomyl, metolcarb, oxamyl, pirimicarb, propoxur, thiodicarb, thiofanox, trimethacarb, XMC, xylylcarb and triazamate; or from the class of
 
M.1B organophosphates, for example acephate, azamethiphos, azinphos-ethyl, azinphosmethyl, cadusafos, chlorethoxyfos, chlorfenvinphos, chlormephos, chlorpyrifos, chlorpyrifos-methyl, coumaphos, cyanophos, demeton-S-methyl, diazinon, dichlorvos/DDVP, dicrotophos, dimethoate, dimethylvinphos, disulfoton, EPN, ethion, ethoprophos, famphur, fenamiphos, fenitrothion, fenthion, fosthiazate, heptenophos, imicyafos, isofenphos, isopropyl O-(methoxyaminothiophosphoryl) salicylate, isoxathion, malathion, mecarbam, methamidophos, methidathion, mevinphos, monocrotophos, naled, omethoate, oxydemeton-methyl, parathion, parathion-methyl, phenthoate, phorate, phosalone, phosmet, phosphamidon, phoxim, pirimiphos-methyl, profenofos, propetamphos, prothiofos, pyraclofos, pyridaphenthion, quinalphos, sulfotep, tebupirimfos, temephos, terbufos, tetrachlorvinphos, thiometon, triazophos, trichlorfon and vamidothion;
 
M.2. GABA-gated chloride channel antagonists such as:
 
M.2A cyclodiene organochlorine compounds, as for example endosulfan or chlordane; or
 
M.2B fiproles (phenylpyrazoles), as for example ethiprole, fipronil, flufiprole, pyrafluprole and pyriprole;
 
M.3 Sodium channel modulators from the class of
 
M.3A pyrethroids, for example acrinathrin, allethrin, d-cis-trans allethrin, d-trans allethrin, bifenthrin, bioallethrin, bioallethrin S-cylclopentenyl, bioresmethrin, cycloprothrin, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, gamma-cyhalothrin, cypermethrin, alpha-cypermethrin, beta-cypermethrin, theta-cypermethrin, zeta-cypermethrin, cyphenothrin, deltamethrin, empenthrin, esfenvalerate, etofenprox, fenpropathrin, fenvalerate, flucythrinate, flumethrin, tau-fluvalinate, halfenprox, imiprothrin, meperfluthrin, metofluthrin, permethrin, phenothrin, prallethrin, profluthrin, pyrethrin (pyrethrum), resmethrin, silafluofen, tefluthrin, tetra-methylfluthrin, tetramethrin, tralomethrin and transfluthrin; or
 
M.3B sodium channel modulators such as DDT or methoxychlor;
 
M.4 Nicotinic acetylcholine receptor agonists (nAChR) from the class of
 
M.4A neonicotinoids, for example acteamiprid, chlothianidin, dinotefuran, imidacloprid, nitenpyram, thiacloprid and thiamethoxam; or M.4B nicotine.
 
M.5 Nicotinic acetylcholine receptor allosteric activators from the class of spinosyns,
 
for example spinosad or spinetoram;
 
M.6 Chloride channel activators from the class of avermectins and milbemycins, for example abamectin, emamectin benzoate, ivermectin, lepimectin or milbemectin;
 
M.7 Juvenile hormone mimics, such as
 
M.7A juvenile hormone analogues as hydroprene, kinoprene and methoprene; or others as
 
M.7B fenoxycarb or M.7C pyriproxyfen;
 
M.8 miscellaneous non-specific (multi-site) inhibitors, for example
 
M.8A alkyl halides as methyl bromide and other alkyl halides, or
 
M.8B chloropicrin, or M.8C sulfuryl fluoride, or M.8D borax, or M.8E tartar emetic;
 
M.9 Selective homopteran feeding blockers, for example
 
M.9B pymetrozine, or M.9C flonicamid;
 
M.10 Mite growth inhibitors, for example
 
M.10A clofentezine, hexythiazox and diflovidazin, or M.10B etoxazole;
 
M.11 Microbial disruptors of insect midgut membranes, for example  bacillus thuringiensis  or  bacillus sphaericus  and the insecticdal proteins they produce such as  bacillus thuringiensis  subsp.  israelensis, bacillus sphaericus, bacillus thuringiensis  subsp.  aizawai, bacillus thuringiensis  subsp.  kurstaki  and  bacillus thuringiensis  subsp.  tenebrionis , or the Bt crop proteins: Cry1Ab, Cry1Ac, Cry1Fa, Cry2Ab, mCry3A, Cry3Ab, Cry3Bb and Cry34/35Ab1;
 
M.12 Inhibitors of mitochondrial ATP synthase, for example
 
M.12A diafenthiuron, or
 
M.12B organotin miticides such as azocyclotin, cyhexatin or fenbutatin oxide, or M.12C propargite, or M.12D tetradifon;
 
M.13 Uncouplers of oxidative phosphorylation via disruption of the proton gradient, for example chlorfenapyr, DNOC or sulfluramid;
 
M.14 Nicotinic acetylcholine receptor (nAChR) channel blockers, for example nereistoxin analogues as bensultap, cartap hydrochloride, thiocyclam or thiosultap sodium;
 
M.15 Inhibitors of the chitin biosynthesis type 0, such as benzoylureas as for example bistrifluron, chlorfluazuron, diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, teflubenzuron or triflumuron;
 
M.16 Inhibitors of the chitin biosynthesis type 1, as for example buprofezin;
 
M.17 Moulting disruptors, Dipteran, as for example cyromazine;
 
M.18 Ecdyson receptor agonists such as diacylhydrazines, for example methoxyfenozide, tebufenozide, halofenozide, fufenozide or chromafenozide;
 
M.19 Octopamin receptor agonists, as for example amitraz;
 
M.20 Mitochondrial complex III electron transport inhibitors, for example
 
M.20A hydramethylnon, or M.20B acequinocyl, or M.20C fluacrypyrim;
 
M.21 Mitochondrial complex I electron transport inhibitors, for example
 
M.21A METI acaricides and insecticides such as fenazaquin, fenpyroximate, pyrimidifen, pyridaben, tebufenpyrad or tolfenpyrad, or M.21B rotenone;
 
M.22 Voltage-dependent sodium channel blockers, for example
 
M.22A indoxacarb, or M.22B metaflumizone;
 
M.23 Inhibitors of the of acetyl CoA carboxylase, such as Tetronic and Tetramic acid derivatives, for example spirodiclofen, spiromesifen or spirotetramat;
 
M.24 Mitochondrial complex IV electron transport inhibitors, for example
 
M.24A phosphine such as aluminium phosphide, calcium phosphide, phosphine or zinc phosphide, or M.24B cyanide.
 
M.25 Mitochondrial complex II electron transport inhibitors, such as beta-ketonitrile derivatives, for example cyenopyrafen or cyflumetofen;
 
M.28 Ryanodine receptor-modulators from the class of diamides, as for example flubendiamide, chlorantraniliprole (Rynaxypyr®), cyantraniliprole (Cyazypyr®), or the phthalamide compounds
 
M.28.1: (R)-3-Chlor-N1-{2-methyl-4-[1,2,2,2-tetrafluor-1-(trifluormethyl)ethyl]phenyl}-N2-(1-methyl-2-methylsulfonylethyl)phthalamid and
 
M.28.2: (S)-3-Chlor-N1-{2-methyl-4-[1,2,2,2-tetrafluor-1-(trifluormethyl)ethyl]phenyl}-N2-(1-methyl-2-methylsulfonylethyl)phthalamid, or the compound
 
M.28.3: 3-bromo-N-{2-bromo-4-chloro-6-[(1-cyclopropylethyl)carbamoyl]phenyl}-1-(3-chlorpyridin-2-yl)-1H-pyrazole-5-carboxamide (proposed ISO name: cyclaniliprole), or the compound
 
M.28.4: methyl-2-[3,5-dibromo-2-({[3-bromo-1-(3-chlorpyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)benzoyl]-1,2-dimethylhydrazinecarboxylate; or a compound selected from M.28.5a) to M.28.5h):
 
M.28.5 a) N-[4,6-dichloro-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide;
 
M.28.5 b) N-[4-chloro-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-6-methyl-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide;
 
M.28.5 c) N-[4-chloro-2-[(di-2-propyl-lambda-4-sulfanylidene)carbamoyl]-6-methyl-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide;
 
M.28.5 d) N-[4,6-dichloro-2-[(di-2-propyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide;
 
M.28.5 e) N-[4,6-dichloro-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(difluoromethyl)pyrazole-3-carboxamide;
 
M.28.5 f) N-[4,6-dibromo-2-[(di-2-propyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide;
 
M.28.5 g) N-[4-chloro-2-[(di-2-propyl-lambda-4-sulfanylidene)carbamoyl]-6-cyano-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide;
 
M.28.5 h) N-[4,6-dibromo-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide;
 
M.UN insecticidal active compounds of unknown or uncertain mode of action, as for example azadirachtin, amidoflumet, benzoximate, bifenazate, bromopropylate, chinomethionat, cryolite, dicofol, flufenerim, flometoquin, fluensulfone, flupyradifurone, piperonyl butoxide, pyridalyl, pyrifluquinazon, sulfoxaflor, or the compound
 
M. UN.1: 4-[5-(3,5-Dichloro-phenyl)-5-trifluoromethyl-4,5-dihydro-isoxazol-3-yl]-2-methyl-N-[(2,2,2-trifluoro-ethylcarbamoyl)-methyl]-benzamide, or the compound
 
M. UN.2: cyclopropaneacetic acid, 1,1′-[(3S,4R,4aR,6S,6aS,12R,12aS,12bS)-4-[[(2-cyclopropylacetyl)oxy]methyl]-1,3,4,4a,5,6,6a,12,12a,12b-decahydro-12-hydroxy-4,6a,12b-trimethyl-11-oxo-9-(3-pyridinyl)-2H,11H-naphtho[2,1-b]pyrano[3,4-e]pyran-3,6-diyl]ester, or the compound
 
M. UN.3: 11-(4-chloro-2,6-dimethylphenyl)-12-hydroxy-1,4-dioxa-9-azadispiro[4.2.4.2]-tetradec-11-en-10-one, or the compound
 
M. UN.4: 3-(4′-fluoro-2,4-dimethylbiphenyl-3-yl)-4-hydroxy-8-oxa-1-azaspiro[4.5]dec-3-en-2-one, or the compound
 
M. UN.5: 1-[2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfinyl]phenyl]-3-(trifluoromethyl)-1H-1,2,4-triazole-5-amine, or actives on basis of  bacillus firmus  (Votivo, I-1582).
 
     The commercially available compounds of the group M listed above may be found in The Pesticide Manual, 15th Edition, C. D. S. Tomlin, British Crop Protection Council (2011) among other publications. 
     The quinoline derivative flometoquin is shown in WO2006/013896. The aminofuranone compounds flupyradifurone is known from WO 2007/115644. The sulfoximine compound sulfoxaflor is known from WO2007/149134. The isoxazoline compound M. UN.1 has been described in WO2005/085216. The pyripyropene derivative M. UN.2 has been described in WO 2006/129714. The spiroketal-substituted cyclic ketoenol derivative M. UN.3 is known from WO2006/089633 and the biphenyl-substituted spirocyclic ketoenol derivative M. UN.4 from WO2008/067911. Triazoylphenylsulfide like M. UN.5 have been described in WO2006/043635 and biological control agents on basis of  bacillus firmus  in WO2009/124707. The phthalamides M.28.1 and M.28.2 are both known from WO 2007/101540. The anthranilamide M.28.3 has been described in WO2005/077934. The hydrazide compound M.28.4 has been described in WO 2007/043677. The anthranilamides M.28.5 a) to M.28.5 h) can be prepared as described in WO 2007/006670, PCT/EP2012/065650 and PCT/EP2012/065651. 
     In another embodiment of the invention, the compounds of formula (I), or their stereoisomers, salts, tautomers and N-oxides, may also be applied with fungicides as compound II. 
     The following list F of active substances, in conjunction with which the compounds according to the invention can be used, is intended to illustrate the possible combinations but does not limit them: 
     F.I) Respiration Inhibitors 
     F.I-1) Inhibitors of complex III at Qo site: 
     strobilurins: azoxystrobin, coumethoxystrobin, coumoxystrobin, dimoxystrobin, enestroburin, fluoxastrobin, kresoxim-methyl, metominostrobin, orysastrobin, picoxystrobin, pyraclostrobin, pyrametostrobin, pyraoxystrobin, pyribencarb, triclopyricarb/chlorodincarb, trifloxystrobin, 2-[2-(2,5-dimethyl-phenoxymethyl)-phenyl]-3-methoxy-acrylic acid methyl ester and 2 (2-(3-(2,6-dichlorophenyl)-1-methyl-allylideneaminooxymethyl)-phenyl)-2-methoxyimino-N methylacetamide;
 
oxazolidinediones and imidazolinones: famoxadone, fenamidone;
 
F.I-2) Inhibitors of complex II (e.g. carboxamides):
 
carboxanilides: benodanil, benzovindiflupyr, bixafen, boscalid, carboxin, fenfuram, fenhexamid, fluopyram, flutolanil, furametpyr, isopyrazam, isotianil, mepronil, oxycarboxin, penflufen, penthiopyrad, sedaxane, tecloftalam, thifluzamide, tiadinil, 2-amino-4 methyl-thiazole-5-carboxanilide, N-(3′,4′,5′ trifluorobiphenyl-2yl)-3-difluoromethyl-1-methyl-1H-pyrazole-4 carboxamide(fluxapyroxad), N-(4′-trifluoromethylthiobiphenyl-2-yl)-3 difluoromethyl-1-methyl-1H pyrazole-4-carboxamide, N-(2-(1,3,3-trimethyl-butyl)-phenyl)-1,3-dimethyl-5 fluoro-1H-pyrazole-4 carboxamide, 3-(difluoromethyl)-1-methyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 3-(trifluoromethyl)-1-methyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 1,3-dimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 3-(trifluoromethyl)-1,5-dimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 3-(difluoromethyl)-1,5-dimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 1,3,5-trimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 3-(difluoromethyl)-1-methyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 3-(trifluoromethyl)-1-methyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 1,3-dimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 3-(trifluoromethyl)-1,5-dimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 3-(difluoromethyl)-1,5-dimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 1,3,5-trimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide;
 
F.I-3) Inhibitors of complex III at Qi site: cyazofamid, amisulbrom, [(3S,6S,7R,8R)-8-benzyl-3-[(3-acetoxy-4-methoxy-pyridine-2-carbonyl)amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl]2-methylpropanoate, [(3S,6S,7R,8R)-8-benzyl-3-[[3-(acetoxymethoxy)-4-methoxy-pyridine-2-carbonyl]amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl]2-methylpropanoate, [(3S,6S,7R,8R)-8-benzyl-3-[(3-isobutoxycarbonyloxy-4-methoxy-pyridine-2-carbonyl)amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl]2-methylpropanoate, [(3S,6S,7R,8R)-8-benzyl-3-[[3-(1,3-benzodioxol-5-ylmethoxy)-4-methoxy-pyridine-2-carbonyl]amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl]2-methylpropanoate, 3S,6S,7R,8R)-3-[[(3-hydroxy-4-methoxy-2-pyridinyl)carbonyl]amino]-6-methyl-4,9-dioxo-8-(phenylmethyl)-1,5-dioxonan-7-yl 2-methylpropanoate;
 
F.I-4) Other respiration inhibitors (complex I, uncouplers) diflumetorim; (5,8-difluoroquinazolin-4-yl)-{2-[2-fluoro-4-(4-trifluoromethylpyridin-2-yloxy)-phenyl]-ethyl}-amine; tecnazen; ametoctradin; silthiofam; nitrophenyl derivates: binapacryl, dinobuton, dinocap, fluazinam, ferimzone, nitrthalisopropyl, and including organometal compounds: fentin salts, such as fentin-acetate, fentin chloride or fentin hydroxide;
 
F.II) Sterol biosynthesis inhibitors (SBI fungicides)
 
F.II-1) C 14  demethylase inhibitors (DMI fungicides, e.g. triazoles, imidazoles) triazoles: azaconazole, bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole, diniconazole-M, epoxiconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imibenconazole, ipconazole, metconazole, myclobutanil, paclobutrazole, penconazole, propiconazole, prothioconazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole, uniconazole, 1-[rel-(2S;3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-oxiranylmethyl]-5-thiocyanato-1H-[1,2,4]triazole, 2-[rel-(2S;3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-oxiranylmethyl]-2H-[1,2,4]triazole-3-thiol;
 
imidazoles: imazalil, pefurazoate, oxpoconazole, prochloraz, triflumizole;
 
pyrimidines, pyridines and piperazines: fenarimol, nuarimol, pyrifenox, triforine, 1-[rel-(2S;3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-oxiranylmethyl]-5-thiocyanato-1H-[1,2,4]triazole, 2-[rel-(2S;3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-oxiranylmethyl]-2H-[1,2,4]triazole-3-thiol;
 
F.II-2) Delta14-reductase inhitors (Amines, e.g. morpholines, piperidines)
 
morpholines: aldimorph, dodemorph, dodemorph-acetate, fenpropimorph, tridemorph; piperidines: fenpropidin, piperalin; spiroketalamines: spiroxamine;
 
F.II-3) Inhibitors of 3-keto reductase: hydroxyanilides: fenhexamid;
 
F.III) Nucleic acid synthesis inhibitors
 
F.III-1) RNA, DNA synthesis
 
phenylamides or acyl amino acid fungicides: benalaxyl, benalaxyl-M, kiralaxyl, metalaxyl, metalaxyl-M (mefenoxam), ofurace, oxadixyl;
 
isoxazoles and iosothiazolones: hymexazole, octhilinone;
 
F.III-2) DNA topisomerase inhibitors: oxolinic acid;
 
F.III-3) Nucleotide metabolism (e.g. adenosin-deaminase), hydroxy(2-amino)-pyrimidines: bupirimate;
 
F.IV) Inhibitors of cell division and or cytoskeleton
 
F.IV-1) Tubulin inhibitors: benzimidazoles and thiophanates: benomyl, carbendazim, fuberidazole, thiabendazole, thiophanate-methyl;
 
triazolopyrimidines: 5-chloro-7 (4-methylpiperidin-1-yl)-6-(2,4,6-trifluorophenyl)-[1,2,4]triazolo[1,5 a]pyrimidine;
 
F.IV-2) Other cell division inhibitors
 
benzamides and phenyl acetamides: diethofencarb, ethaboxam, pencycuron, fluopicolide, zoxamide;
 
F.IV-3) Actin inhibitors: benzophenones: metrafenone; pyriofenone;
 
F.V) Inhibitors of amino acid and protein synthesis
 
F.V-1) Methionine synthesis inhibitors (anilino-pyrimidines)
 
anilino-pyrimidines: cyprodinil, mepanipyrim, nitrapyrin, pyrimethanil;
 
F.V-2) Protein synthesis inhibitors (anilino-pyrimidines)
 
antibiotics: blasticidin-S, kasugamycin, kasugamycin hydrochloride-hydrate, mildiomycin, streptomycin, oxytetracyclin, polyoxine, validamycin A;
 
F.VI) Signal transduction inhibitors
 
F.VI-1) MAP/Histidine kinase inhibitors (e.g. anilino-pyrimidines)
 
dicarboximides: fluoroimid, iprodione, procymidone, vinclozolin;
 
phenylpyrroles: fenpiclonil, fludioxonil;
 
F.VI-2) G protein inhibitors: quinolines: quinoxyfen;
 
F.VII) Lipid and membrane synthesis inhibitors
 
F.VII-1) Phospholipid biosynthesis inhibitors
 
organophosphorus compounds: edifenphos, iprobenfos, pyrazophos;
 
dithiolanes: isoprothiolane;
 
F.VII-2) Lipid peroxidation: aromatic hydrocarbons: dicloran, quintozene, tecnazene, tolclofos-methyl, biphenyl, chloroneb, etridiazole;
 
F.VII-3) Carboxyl acid amides (CAA fungicides)
 
cinnamic or mandelic acid amides: dimethomorph, flumorph, mandiproamid, pyrimorph; valinamide carbamates: benthiavalicarb, iprovalicarb, pyribencarb, valifenalate and N-(1-(1-(4-cyano-phenyl)ethanesulfonyl)-but-2-yl) carbamic acid-(4-fluorophenyl) ester;
 
F.VII-4) Compounds affecting cell membrane permeability and fatty acids: 1-[4-[4-[5-(2,6-difluorophenyl)-4,5-dihydro-3-isoxazolyl]-2-thiazolyl]-1-piperidinyl]-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone, carbamates: propamocarb, propamocarb-hydrochlorid,
 
F.VII-5) fatty acid amide hydrolase inhibitors: 1-[4-[4-[5-(2,6-difluorophenyl)-4,5-dihydro-3-isoxazolyl]-2-thiazolyl]-1-piperidinyl]-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone;
 
F.VIII) Inhibitors with Multi Site Action
 
F.VIII-1) Inorganic active substances: Bordeaux mixture, copper acetate, copper hydroxide, copper oxychloride, basic copper sulfate, sulfur;
 
F.VIII-2) Thio- and dithiocarbamates: ferbam, mancozeb, maneb, metam, methasulphocarb, metiram, propineb, thiram, zineb, ziram;
 
F.VIII-3) Organochlorine compounds (e.g. phthalimides, sulfamides, chloronitriles): anilazine, chlorothalonil, captafol, captan, folpet, dichlofluanid, dichlorophen, flusulfamide, hexachlorobenzene, pentachlorphenole and its salts, phthalide, tolylfluanid, N-(4-chloro-2-nitrophenyl)-N-ethyl-4-methyl-benzenesulfonamide;
 
F.VIII-4) Guanidines and other: guanidine, dodine, dodine free base, guazatine, guazatine-acetate, iminoctadine, iminoctadine-triacetate, iminoctadine-tris(albesilate), 2,6-dimethyl-1H,5H[1,4]dithiino[2,3-c:5,6-c′]dipyrrole-1,3,5,7(2H,6H)-tetraone;
 
F.VIII-5) Ahtraquinones: dithianon;
 
F.IX) Cell wall synthesis inhibitors
 
F.IX-1) Inhibitors of glucan synthesis: validamycin, polyoxin B;
 
F.IX-2) Melanin synthesis inhibitors: pyroquilon, tricyclazole, carpropamide, dicyclomet, fenoxanil;
 
F.X) Plant defence inducers
 
F.X-1) Salicylic acid pathway: acibenzolar-S-methyl;
 
F.X-2) Others: probenazole, isotianil, tiadinil, prohexadione-calcium;
 
phosphonates: fosetyl, fosetyl-aluminum, phosphorous acid and its salts;
 
F.XI) Unknown mode of action:bronopol, chinomethionat, cyflufenamid, cymoxanil, dazomet, debacarb, diclomezine, difenzoquat, difenzoquat-methylsulfate, diphenylamin, fenpyrazamine, flumetover, flusulfamide, flutianil, methasulfocarb, nitrapyrin, nitrothal-isopropyl, oxathiapiprolin, oxin-copper, proquinazid, tebufloquin, tecloftalam, triazoxide, 2-butoxy-6-iodo-3-propylchromen-4-one, N-(cyclopropylmethoxyimino-(6-difluoro-methoxy-2,3-difluoro-phenyl)-methyl)-2-phenyl acetamide, N′-(4-(4-chloro-3-trifluoromethyl-phenoxy)-2,5-dimethyl-phenyl)-N-ethyl-N methyl formamidine, N′ (4-(4-fluoro-3-trifluoromethyl-phenoxy)-2,5-dimethyl-phenyl)-N-ethyl-N-methyl formamidine, N′-(2-methyl-5-trifluoromethyl-4-(3-trimethylsilanyl-propoxy)-phenyl)-N-ethyl-N-methyl formamidine, N′-(5-difluoromethyl-2 methyl-4-(3-trimethylsilanyl-propoxy)-phenyl)-N-ethyl-N-methyl formamidine, 2-{1-[2-(5-methyl-3-trifluoromethyl-pyrazole-1-yl)-acetyl]-piperidin-4-yl}-thiazole-4-carboxylic acid methyl-(1,2,3,4-tetrahydro-naphthalen-1-yl)-amide, 2-{1-[2-(5-methyl-3-trifluoromethyl-pyrazole-1-yl)-acetyl]-piperidin-4-yl}-thiazole-4-carboxylic acid methyl(h)-1,2,3,4-tetrahydro-naphthalen-1-yl-amide, methoxy-acetic acid 6-tert-butyl-8-fluoro-2,3-dimethyl-quinolin-4-yl ester and N-Methyl-2-{1-[(5-methyl-3-trifluoromethyl-1H-pyrazol-1-yl)acetyl]-piperidin-4-yl}-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]-4-thiazolecarboxamide, 3-[5-(4-chloro-phenyl)-2,3-dimethyl-isoxazolidin-3 yl]-pyridine, pyrisoxazole, 5-amino-2-isopropyl-3-oxo-4-ortho-tolyl-2,3-dihydro-pyrazole-1 carbothioic acid S-allyl ester, N-(6-methoxy-pyridin-3-yl)cyclopropanecarboxylic acid amide, 5-chloro-1 (4,6-dimethoxy-pyrimidin-2-yl)-2-methyl-1H-benzoimidazole, 2-(4-chloro-phenyl)-N-[4-(3,4-dimethoxy-phenyl)-isoxazol-5-yl]-2-prop-2-ynyloxy-acetamide;
 
F.XI) Growth regulators: abscisic acid, amidochlor, ancymidol, 6-benzylaminopurine, brassinolide, butralin, chlormequat (chlormequat chloride), choline chloride, cyclanilide, daminozide, dikegulac, dimethipin, 2,6-dimethylpuridine, ethephon, flumetralin, flurprimidol, fluthiacet, forchlorfenuron, gibberellic acid, inabenfide, indole-3-acetic acid, maleic hydrazide, mefluidide, mepiquat (mepiquat chloride), naphthaleneacetic acid, N 6-benzyladenine, paclobutrazol, prohexadione (prohexadione-calcium), prohydrojasmon, thidiazuron, triapenthenol, tributyl phosphorotrithioate, 2,3,5 tri iodobenzoic acid, trinexapac-ethyl and uniconazole;
 
F.XII) Biological control agents
 
 Ampelomyces quisqualis  (e.g. AQ 10® from Intrachem Bio GmbH &amp; Co. KG, Germany),  Aspergillus flavus  (e.g. AFLAGUARD® from Syngenta, CH),  Aureobasidium pullulans  (e.g. BOTECTOR® from bio-ferm GmbH, Germany),  Bacillus pumilus  (e.g. NRRL Accession No. B-30087 in SONATA® and BALLAD® Plus from AgraQuest Inc., USA),  Bacillus subtilis  (e.g. isolate NRRLNr. B-21661 in RHAPSODY®, SERENADE® MAX and SERENADE® ASO from AgraQuest Inc., USA),  Bacillus subtilis  var.  amyloliquefaciens  FZB24 (e.g. TAEGRO® from Novozyme Biologicals, Inc., USA),  Candida oleophila  I-82 (e.g. ASPIRE® from Ecogen Inc., USA),  Candida saitoana  (e.g. BIOCURE® (in mixture with lysozyme) and BIOCOAT® from Micro Flo Company, USA (BASF SE) and Arysta), Chitosan (e.g. ARMOUR-ZEN from BotriZen Ltd., NZ),  Clonostachys rosea  f.  catenulata , also named  Gliocladium catenulatum  (e.g. isolate J1446: PRESTOP® from Verdera, Finland),  Coniothyrium minitans  (e.g. CONTANS® from Prophyta, Germany),  Cryphonectria parasitica  (e.g.  Endothia parasitica  from CNICM, France),  Cryptococcus albidus  (e.g. YIELD PLUS® from Anchor Bio-Technologies, South Africa),  Fusarium oxysporum  (e.g. BIOFOX® from S.I.A.P.A., Italy, FUSACLEAN® from Natural Plant Protection, France),  Metschnikowia fructicola  (e.g. SHEMER® from Agrogreen, Israel),  Microdochium dimerum  (e.g. ANTIBOT® from Agrauxine, France),  Phlebiopsis gigantea  (e.g. ROTSOP® from Verdera, Finland),  Pseudozyma flocculosa  (e.g. SPORODEX® from Plant Products Co. Ltd., Canada),  Pythium oligandrum  DV74 (e.g. POLYVERSUM® from Remeslo SSRO, Biopreparaty, Czech Rep.),  Reynoutria sachlinensis  (e.g. REGALIA® from Marrone Biolnnovations, USA),  Talaromyces flavus  V117b (e.g. PROTUS® from Prophyta, Germany),  Trichoderma asperellum  SKT-1 (e.g. ECO-HOPE® from Kumiai Chemical Industry Co., Ltd., Japan),  T. atroviride  LC52 (e.g. SENTINEL® from Agrimm Technologies Ltd, NZ),  T. harzianum  T-22 (e.g. PLANTSHIELD® der Firma BioWorks Inc., USA),  T. harzianum  TH 35 (e.g. ROOT PRO® from Mycontrol Ltd., Israel),  T. harzianum  T-39 (e.g. TRICHODEX® and  TRICHODERMA  2000® from Mycontrol Ltd., Israel and Makhteshim Ltd., Israel),  T. harzianum  and  T. viride  (e.g. TRICHOPEL from Agrimm Technologies Ltd, NZ),  T. harzianum  ICC012 and  T. viride  ICC080 (e.g. REMEDIER® WP from Isagro Ricerca, Italy),  T. polysporum  and  T. harzianum  (e.g. BINAB® from BINAB Bio-Innovation AB, Sweden),  T. stromaticum  (e.g. TRICOVAB® from C.E.P.L.A.C., Brazil),  T. virens  GL-21 (e.g. SOILGARD® from Certis LLC, USA),  T. viride  (e.g. TRIECO® from Ecosense Labs. (India) Pvt. Ltd., Indien, BIO-CURE® F from T. Stanes &amp; Co. Ltd., Indien),  T. viride  TV1 (e.g.  T. viride  TV1 from Agribiotec srl, Italy),  Ulocladium oudemansii  HRU3 (e.g. BOTRY-ZEN® from Botry-Zen Ltd, NZ).
 
     The commercially available compounds II of the group F listed above may be found in The Pesticide Manual, 15th Edition, C. D. S. Tomlin, British Crop Protection Council (2011) among other publications. Their preparation and their activity against harmful fungi is known (cf.: http://www.alanwood.net/pesticides/); these substances are commercially available. The compounds described by IUPAC nomenclature, their preparation and their fungicidal activity are also known (cf. Can. J. Plant Sci. 48(6), 587-94, 1968; EPA 141 317; EP-A 152 031; EP-A 226 917; EPA 243 970; EPA 256 503; EP-A 428 941; EP-A 532 022; EP-A 1 028 125; EP-A 1 035 122; EPA 1 201 648; EPA 1 122 244, JP 2002316902; DE 19650197; DE 10021412; DE 102005009458; U.S. Pat. No. 3,296,272; U.S. Pat. No. 3,325,503; WO 98/46608; WO 99/14187; WO 99/24413; WO 99/27783; WO 00/29404; WO 00/46148; WO 00/65913; WO 01/54501; WO 01/56358; WO 02/22583; WO 02/40431; WO 03/10149; WO 03/11853; WO 03/14103; WO 03/16286; WO 03/53145; WO 03/61388; WO 03/66609; WO 03/74491; WO 04/49804; WO 04/83193; WO 05/120234; WO 05/123689; WO 05/123690; WO 05/63721; WO 05/87772; WO 05/87773; WO 06/15866; WO 06/87325; WO 06/87343; WO 07/82098; WO 07/90624, WO 11/028657). 
     Applications 
     The animal pest, i.e. the insects, arachnids and nematodes, the plant, soil or water in which the plant is growing can be contacted with the present compounds of formula I or composition(s) containing them by any application method known in the art. As such, “contacting” includes both direct contact (applying the compounds/compositions directly on the animal pest or plant—typically to the foliage, stem or roots of the plant) and indirect contact (applying the compounds/compositions to the locus of the animal pest or plant). 
     The compounds of formula I or the pesticidal compositions comprising them may be used to protect growing plants and crops from attack or infestation by animal pests, especially insects, acaridae or arachnids by contacting the plant/crop with a pesticidally effective amount of compounds of formula I. The term “crop” refers both to growing and harvested crops. 
     The compounds of the present invention and the compositions comprising them are particularly important in the control of a multitude of insects on various cultivated plants, such as cereal, root crops, oil crops, vegetables, spices, ornamentals, for example seed of durum and other wheat, barley, oats, rye, maize (fodder maize and sugar maize/sweet and field corn), soybeans, oil crops, crucifers, cotton, sunflowers, bananas, rice, oilseed rape, turnip rape, sugarbeet, fodder beet, eggplants, potatoes, grass, lawn, turf, fodder grass, tomatoes, leeks, pumpkin/squash, cabbage, iceberg lettuce, pepper, cucumbers, melons,  Brassica  species, melons, beans, peas, garlic, onions, carrots, tuberous plants such as potatoes, sugar cane, tobacco, grapes, petunias, geranium/pelargoniums, pansies and impatiens. 
     The compounds of the present invention are employed as such or in form of compositions by treating the insects or the plants, plant propagation materials, such as seeds, soil, surfaces, materials or rooms to be protected from insecticidal attack with a insecticidally effective amount of the active compounds. The application can be carried out both before and after the infection of the plants, plant propagation materials, such as seeds, soil, surfaces, materials or rooms by the insects. 
     The present invention also includes a method of combating animal pests which comprises contacting the animal pests, their habit, breeding ground, food supply, cultivated plants, seed, soil, area, material or environment in which the animal pests are growing or may grow, or the materials, plants, seeds, soils, surfaces or spaces to be protected from animal attack or infestation with a pesticidally effective amount of a mixture of at least one active compound I. 
     Moreover, animal pests may be controlled by contacting the target pest, its food supply, habitat, breeding ground or its locus with a pesticidally effective amount of compounds of formula I. As such, the application may be carried out before or after the infection of the locus, growing crops, or harvested crops by the pest. 
     The compounds of the invention can also be applied preventively to places at which occurrence of the pests is expected. 
     The compounds of formula I may be also used to protect growing plants from attack or infestation by pests by contacting the plant with a pesticidally effective amount of compounds of formula I. As such, “contacting” includes both direct contact (applying the compounds/compositions directly on the pest and/or plant—typically to the foliage, stem or roots of the plant) and indirect contact (applying the compounds/compositions to the locus of the pest and/or plant). 
     “Locus” means a habitat, breeding ground, plant, seed, soil, area, material or environment in which a pest or parasite is growing or may grow. 
     The term “plant propagation material” is to be understood to denote all the generative parts of the plant such as seeds and vegetative plant material such as cuttings and tubers (e.g. potatoes), which can be used for the multiplication of the plant. This includes seeds, roots, fruits, tubers, bulbs, rhizomes, shoots, sprouts and other parts of plants. Seedlings and young plants, which are to be transplanted after germination or after emergence from soil, may also be included. These plant propagation materials may be treated prophylactically with a plant protection compound either at or before planting or transplanting. 
     The term “cultivated plants” is to be understood as including plants which have been modified by breeding, mutagenesis or genetic engineering. Genetically modified plants are plants, which genetic material has been so modified by the use of recombinant DNA techniques that under natural circumstances cannot readily be obtained by cross breeding, mutations or natural recombination. Typically, one or more genes have been integrated into the genetic material of a genetically modified plant in order to improve certain properties of the plant. Such genetic modifications also include but are not limited to targeted post-transtional modification of protein(s) (oligo- or polypeptides) poly for example by glycosylation or polymer additions such as prenylated, acetylated or farnesylated moieties or PEG moieties (e.g. as disclosed in Biotechnol Prog. 2001 July-August; 17(4):720-8., Protein Eng Des Sel. 2004 January; 17(1):57-66, Nat Protoc. 2007; 2(5):1225-35., Curr Opin Chem Biol. 2006 October; 10(5):487-91. Epub 2006 Aug. 28., Biomaterials. 2001 March; 22(5):405-17, Bioconjug Chem. 2005 January-February; 16(1):113-21). 
     The term “cultivated plants” is to be understood also including plants that have been rendered tolerant to applications of specific classes of herbicides, such as hydroxy-phenylpyruvate dioxygenase (HPPD) inhibitors; acetolactate synthase (ALS) inhibitors, such as sulfonyl ureas (see e.g. U.S. Pat. No. 6,222,100, WO 01/82685, WO 00/26390, WO 97/41218, WO 98/02526, WO 98/02527, WO 04/106529, WO 05/20673, WO 03/14357, WO 03/13225, WO 03/14356, WO 04/16073) or imidazolinones (see e.g. U.S. Pat. No. 6,222,100, WO 01/82685, WO 00/26390, WO 97/41218, WO 98/02526, WO 98/02527, WO 04/106529, WO 05/20673, WO 03/14357, WO 03/13225, WO 03/14356, WO 04/16073); enolpyruvylshikimate-3-phosphate synthase (EPSPS) inhibitors, such as glyphosate (see e.g. WO 92/00377); glutamine synthetase (GS) inhibitors, such as glufosinate (see e.g. EP-A-0242236, EP-A-242246) or oxynil herbicides (see e.g. U.S. Pat. No. 5,559,024) as a result of conventional methods of breeding or genetic engineering. Several cultivated plants have been rendered tolerant to herbicides by conventional methods of breeding (mutagenesis), for example Clearfield® summer rape (Canola) being tolerant to imidazolinones, e.g. imazamox. Genetic engineering methods have been used to render cultivated plants, such as soybean, cotton, corn, beets and rape, tolerant to herbicides, such as glyphosate and glufosinate, some of which are commercially available under the trade names RoundupReady® (glyphosate) and LibertyLink® (glufosinate). 
     The term “cultivated plants” is to be understood also including plants that are by the use of recombinant DNA techniques capable to synthesize one or more insecticidal proteins, especially those known from the bacterial genus  Bacillus , particularly from  Bacillus thuringiensis , such as ä-endotoxins, e.g. CryIA(b), CryIA(c), CryIF, CryIF(a2), CryIIA(b), CryIIIA, CryIIIB(b1) or Cry9c; vegetative insecticidal proteins (VIP), e.g. VIP1, VIP2, VIP3 or VIP3A; insecticidal proteins of bacteria colonizing nematodes, for example  Photorhabdus  spp. or  Xenorhabdus  spp.; toxins produced by animals, such as scorpion toxins, arachnid toxins, wasp toxins, or other insectspecific neurotoxins; toxins produced by fungi, such Streptomycetes toxins, plant lectins, such as pea or barley lectins; agglutinins; proteinase inhibitors, such as trypsin inhibitors, serine protease inhibitors, patatin, cystatin or papain inhibitors; ribosome-inactivating proteins (RIP), such as ricin, maize-RIP, abrin, luffin, saporin or bryodin; steroid metabolism enzymes, such as 3-hydroxysteroid oxidase, ecdysteroid-IDP-glycosyl-transferase, cholesterol oxidases, ecdysone inhibitors or HMG-CoA-reductase; ion channel blockers, such as blockers of sodium or calcium channels; juvenile hormone esterase; diuretic hormone receptors (helicokinin receptors); stilben synthase, bibenzyl synthase, chitinases or glucanases. In the context of the present invention these insecticidal proteins or toxins are to be understood expressly also as pre-toxins, hybrid proteins, truncated or otherwise modified proteins. Hybrid proteins are characterized by a new combination of protein domains, (see, for example WO 02/015701). Further examples of such toxins or genetically-modified plants capable of synthesizing such toxins are dis-closed, for ex-ample, in EP-A 374 753, WO 93/007278, WO 95/34656, EP-A 427 529, EP-A 451 878, WO 03/018810 and WO 03/052073. The methods for producing such genetically modified plants are generally known to the person skilled in the art and are described, for example, in the publications mentioned above. These insecticidal proteins contained in the genetically modified plants impart to the plants producing these proteins protection from harmful pests from certain taxonomic groups of arthropods, particularly to beetles (Coleoptera), flies (Diptera), and butterflies and moths (Lepidoptera) and to plant parasitic nematodes (Nematoda). 
     The term “cultivated plants” is to be understood also including plants that are by the use of recombinant DNA techniques capable to synthesize one or more proteins to increase the resistance or tolerance of those plants to bacterial, viral or fungal pathogens. Examples of such proteins are the so-called “pathogenesis-related proteins” (PR proteins, see, for example EP-A0 392 225), plant disease resistance genes (for example potato cultivars, which express resistance genes acting against  Phytophthora infestans  derived from the mexican wild potato Solanum bulbocastanum) or T4-lyso-zym (e.g. potato cultivars capable of synthesizing these proteins with increased resistance against bacteria such as  Erwinia amylvora ). The methods for producing such genetically modified plants are generally known to the person skilled in the art and are described, for example, in the publications mentioned above. 
     The term “cultivated plants” is to be understood also including plants that are by the use of recombinant DNA techniques capable to synthesize one or more proteins to increase the productivity (e.g. bio mass production, grain yield, starch content, oil content or protein content), tolerance to drought, salinity or other growth-limiting environ-mental factors or tolerance to pests and fungal, bacterial or viral pathogens of those plants. 
     The term “cultivated plants” is to be understood also including plants that contain by the use of recombinant DNA techniques a modified amount of substances of content or new substances of content, specifically to improve human or animal nutrition, for ex-ample oil crops that produce health-promoting long-chain omega-3 fatty acids or unsaturated omega-9 fatty acids (e.g. Nexera® rape). 
     The term “cultivated plants” is to be understood also including plants that contain by the use of recombinant DNA techniques a modified amount of substances of content or new substances of content, specifically to improve raw material production, for example potatoes that produce increased amounts of amylopectin (e.g. Amflora® potato). 
     In general, “pesticidally effective amount” means the amount of active ingredient needed to achieve an observable effect on growth, including the effects of necrosis, death, retardation, prevention, and removal, destruction, or otherwise diminishing the occurrence and activity of the target organism. The pesticidally effective amount can vary for the various compounds/compositions used in the invention. A pesticidally effective amount of the compositions will also vary according to the prevailing conditions such as desired pesticidal effect and duration, weather, target species, locus, mode of application, and the like. 
     In the case of soil treatment or of application to the pests dwelling place or nest, the quantity of active ingredient ranges from 0.0001 to 500 g per 100 m 2 , preferably from 0.001 to 20 g per 100 m 2 . 
     Customary application rates in the protection of materials are, for example, from 0.01 g to 1000 g of active compound per m 2  treated material, desirably from 0.1 g to 50 g per m 2 . 
     Insecticidal compositions for use in the impregnation of materials typically contain from 0.001 to 95 weight %, preferably from 0.1 to 45 weight %, and more preferably from 1 to 25 weight % of at least one repellent and/or insecticide. 
     For use in treating crop plants, the rate of application of the active ingredients of this invention may be in the range of 0.1 g to 4000 g per hectare, desirably from 25 g to 600 g per hectare, more desirably from 50 g to 500 g per hectare. 
     The compounds of formula I are effective through both contact (via soil, glass, wall, bed net, carpet, plant parts or animal parts), and ingestion (bait, or plant part). 
     The compounds of the invention may also be applied against non-crop insect pests, such as ants, termites, wasps, flies, mosquitos, crickets, or cockroaches. For use against said non-crop pests, compounds of formula I are preferably used in a bait composition. 
     The bait can be a liquid, a solid or a semisolid preparation (e.g. a gel). Solid baits can be formed into various shapes and forms suitable to the respective application e.g. granules, blocks, sticks, disks. Liquid baits can be filled into various devices to ensure proper application, e.g. open containers, spray devices, droplet sources, or evaporation sources. Gels can be based on aqueous or oily matrices and can be formulated to particular necessities in terms of stickyness, moisture retention or aging characteristics. 
     The bait employed in the composition is a product, which is sufficiently attractive to incite insects such as ants, termites, wasps, flies, mosquitos, crickets etc. or cockroaches to eat it. The attractiveness can be manipulated by using feeding stimulants or sex pheromones. Food stimulants are chosen, for example, but not exclusively, from animal and/or plant proteins (meat-, fish- or blood meal, insect parts, egg yolk), from fats and oils of animal and/or plant origin, or mono-, oligo- or polyorganosaccharides, especially from sucrose, lactose, fructose, dextrose, glucose, starch, pectin or even molasses or honey. Fresh or decaying parts of fruits, crops, plants, animals, insects or specific parts thereof can also serve as a feeding stimulant. Sex pheromones are known to be more insect specific. Specific pheromones are described in the literature and are known to those skilled in the art. 
     For use in bait compositions, the typical content of active ingredient is from 0.001 weight % to 15 weight %, desirably from 0.001 weight % to 5% weight % of active compound. 
     Formulations of compounds of formula I as aerosols (e.g in spray cans), oil sprays or pump sprays are highly suitable for the non-professional user for controlling pests such as flies, fleas, ticks, mosquitos or cockroaches. Aerosol recipes are preferably composed of the active compound, solvents such as lower alcohols (e.g. methanol, ethanol, propanol, butanol), ketones (e.g. acetone, methyl ethyl ketone), paraffin hydrocarbons (e.g. kerosenes) having boiling ranges of approximately 50 to 250° C., dimethylformamide, N-methylpyrrolidone, dimethyl sulfoxide, aromatic hydrocarbons such as toluene, xylene, water, furthermore auxiliaries such as emulsifiers such as sorbitol monooleate, oleyl ethoxylate having 3-7 mol of ethylene oxide, fatty alcohol ethoxylate, perfume oils such as ethereal oils, esters of medium fatty acids with lower alcohols, aromatic carbonyl compounds, if appropriate stabilizers such as sodium benzoate, amphoteric surfactants, lower epoxides, triethyl orthoformate and, if required, propellants such as propane, butane, nitrogen, compressed air, dimethyl ether, carbon dioxide, nitrous oxide, or mixtures of these gases. 
     The oil spray formulations differ from the aerosol recipes in that no propellants are used. 
     For use in spray compositions, the content of active ingredient is from 0.001 to 80 weights %, preferably from 0.01 to 50 weight % and most preferably from 0.01 to 15 weight %. 
     The compounds of formula I and its respective compositions can also be used in mosquito and fumigating coils, smoke cartridges, vaporizer plates or long-term vaporizers and also in moth papers, moth pads or other heat-independent vaporizer systems. 
     Methods to control infectious diseases transmitted by insects (e.g. malaria, dengue and yellow fever, lymphatic filariasis, and leishmaniasis) with compounds of formula I and its respective compositions also comprise treating surfaces of huts and houses, air spraying and impregnation of curtains, tents, clothing items, bed nets, tsetse-fly trap or the like. Insecticidal compositions for application to fibers, fabric, knitgoods, nonwovens, netting material or foils and tarpaulins preferably comprise a mixture including the insecticide, optionally a repellent and at least one binder. Suitable repellents for example are N,N-Diethyl-meta-toluamide (DEET), N,N-diethylphenylacetamide (DEPA), 1-(3-cyclohexan-1-yl-carbonyl)-2-methylpiperine, (2-hydroxymethylcyclohexyl) acetic acid lactone, 2-ethyl-1,3-hexandiol, indalone, Methyl-neodecanamide (MNDA), a pyrethroid not used for insect control such as {(+/−)-3-allyl-2-methyl-4-oxocyclopent-2-(+)-enyl-(+)-trans-chrysantemate (Esbiothrin), a repellent derived from or identical with plant extracts like limonene, eugenol, (+)-Eucamalol (1), (−)-1-epi-eucamalol or crude plant extracts from plants like  Eucalyptus maculata, Vitex rotundifolia, Cymbopogan martinii, Cymbopogan citratus  (lemon grass),  Cymopogan nartdus  (citronella). Suitable binders are selected for example from polymers and copolymers of vinyl esters of aliphatic acids (such as such as vinyl acetate and vinyl versatate), acrylic and methacrylic esters of alcohols, such as butyl acrylate, 2-ethylhexylacrylate, and methyl acrylate, mono- and di-ethylenically unsaturated hydrocarbons, such as styrene, and aliphatic diens, such as butadiene. 
     The impregnation of curtains and bednets is done in general by dipping the textile material into emulsions or dispersions of the insecticide or spraying them onto the nets. 
     The compounds of formula I and its compositions can be used for protecting wooden materials such as trees, board fences, sleepers, etc. and buildings such as houses, outhouses, factories, but also construction materials, furniture, leathers, fibers, vinyl articles, electric wires and cables etc. from ants and/or termites, and for controlling ants and termites from doing harm to crops or human being (e.g. when the pests invade into houses and public facilities). The compounds of formula I are applied not only to the surrounding soil surface or into the under-floor soil in order to protect wooden materials but it can also be applied to lumbered articles such as surfaces of the under-floor concrete, alcove posts, beams, plywoods, furniture, etc., wooden articles such as particle boards, half boards, etc. and vinyl articles such as coated electric wires, vinyl sheets, heat insulating material such as styrene foams, etc. In case of application against ants doing harm to crops or human beings, the ant controller of the present invention is applied to the crops or the surrounding soil, or is directly applied to the nest of ants or the like. 
     Seed Treatment 
     The compounds of formula I are also suitable for the treatment of seeds in order to protect the seed from insect pest, in particular from soil-living insect pests and the resulting plant&#39;s roots and shoots against soil pests and foliar insects. 
     The compounds of formula I are particularly useful for the protection of the seed from soil pests and the resulting plant&#39;s roots and shoots against soil pests and foliar insects. The protection of the resulting plant&#39;s roots and shoots is preferred. More preferred is the protection of resulting plant&#39;s shoots from piercing and sucking insects, wherein the protection from aphids is most preferred. 
     The present invention therefore comprises a method for the protection of seeds from insects, in particular from soil insects and of the seedling&#39;s roots and shoots from insects, in particular from soil and foliar insects, said method comprising contacting the seeds before sowing and/or after pregermination with a compound of the general formula I or a salt thereof. Particularly preferred is a method, wherein the plant&#39;s roots and shoots are protected, more preferably a method, wherein the plants shoots are protected form piercing and sucking insects, most preferably aa method, wherein the plants shoots are protected from aphids. 
     The term seed embraces seeds and plant propagules of all kinds including but not limited to true seeds, seed pieces, suckers, corms, bulbs, fruit, tubers, grains, cuttings, cut shoots and the like and means in a preferred embodiment true seeds. 
     The term seed treatment comprises all suitable seed treatment techniques known in the art, such as seed dressing, seed coating, seed dusting, seed soaking and seed pelleting. The present invention also comprises seeds coated with or containing the active compound. 
     The term “coated with and/or containing” generally signifies that the active ingredient is for the most part on the surface of the propagation product at the time of application, although a greater or lesser part of the ingredient may penetrate into the propagation product, depending on the method of application. When the said propagation product is (re)planted, it may absorb the active ingredient. 
     Suitable seed is seed of cereals, root crops, oil crops, vegetables, spices, ornamentals, for example seed of durum and other wheat, barley, oats, rye, maize (fodder maize and sugar maize/sweet and field corn), soybeans, oil crops, crucifers, cotton, sunflowers, bananas, rice, oilseed rape, turnip rape, sugarbeet, fodder beet, eggplants, potatoes, grass, lawn, turf, fodder grass, tomatoes, leeks, pumpkin/squash, cabbage, iceberg lettuce, pepper, cucumbers, melons,  Brassica  species, melons, beans, peas, garlic, onions, carrots, tuberous plants such as potatoes, sugar cane, tobacco, grapes, petunias, geranium/pelargoniums, pansies and impatiens. 
     In addition, the active compound may also be used for the treatment seeds from plants, which tolerate the action of herbicides or fungicides or insecticides owing to breeding, including genetic engineering methods. 
     For example, the active compound can be employed in treatment of seeds from plants, which are resistant to herbicides from the group consisting of the sulfonylureas, imidazolinones, glufosinate-ammonium or glyphosate-isopropylammonium and analogous active substances (see for example, EP-A-0242236, EP-A-242246) (WO 92/00377) (EP-A-0257993, U.S. Pat. No. 5,013,659) or in transgenic crop plants, for example cotton, with the capability of producing  Bacillus thuringiensis  toxins (Bt toxins) which make the plants resistant to certain pests (EP-A0142924, EP-A-0193259), 
     Furthermore, the active compound can be used also for the treatment of seeds from plants, which have modified characteristics in comparison with existing plants consist, which can be generated for example by traditional breeding methods and/or the generation of mutants, or by recombinant procedures). For example, a number of cases have been described of recombinant modifications of crop plants for the purpose of modifying the starch synthesized in the plants (e.g. WO 92/11376, WO 92/14827, WO 91/19806) or of transgenic crop plants having a modified fatty acid composition (WO 91/13972). 
     The seed treatment application of the active compound is carried out by spraying or by dusting the seeds before sowing of the plants and before emergence of the plants. 
     Compositions which are especially useful for seed treatment are e.g.: 
     A Soluble concentrates (SL, LS) 
     D Emulsions (EW, EO, ES) 
     E Suspensions (SC, OD, FS) 
     F Water-dispersible granules and water-soluble granules (WG, SG) 
     G Water-dispersible powders and water-soluble powders (WP, SP, WS) 
     H Gel-Formulations (GF) 
     I Dustable powders (DP, DS) 
     Conventional seed treatment formulations include for example flowable concentrates FS, solutions LS, powders for dry treatment DS, water dispersible powders for slurry treatment WS, water-soluble powders SS and emulsion ES and EC and gel formulation GF. These formulations can be applied to the seed diluted or undiluted. Application to the seeds is carried out before sowing, either directly on the seeds or after having pregerminated the latter 
     In a preferred embodiment a FS formulation is used for seed treatment. Typcially, a FS formulation may comprise 1-800 g/l of active ingredient, 1-200 g/l Surfactant, 0 to 200 g/l antifreezing agent, 0 to 400 g/l of binder, 0 to 200 g/l of a pigment and up to 1 liter of a solvent, preferably water. 
     Especially preferred FS formulations of compounds of formula I for seed treatment usually comprise from 0.1 to 80% by weight (1 to 800 g/l) of the active ingredient, from 0.1 to 20% by weight (1 to 200 g/l) of at least one surfactant, e.g. 0.05 to 5% by weight of a wetter and from 0.5 to 15% by weight of a dispersing agent, up to 20% by weight, e.g. from 5 to 20% of an anti-freeze agent, from 0 to 15% by weight, e.g. 1 to 15% by weight of a pigment and/or a dye, from 0 to 40% by weight, e.g. 1 to 40% by weight of a binder (sticker/adhesion agent), optionally up to 5% by weight, e.g. from 0.1 to 5% by weight of a thickener, optionally from 0.1 to 2% of an anti-foam agent, and optionally a preservative such as a biocide, antioxidant or the like, e.g. in an amount from 0.01 to 1% by weight and a filler/vehicle up to 100% by weight. 
     Seed Treatment formulations may additionally also comprise binders and optionally colorants. 
     Binders can be added to improve the adhesion of the active materials on the seeds after treatment. Suitable binders are homo- and copolymers from alkylene oxides like ethylene oxide or propylene oxide, polyvinylacetate, polyvinylalcohols, polyvinylpyrrolidones, and copolymers thereof, ethylene-vinyl acetate copolymers, acrylic homo- and copolymers, polyethyleneamines, polyethyleneamides and polyethyleneimines, polysaccharides like celluloses, tylose and starch, polyolefin homo- and copolymers like olefin/maleic anhydride copolymers, polyurethanes, polyesters, polystyrene homo and copolymers 
     Optionally, also colorants can be included in the formulation. Suitable colorants or dyes for seed treatment formulations are Rhodamin B, C.I. Pigment Red 112, C.I. Solvent Red 1, pigment blue 15:4, pigment blue 15:3, pigment blue 15:2, pigment blue 15:1, pigment blue 80, pigment yellow 1, pigment yellow 13, pigment red 112, pigment red 48:2, pigment red 48:1, pigment red 57:1, pigment red 53:1, pigment orange 43, pigment orange 34, pigment orange 5, pigment green 36, pigment green 7, pigment white 6, pigment brown 25, basic violet 10, basic violet 49, acid red 51, acid red 52, acid red 14, acid blue 9, acid yellow 23, basic red 10, basic red 108. 
     Examples of a gelling agent is carrageen (Satiagel®) 
     In the treatment of seed, the application rates of the compounds I are generally from 0.1 g to 10 kg per 100 kg of seed, preferably from 1 g to 5 kg per 100 kg of seed, more preferably from 1 g to 1000 g per 100 kg of seed and in particular from 1 g to 200 g per 100 kg of seed. 
     The invention therefore also relates to seed comprising a compound of the formula I, or an agriculturally useful salt of I, as defined herein. The amount of the compound I or the agriculturally useful salt thereof will in general vary from 0.1 g to 10 kg per 100 kg of seed, preferably from 1 g to 5 kg per 100 kg of seed, in particular from 1 g to 1000 g per 100 kg of seed. For specific crops such as lettuce the rate can be higher. 
     Animal Health 
     The compounds of formula I or the enantiomers or veterinarily acceptable salts thereof are in particular also suitable for being used for combating parasites in and on animals. 
     An object of the present invention is therefore also to provide new methods to control parasites in and on animals. Another object of the invention is to provide safer pesticides for animals. Another object of the invention is further to provide pesticides for animals that may be used in lower doses than existing pesticides. And another object of the invention is to provide pesticides for animals, which provide a long residual control of the parasites. 
     The invention also relates to compositions containing a parasiticidally effective amount of compounds of formula I or the enantiomers or veterinarily acceptable salts thereof and an acceptable carrier, for combating parasites in and on animals. 
     The present invention also provides a method for treating, controlling, preventing and protecting animals against infestation and infection by parasites, which comprises orally, topically or parenterally administering or applying to the animals a parasiticidally effective amount of a compound of formula I or the enantiomers or veterinarily acceptable salts thereof or a composition comprising it. 
     The invention also provides a process for the preparation of a composition for treating, controlling, preventing or protecting animals against infestation or infection by parasites which comprises a parasiticidally effective amount of a compound of formula I or the enantiomers or veterinarily acceptable salts thereof or a composition comprising it. 
     Activity of compounds against agricultural pests does not suggest their suitability for control of endo- and ectoparasites in and on animals which requires, for example, low, non-emetic dosages in the case of oral application, metabolic compatibility with the animal, low toxicity, and a safe handling. 
     Surprisingly it has now been found that compounds of formula I are suitable for combating endo- and ectoparasites in and on animals. 
     Compounds of formula I or the enantiomers or veterinarily acceptable salts thereof and compositions comprising them are preferably used for controlling and preventing infestations and infections animals including warm-blooded animals (including humans) and fish. They are for example suitable for controlling and preventing infestations and infections in mammals such as cattle, sheep, swine, camels, deer, horses, pigs, poultry, rabbits, goats, dogs and cats, water buffalo, donkeys, fallow deer and reindeer, and also in fur-bearing animals such as mink, chinchilla and raccoon, birds such as hens, geese, turkeys and ducks and fish such as fresh- and salt-water fish such as trout, carp and eels. 
     Compounds of formula I or the enantiomers or veterinarily acceptable salts thereof and compositions comprising them are preferably used for controlling and preventing infestations and infections in domestic animals, such as dogs or cats. 
     Infestations in warm-blooded animals and fish include, but are not limited to, lice, biting lice, ticks, nasal bots, keds, biting flies, muscoid flies, flies, myiasitic fly larvae, chiggers, gnats, mosquitoes and fleas. 
     The compounds of formula I or the enantiomers or veterinarily acceptable salts thereof and compositions comprising them are suitable for systemic and/or non-systemic control of ecto- and/or endoparasites. They are active against all or some stages of development. 
     The compounds of formula I are especially useful for combating ectoparasites. 
     The compounds of formula I are especially useful for combating parasites of the following orders and species, respectively: 
     fleas (Siphonaptera), e.g.  Ctenocephalides felis, Ctenocephalides canis, Xenopsylla cheopis, Pulex irritans, Tunga penetrans , and  Nosopsyllus fasciatus,    
     cockroaches (Blattaria-Blattodea), e.g.  Blattella germanica, Blattella asahinae, Periplaneta americana, Periplaneta japonica, Periplaneta brunnea, Periplaneta fuligginosa, Periplaneta australasiae , and  Blatta orientalis,    
     flies, mosquitoes (Diptera), e.g.  Aedes aegypti, Aedes albopictus, Aedes vexans, Anastrepha ludens, Anopheles maculipennis, Anopheles crucians, Anopheles albimanus, Anopheles gambiae, Anopheles freeborni, Anopheles leucosphyrus, Anopheles minimus, Anopheles quadrimaculatus, Calliphora vicina, Chrysomya bezziana, Chrysomya hominivorax, Chrysomya macellaria, Chrysops discalis, Chrysops silacea, Chrysops atlanticus, Cochliomyia hominivorax, Cordylobia anthropophaga, Culicoides furens, Culex pipiens, Culex nigripalpus, Culex quinquefasciatus, Culex tarsalis, Culiseta inornata, Culiseta melanura, Dermatobia hominis, Fannia canicularis, Gasterophilus intestinalis, Glossina morsitans, Glossina palpalis, Glossina fuscipes, Glossina tachinoides, Haematobia irritans, Haplodiplosis equestris, Hippelates  spp.,  Hypoderma lineata, Leptoconops torrens, Lucilia caprina, Lucilia cuprina, Lucilia sericata, Lycoria pectoralis, Mansonia  spp.,  Musca domestica, Muscina stabulans, Oestrus ovis, Phlebotomus argentipes, Psorophora columbiae, Psorophora discolor, Prosimulium mixtum, Sarcophaga haemorrhoidalis, Sarcophaga  sp.,  Simulium vittatum, Stomoxys calcitrans, Tabanus bovinus, Tabanus atratus, Tabanus lineola , and  Tabanus similis,    
     lice (Phthiraptera), e.g.  Pediculus humanus capitis, Pediculus humanus corporis, Pthirus pubis, Haematopinus eurysternus, Haematopinus suis, Linognathus vituli, Bovicola bovis, Menopon gallinae, Menacanthus stramineus  and  Solenopotes capillatus.    
     ticks and parasitic mites (Parasitiformes): ticks (Ixodida), e.g.  Ixodes scapularis, Ixodes holocyclus, Ixodes pacificus, Rhiphicephalus sanguineus, Dermacentor andersoni, Dermacentor variabilis, Amblyomma americanum, Ambryomma maculatum, Ornithodorus hermsi, Ornithodorus turicata  and parasitic mites (Mesostigmata), e.g.  Ornithonyssus bacoti  and  Dermanyssus gallinae,    
     Actinedida (Prostigmata) and Acaridida (Astigmata) e.g.  Acarapis  spp.,  Cheyletiella  spp.,  Ornithocheyletia  spp.,  Myobia  spp.,  Psorergates  spp.,  Demodex  spp.,  Trombicula  spp.,  Listrophorus  spp.,  Acarus  spp.,  Tyrophagus  spp.,  Caloglyphus  spp.,  Hypodectes  spp.,  Pterolichus  spp.,  Psoroptes  spp.,  Chorioptes  spp.,  Otodectes  spp.,  Sarcoptes  spp.,  Notoedres  spp.,  Knemidocoptes  spp.,  Cytodites  spp., and  Laminosioptes  spp, 
     Bugs (Heteropterida):  Cimex lectularius, Cimex hemipterus, Reduvius senilis, Triatoma  spp.,  Rhodnius  ssp.,  Panstrongylus  ssp. and  Arilus critatus,    
     Anoplurida, e.g.  Haematopinus  spp.,  Linognathus  spp.,  Pediculus  spp.,  Phtirus  spp., and  Solenopotes  spp, 
     Mallophagida (suborders Arnblycerina and Ischnocerina), e.g.  Trimenopon  spp.,  Menopon  spp.,  Trinoton  spp.,  Bovicola  spp.,  Werneckiella  spp.,  Lepikentron  spp.,  Trichodectes  spp., and  Felicola  spp, 
     Roundworms Nematoda: 
     Wipeworms and Trichinosis (Trichosyringida), e.g. Trichinellidae ( Trichinella  spp.), (Trichuridae)  Trichuris  spp.,  Capillaria  spp, 
     Rhabditida, e.g.  Rhabditis  spp,  Strongyloides  spp.,  Helicephalobus  spp, 
     Strongylida, e.g.  Strongylus  spp.,  Ancylostoma  spp.,  Necator americanus, Bunostomum  spp. (Hookworm),  Trichostrongylus  spp.,  Haemonchus contortus., Ostertagia  spp.,  Cooperia  spp.,  Nematodirus  spp.,  Dictyocaulus  spp.,  Cyathostoma  spp.,  Oesophagostomum  spp.,  Stephanurus dentatus, Ollulanus  spp.,  Chabertia  spp.,  Stephanurus dentatus, Syngamus trachea, Ancylostoma  spp.,  Uncinaria  spp.,  Globocephalus  spp.,  Necator  spp.,  Metastrongylus  spp.,  Muellerius capillaris, Protostrongylus  spp.,  Angiostrongylus  spp.,  Parelaphostrongylus  spp.  Aleurostrongylus abstrusus , and  Dioctophyma renale,    
     Intestinal roundworms (Ascaridida), e.g.  Ascaris lumbricoides, Ascaris suum, Ascaridia galli, Parascaris equorum, Enterobius vermicularis  (Threadworm),  Toxocara canis, Toxascaris leonine, Skrjabinema  spp., and  Oxyuris equi,    
     Camallanida, e.g.  Dracunculus medinensis  (guinea worm) 
     Spirurida, e.g.  Thelazia  spp.  Wuchereria  spp.,  Brugia  spp.,  Onchocerca  spp.,  Dirofilari  spp. a,  Dipetalonema  spp.,  Setaria  spp.,  Elaeophora  spp.,  Spirocerca lupi , and  Habronema  spp., 
     Thorny headed worms (Acanthocephala), e.g.  Acanthocephalus  spp.,  Macracanthorhynchus hirudinaceus  and  Oncicola  spp, 
     Planarians (Plathelminthes): 
     Flukes (Trematoda), e.g.  Faciola  spp.,  Fascioloides magna, Paragonimus  spp.,  Dicrocoelium  spp.,  Fasciolopsis buski, Clonorchis sinensis, Schistosoma  spp.,  Trichobilharzia  spp.,  Alana alata, Paragonimus  spp., and  Nanocyetes  spp, 
     Cercomeromorpha, in particular Cestoda (Tapeworms), e.g.  Diphyllobothrium  spp.,  Tenia  spp.,  Echinococcus  spp.,  Dipyldium caninum, Multiceps  spp.,  Hymenolepis  spp.,  Mesocestoides  spp.,  Vampirolepis  spp.,  Moniezia  spp.,  Anoplocephala  spp.,  Sirometra  spp.,  Anoplocephala  spp., and  Hymenolepis  spp. 
     The compounds of formula I and compositions containing them are particularly useful for the control of pests from the orders Diptera, Siphonaptera and Ixodida. 
     Moreover, the use of the compounds of formula I and compositions containing them for combating mosquitoes is especially preferred. 
     The use of the compounds of formula I and compositions containing them for combating flies is a further preferred embodiment of the present invention. 
     Furthermore, the use of the compounds of formula I and compositions containing them for combating fleas is especially preferred. 
     The use of the compounds of formula I and compositions containing them for combating ticks is a further preferred embodiment of the present invention. 
     The compounds of formula I also are especially useful for combating endoparasites (roundworms nematoda, thorny headed worms and planarians). 
     Administration can be carried out both prophylactically and therapeutically. 
     Administration of the active compounds is carried out directly or in the form of suitable preparations, orally, topically/dermally or parenterally. 
     For oral administration to warm-blooded animals, the formula I compounds may be formulated as animal feeds, animal feed premixes, animal feed concentrates, pills, solutions, pastes, suspensions, drenches, gels, tablets, boluses and capsules. In addition, the formula I compounds may be administered to the animals in their drinking water. For oral administration, the dosage form chosen should provide the animal with 0.01 mg/kg to 100 mg/kg of animal body weight per day of the formula I compound, preferably with 0.5 mg/kg to 100 mg/kg of animal body weight per day. 
     Alternatively, the formula I compounds may be administered to animals parenterally, for example, by intraruminal, intramuscular, intravenous or subcutaneous injection. The formula I compounds may be dispersed or dissolved in a physiologically acceptable carrier for subcutaneous injection. Alternatively, the formula I compounds may be formulated into an implant for subcutaneous administration. In addition the formula I compound may be transdermally administered to animals. For parenteral administration, the dosage form chosen should provide the animal with 0.01 mg/kg to 100 mg/kg of animal body weight per day of the formula I compound. 
     The formula I compounds may also be applied topically to the animals in the form of dips, dusts, powders, collars, medallions, sprays, shampoos, spot-on and pour-on formulations and in ointments or oil-in-water or water-in-oil emulsions. For topical application, dips and sprays usually contain 0.5 ppm to 5,000 ppm and preferably 1 ppm to 3,000 ppm of the formula I compound. In addition, the formula I compounds may be formulated as ear tags for animals, particularly quadrupeds such as cattle and sheep. 
     Suitable preparations are:
         Solutions such as oral solutions, concentrates for oral administration after dilution, solutions for use on the skin or in body cavities, pouring-on formulations, gels;   Emulsions and suspensions for oral or dermal administration; semi-solid preparations;   Formulations in which the active compound is processed in an ointment base or in an oil-inwater or water-in-oil emulsion base;   Solid preparations such as powders, premixes or concentrates, granules, pellets, tablets, boluses, capsules; aerosols and inhalants, and active compound-containing shaped articles.       

     Compositions suitable for injection are prepared by dissolving the active ingredient in a suitable solvent and optionally adding further ingredients such as acids, bases, buffer salts, preservatives, and solubilizers. The solutions are filtered and filled sterile. 
     Suitable solvents are physiologically tolerable solvents such as water, alkanols such as ethanol, butanol, benzyl alcohol, glycerol, propylene glycol, polyethylene glycols, N-methyl-pyrrolidone, 2-pyrrolidone, and mixtures thereof. 
     The active compounds can optionally be dissolved in physiologically tolerable vegetable or synthetic oils which are suitable for injection. 
     Suitable solubilizers are solvents which promote the dissolution of the active compound in the main solvent or prevent its precipitation. Examples are polyvinylpyrrolidone, polyvinyl alcohol, polyoxyethylated castor oil, and polyoxyethylated sorbitan ester. 
     Suitable preservatives are benzyl alcohol, trichlorobutanol, p-hydroxybenzoic acid esters, and n-butanol. 
     Oral solutions are administered directly. Concentrates are administered orally after prior dilution to the use concentration. Oral solutions and concentrates are prepared according to the state of the art and as described above for injection solutions, sterile procedures not being necessary. 
     Solutions for use on the skin are trickled on, spread on, rubbed in, sprinkled on or sprayed on. 
     Solutions for use on the skin are prepared according to the state of the art and according to what is described above for injection solutions, sterile procedures not being necessary. 
     Further suitable solvents are polypropylene glycol, phenyl ethanol, phenoxy ethanol, ester such as ethyl or butyl acetate, benzyl benzoate, ethers such as alkyleneglycol alkylether, e.g. dipropylenglycol monomethylether, ketons such as acetone, methylethylketone, aromatic hydrocarbons, vegetable and synthetic oils, dimethylformamide, dimethylacetamide, transcutol, solketal, propylencarbonate, and mixtures thereof. 
     It may be advantageous to add thickeners during preparation. Suitable thickeners are inorganic thickeners such as bentonites, colloidal silicic acid, aluminium monostearate, organic thickeners such as cellulose derivatives, polyvinyl alcohols and their copolymers, acrylates and methacrylates. 
     Gels are applied to or spread on the skin or introduced into body cavities. Gels are prepared by treating solutions which have been prepared as described in the case of the injection solutions with sufficient thickener that a clear material having an ointment-like consistency results. The thickeners employed are the thickeners given above. 
     Pour-on formulations are poured or sprayed onto limited areas of the skin, the active compound penetrating the skin and acting systemically. 
     Pour-on formulations are prepared by dissolving, suspending or emulsifying the active compound in suitable skin-compatible solvents or solvent mixtures. If appropriate, other auxiliaries such as colorants, bioabsorption-promoting substances, antioxidants, light stabilizers, adhesives are added. 
     Suitable solvents which are: water, alkanols, glycols, polyethylene glycols, polypropylene glycols, glycerol, aromatic alcohols such as benzyl alcohol, phenylethanol, phenoxyethanol, esters such as ethyl acetate, butyl acetate, benzyl benzoate, ethers such as alkylene glycol alkyl ethers such as dipropylene glycol monomethyl ether, diethylene glycol mono-butyl ether, ketones such as acetone, methyl ethyl ketone, cyclic carbonates such as propylene carbonate, ethylene carbonate, aromatic and/or aliphatic hydrocarbons, vegetable or synthetic oils, DMF, dimethylacetamide, n-alkylpyrrolidones such as methylpyrrolidone, n-butylpyrrolidone or n-octylpyrrolidone, N-methylpyrrolidone, 2-pyrrolidone, 2,2-dimethyl-4-oxy-methylene-1,3-dioxolane and glycerol formal. 
     Suitable colorants are all colorants permitted for use on animals and which can be dissolved or suspended. 
     Suitable absorption-promoting substances are, for example, DMSO, spreading oils such as isopropyl myristate, dipropylene glycol pelargonate, silicone oils and copolymers thereof with polyethers, fatty acid esters, triglycerides, fatty alcohols. 
     Suitable antioxidants are sulfites or metabisulfites such as potassium metabisulfite, ascorbic acid, butylhydroxytoluene, butylhydroxyanisole, tocopherol. 
     Suitable light stabilizers are, for example, novantisolic acid. 
     Suitable adhesives are, for example, cellulose derivatives, starch derivatives, polyacrylates, natural polymers such as alginates, gelatin. 
     Emulsions can be administered orally, dermally or as injections. 
     Emulsions are either of the water-in-oil type or of the oil-in-water type. 
     They are prepared by dissolving the active compound either in the hydrophobic or in the hydrophilic phase and homogenizing this with the solvent of the other phase with the aid of suitable emulsifiers and, if appropriate, other auxiliaries such as colorants, absorption-promoting substances, preservatives, antioxidants, light stabilizers, viscosity-enhancing substances. 
     Suitable hydrophobic phases (oils) are: 
     liquid paraffins, silicone oils, natural vegetable oils such as sesame oil, almond oil, castor oil, synthetic triglycerides such as caprylic/capric biglyceride, triglyceride mixture with vegetable fatty acids of the chain length C 8 -C 12  or other specially selected natural fatty acids, partial glyceride mixtures of saturated or unsaturated fatty acids possibly also containing hydroxyl groups, mono- and diglycerides of the C 8 -C 10  fatty acids, 
     fatty acid esters such as ethyl stearate, di-n-butyryl adipate, hexyl laurate, dipropylene glycol perlargonate, esters of a branched fatty acid of medium chain length with saturated fatty alcohols of chain length C 16 -C 18 , isopropyl myristate, isopropyl palmitate, caprylic/capric acid esters of saturated fatty alcohols of chain length C 12 -C 18 , isopropyl stearate, oleyl oleate, decyl oleate, ethyl oleate, ethyl lactate, waxy fatty acid esters such as synthetic duck coccygeal gland fat, dibutyl phthalate, diisopropyl adipate, and ester mixtures related to the latter, fatty alcohols such as isotridecyl alcohol, 2-octyldodecanol, cetylstearyl alcohol, oleyl alcohol, and fatty acids such as oleic acid and mixtures thereof. 
     Suitable hydrophilic phases are: water, alcohols such as propylene glycol, glycerol, sorbitol and mixtures thereof. 
     Suitable emulsifiers are: 
     non-ionic surfactants, e.g. polyethoxylated castor oil, polyethoxylated sorbitan monooleate, sorbitan monostearate, glycerol monostearate, polyoxyethyl stearate, alkylphenol polyglycol ether; 
     ampholytic surfactants such as di-sodium N-lauryl-p-iminodipropionate or lecithin; 
     anionic surfactants, such as sodium lauryl sulfate, fatty alcohol ether sulfates, mono/dialkyl polyglycol ether orthophosphoric acid ester monoethanolamine salt; 
     cation-active surfactants, such as cetyltrimethylammonium chloride. 
     Suitable further auxiliaries are: substances which enhance the viscosity and stabilize the emulsion, such as carboxymethylcellulose, methylcellulose and other cellulose and starch derivatives, polyacrylates, alginates, gelatin, gum arabic, polyvinylpyrrolidone, polyvinyl alcohol, copolymers of methyl vinyl ether and maleic anhydride, polyethylene glycols, waxes, colloidal silicic acid or mixtures of the substances mentioned. 
     Suspensions can be administered orally or topically/dermally. They are prepared by suspending the active compound in a suspending agent, if appropriate with addition of other auxiliaries such as wetting agents, colorants, bioabsorption-promoting substances, preservatives, antioxidants, light stabilizers. 
     Liquid suspending agents are all homogeneous solvents and solvent mixtures. 
     Suitable wetting agents (dispersants) are the emulsifiers given above. 
     Other auxiliaries which may be mentioned are those given above. 
     Semi-solid preparations can be administered orally or topically/dermally. They differ from the suspensions and emulsions described above only by their higher viscosity. 
     For the production of solid preparations, the active compound is mixed with suitable excipients, if appropriate with addition of auxiliaries, and brought into the desired form. 
     Suitable excipients are all physiologically tolerable solid inert substances. Those used are inorganic and organic substances. Inorganic substances are, for example, sodium chloride, carbonates such as calcium carbonate, hydrogencarbonates, aluminium oxides, titanium oxide, silicic acids, argillaceous earths, precipitated or colloidal silica, or phosphates. Organic substances are, for example, sugar, cellulose, foodstuffs and feeds such as milk powder, animal meal, grain meals and shreds, starches. 
     Suitable auxiliaries are preservatives, antioxidants, and/or colorants which have been mentioned above. 
     Other suitable auxiliaries are lubricants and glidants such as magnesium stearate, stearic acid, talc, bentonites, disintegration-promoting substances such as starch or crosslinked polyvinylpyrrolidone, binders such as starch, gelatin or linear polyvinylpyrrolidone, and dry binders such as microcrystalline cellulose. 
     In general, “parasiticidally effective amount” means the amount of active ingredient needed to achieve an observable effect on growth, including the effects of necrosis, death, retardation, prevention, and removal, destruction, or otherwise diminishing the occurrence and activity of the target organism. The parasiticidally effective amount can vary for the various compounds/compositions used in the invention. A parasiticidally effective amount of the compositions will also vary according to the prevailing conditions such as desired parasiticidal effect and duration, target species, mode of application, and the like. 
     The compositions which can be used in the invention can comprise generally from about 0.001 to 95% of the compound of formula I. 
     Generally it is favorable to apply the compounds of formula I in total amounts of 0.5 mg/kg to 100 mg/kg per day, preferably 1 mg/kg to 50 mg/kg per day. 
     Ready-to-use preparations contain the compounds acting against parasites, preferably ectoparasites, in concentrations of 10 ppm to 80 percent by weight, preferably from 0.1 to 65 percent by weight, more preferably from 1 to 50 percent by weight, most preferably from 5 to 40 percent by weight. 
     Preparations which are diluted before use contain the compounds acting against ectoparasites in concentrations of 0.5 to 90 percent by weight, preferably of 1 to 50 percent by weight. 
     Furthermore, the preparations comprise the compounds of formula I against endoparasites in concentrations of 10 ppm to 2 percent by weight, preferably of 0.05 to 0.9 percent by weight, very particularly preferably of 0.005 to 0.25 percent by weight. 
     In a preferred embodiment of the present invention, the compositions comprising the compounds of formula I them are applied dermally/topically. 
     In a further preferred embodiment, the topical application is conducted in the form of compound-containing shaped articles such as collars, medallions, ear tags, bands for fixing at body parts, and adhesive strips and foils. 
     Generally it is favorable to apply solid formulations which release compounds of formula I in total amounts of 10 mg/kg to 300 mg/kg, preferably 20 mg/kg to 200 mg/kg, most preferably 25 mg/kg to 160 mg/kg body weight of the treated animal in the course of three weeks. 
     For the preparation of the shaped articles, thermoplastic and flexible plastics as well as elastomers and thermoplastic elastomers are used. Suitable plastics and elastomers are polyvinyl resins, polyurethane, polyacrylate, epoxy resins, cellulose, cellulose derivatives, polyamides and polyester which are sufficiently compatible with the compounds of formula I. A detailed list of plastics and elastomers as well as preparation procedures for the shaped articles is given e.g. in WO 03/086075. 
    
    
     EXAMPLES 
     The present invention is now illustrated in further details by the following examples, without imposing any limitation thereto. 
     Compounds can in general be characterized e.g. by coupled High Performance Liquid Chromatography/mass spectrometry (HPLC/MS), by  1 H-NMR and/or by their melting points. 
     Conditions: 
     Analytical HPLC column: RP-18 column Chromolith Speed ROD from Merck KgaA, Germany). 
     Elution: acetonitrile+0.1% trifluoroacetic acid (TFA)/water+0.1% trifluoroacetic acid (TFA) in a ratio of from 5:95 to 95:5 in 5 minutes at 40° C. 
     *Analytical UPLC column: Phenomenex Kinetex 1.7 μm XB-C18 100A; 50×2.1 mm; mobile phase: A: water+0.1% trifluoroacetic acid (TFA); B: acetonitrile+0.1% TFA; gradient: 5-100% B in 1.50 minutes; 100% B 0.20 min; flow: 0.8-1.0 mL/min in 1.50 minutes at 60° C. MS-method: ESI positive. 
     S. Synthesis Examples 
     S.1 4-[(6-chloro-3-pyridyl)methyl]-2-methylsulfanyl-imidazo[4,5-b]pyridine 
     
       
         
         
             
             
         
       
     
     A solution of 2-methylsulfanyl-4H-imidazo[4,5-b]pyridine (900 mg, 5.45 mmol), 2-chloro-5-(chloromethyl)pyridine (1.32 g, 8.17 mmol) and triethylamine (1.1 mL, 8.17 mmol) in benzene (18 mL) was stirred at 100° C. for 12 h (microwave). After cooling to room temperature the benzene was decanted off and the resulting solid was triturated with boiling benzene (3×15 mL). The benzene phases were combined and the solvent was removed under reduced pressure. The resulting solid was triturated with CH 2 Cl 2 , filtered and dried under reduced pressure to yield 760 mg (2.62 mmol, 48%) of compound E1.4. 
     LC-MS: mass calcd. for C 13 H 11 ClN 4 S [M+H] +  290.0 found 291.0; t R =0.82 min*). 
     S.2 2-chloro-4-[(6-chloro-3-pyridyl)methyl]imidazo[4,5-b]pyridine 
     
       
         
         
             
             
         
       
     
     A solution of 4-[(6-chloro-3-pyridyl)methyl]-2-methylsulfanyl-imidazo[4,5-b]pyridine (2.22 g, 7.63 mmol) in 25 mL concentrated aqueous hydrochloric acid was cooled to −10° C. and gaseous Cl 2  was bubbled through the solution for 1 h. The mixture was stirred at −10° C. for additional 2 h and for 12 h at room temperature. Afterwards the reaction mixture was poured into ice-water, basified to pH 4-5 with NaOH solution (15% in H 2 O) and extracted three times with CH 2 Cl 2 . The combined organic extracts were washed with water, dried with Na 2 SO 4  and the solvent was removed under reduced pressure. Purification by flash column chromatography (SiO 2 , gradient of MeOH/CH 2 C 12 ) yielded 1.23 g (4.43 mmol, 58%) of compound E1.8. 
     LC-MS: mass calcd. for C 12 H 8 Cl 2 N 4  [M+H] +  278.0 found 279.0; t R =0.92 min*). 
     S.3 4-[(6-chloro-3-pyridyl)methyl]-2-(trifluoromethyl)imidazo[4,5-b]pyridine 
     
       
         
         
             
             
         
       
     
     Step 1: A solution of 2,3-diaminopyridine (1.00 g, 9.16 mmol) in trifluoroacetic acid (10 mL) was stirred for 15 h at 110° C. (microwave). The trifluoroacetic acid was then evaporated under reduced pressure and the residue was co-evaporated with toluene three times. The resulting solid was triturated with water, filtered and dried under reduced pressure to give 1.30 g (6.95 mmol, 76%) 2-(trifluoromethyl)-4H-imidazo[4,5-b]pyridine. Alternatively, the latter can be prepared according to J. Chem. Soc., Perkin 1 1996, (22), 2685-2691. 
     LC-MS: mass calcd. for C 12 H 8 Cl 2 N 4  [M+H]+187.0 found 188.0; t R =0.61 min*). 
     Step 2: A solution of 2-(trifluoromethyl)-4H-imidazo[4,5-b]pyridine (250 mg, 1.34 mmol) and 2-chloro-5-(iodomethyl)pyridine (508 mg, 2.00 mmol, prepared from 2-chloro-5-(chloromethyl)pyridine according to US2005/0228027) in acetone (7 mL) was stirred at 60° C. for 12 h. The solvent was evaporated under reduced pressure, the residue redissolved in CH 2 Cl 2 , washed twice with Na 2 CO 3 -solution (10% in H 2 O) and H 2 O and dried with Na 2 SO 4 . The solvent was removed under reduced pressure and the residue was purified by flash column chromatography (SiO 2 , gradient of MeOH/CH 2 C 12 ) to yield 240 mg (0.77 mmol, 57%) of compound E1.15. 
     LC-MS: mass calcd. for C 12 H 8 Cl 2 N 4  [M+H] +  278.0 found 312.0; t R =2.16 min. 
     C. Compound Examples 
     Some compound examples of the present invention are shown in the synthesis examples above. 
     Further examples of compounds of formula I according to the present invention are given in table E.1 below. 
     
       
         
           
               
             
               
                 TABLE E1 
               
             
            
               
                   
               
               
                 Examples of compounds according to formula I-E1: 
               
               
                 (I-E1) 
               
               
                 
                   
                     
                     
                         
                         
                     
                   
                 
               
               
                   
               
            
           
           
               
               
               
               
               
               
               
               
            
               
                   
                   
                   
                   
                   
                   
                   
                 Physico-chemical 
               
               
                 No. 
                 Het  a)   
                 R 1   
                 R 2   
                 A 
                 X 
                 R 6   
                 data  b)   
               
               
                   
               
               
                 E1.1 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 H 
                 H 
                 r.t. = 1.78 min m/z = 245.1 
               
               
                   
               
               
                 E1.2 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 S(O) 2 CH 2 CH 3   
                 H 
                 r.t. = 1.92 min m/z = 337.0 
               
               
                   
               
               
                 E1.3 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 SCH 2 CH 3   
                 H 
                 r.t. = 2.11 min m/z = 305.5 
               
               
                   
               
               
                 E1.4 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 SCH 3   
                 H 
                 r.t. = 0.82 min* )  m/z = 291.0 
               
               
                   
               
               
                 E1.5 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 S(O) 2 CH 3   
                 H 
                 r.t. = 1.68 min m/z = 322.9 
               
               
                   
               
               
                 E1.6 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 S(O)CH 2 CH 3   
                 H 
                 r.t. = 1.68 min m/z = 321.1 
               
               
                   
               
               
                 E1.7 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 S(O)CH 3   
                 H 
                 r.t. = 0.62 min* )  m/z = 307.0 
               
               
                   
               
               
                 E1.8 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 Cl 
                 H 
                 r.t. = 0.92 min* )  m/z = 279.0 
               
               
                   
               
               
                 E1.9 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 SBn 
                 H 
                 r.t. = 1.25 min* )  m/z = 367.0 
               
               
                   
               
               
                 E1.10 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 S(O) 2 Bn 
                 H 
                 r.t. = 2.36 min m/z = 399.0 
               
               
                   
               
               
                 E1.11 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 S(O)Bn 
                 H 
                 r.t. = 2.11 min m/z = 383.0 
               
               
                   
               
               
                 E1.12 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 S(O) 2 CH 2 CF 3   
                 H 
                 r.t. = 2.41 min m/z = 391.0 
               
               
                   
               
               
                 E1.13 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 S(O)CH 2 CF 3   
                 H 
                 r.t. = 2.16 min m/z = 375.0 
               
               
                   
               
               
                 E1.14 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 CCl 3   
                 H 
                 r.t. = 0.93 min* )  m/z = 362.8 
               
               
                   
               
               
                 E1.15 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 CF 3   
                 H 
                 r.t. = 2.16 min m/z = 313.0 
               
               
                   
               
               
                 E1.16 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 S(O) 2 CH 2 CCH 
                 H 
                 r.t. = 0.76 min* )  m/z = 342.7 
               
               
                   
               
               
                 E1.17 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 CF 3   
                 H 
                 r.t. = 0.89 min* )  m/z = 319.1 
               
               
                   
               
               
                 E1.18 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 CF 3   
                 H 
                 r.t. = 0.92 min* )  m/z = 331.2 
               
               
                   
               
               
                 E1.19 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 CF 2 CF 3   
                 H 
                 r.t. = 2.72 min m/z = 362.9 
               
               
                   
               
               
                 E1.20 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 CF 2 CF 3   
                 H 
                 r.t. = 0.85 min* )  m/z = 322.2 
               
               
                   
               
               
                 E1.21 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 CF 3   
                 2-Cl 
                 r.t. = 0.98 min* )  m/z = 347.2 
               
               
                   
               
               
                 E1.22 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 CF 3   
                 H 
                 r.t. = 0.93 min* )  m/z = 347.2 
               
               
                   
               
               
                 E1.23 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 CF 3   
                 H 
                 r.t. = 0.73 min* )  m/z = 272.1 
               
               
                   
               
               
                 E1.24 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 C 
                 CF 3   
                 H 
                 r.t. = 0.80 min* )  m/z = 312.2 
               
               
                   
               
               
                 E1.25 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 CF 3   
                 1-CH 3   
                 r.t. = 0.86 min* )  m/z = 327.2 
               
               
                   
               
               
                 E1.26 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 CHF 2   
                 H 
                 r.t. = 1.02 min* )  m/z = 329.2 
               
               
                   
               
               
                 E1.27 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 CHF 2   
                 H 
                 r.t. = 0.76 min* )  m/z = 270.0 
               
               
                   
               
               
                 E1.28 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 C 
                 CF 3   
                 H 
                 r.t. = 0.66 min* )  m/z = 295.2 
               
               
                   
               
               
                 E1.29 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 C 
                 CF 3   
                 H 
                 r.t. = 0.90 min* )  m/z = 319.0 
               
               
                   
               
               
                 E130 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 C 
                 Cl 
                 H 
                 r.t. = 0.70 min* )  m/z = 278.1 
               
               
                   
               
               
                 E1.31 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 C 
                 Cl 
                 H 
                 r.t. = 0.74 min* )  m/z = 284.0 
               
               
                   
               
               
                 E1.32 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 CN 
                 H 
                 r.t. = 0.76 min* )  m/z = 270.0 
               
               
                   
               
               
                 E1.33 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 CF 3   
                 3-CH 3   
                 r.t. = 0.89 min* )  m/z = 327.5 
               
               
                   
               
               
                 E1.34 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 CH 2 F 
                 H 
                 r.t. = 1.02 min* )  m/z = 329.2 
               
               
                   
               
               
                 E1.35 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 CF 3   
                 2-CH 3   
                 r.t. = 0.88 min* )  m/z = 327.1 
               
               
                   
               
               
                 E1.36 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 SCHF 2   
                 H 
                 r.t. = 0.75 min* )  m/z = 327.1 
               
               
                   
               
               
                 E1.37 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 H 
                 N 
                 CF 3   
                 H 
                 r.t. = 0.91 min* )  m/z = 327.1 
               
               
                   
               
               
                 E1.38 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 C(O)OCH 2 CH 3   
                 H 
                 r.t. = 0.73 min* )  m/z = 317.2 
               
               
                   
               
               
                 E1.39 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 S(O)CHF 2   
                 H 
                 r.t. = 0.73 min* )  m/z = 343.0 
               
               
                   
               
               
                 E1.40 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 CClF 2   
                 H 
                 r.t. = 0.88 min* )  m/z = 330.9 
               
               
                   
               
               
                 E1.41 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 CN 
                 H 
                 r.t. = 0.81 min* )  m/z = 229.1 
               
               
                   
               
               
                 E1.42 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 CH 2 CN 
                 H 
                 r.t. = 0.59 min* )  m/z = 306.1 
               
               
                   
               
               
                 E1.43 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 CN 
                 H 
                 r.t. = 0.81 min* )  m/z = 275.9 
               
               
                   
               
               
                 E1.44 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 C(O)NH 2   
                 H 
                 r.t. = 0.68 min* )  m/z = 280.1 
               
               
                   
               
               
                 E1.45 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 CF 3   
                 H 
                 r.t. = 0.68 min* )  m/z = 280.1 
               
               
                   
               
               
                 E1.46 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 F 
                 H 
                 r.t. = 0.71 min* )  m/z = 263.1 
               
               
                   
               
               
                 E1.47 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 F 
                 H 
                 r.t. = 0.74 min* )  m/z = 269.0 
               
               
                   
               
               
                 E1.48 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 Cl 
                 H 
                 r.t. = 0.92 min* )  m/z = 320.0 
               
               
                   
               
               
                 E1.49 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 CF 2 CN 
                 H 
                 r.t. = 0.61 min* )  m/z = 288.1 
               
               
                   
               
               
                 E1.50 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 CF 3   
                 H 
                 r.t. = 0.91 min* )  m/z = 357.0 
               
               
                   
               
               
                 E1.51 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 CF 3   
                 H 
                 r.t. = 0.77 min* )  m/z = 314.1 
               
               
                   
               
               
                 E1.52 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 N 
                 CF 3   
                 H 
                 r.t. = 0.84 min* )  m/z = 288.1 
               
               
                   
               
               
                   a)  # denotes the attachment point to the remainder of the molecule; 
               
               
                   b)  r.t. = HPLC retention time; m/z of the [M + H] + , [M + Na] +  or [M + K] +  peaks. 
               
               
                 * ) analytical UPLC column (see above) 
               
            
           
         
       
     
     
       
         
           
               
             
               
                 TABLE E2 
               
             
            
               
                   
               
               
                 Examples of compounds according to formula I-E2: 
               
               
                 (I-E2) 
               
               
                 
                   
                     
                     
                         
                         
                     
                   
                 
               
               
                   
               
            
           
           
               
               
               
               
               
               
               
               
            
               
                   
                   
                   
                   
                   
                   
                   
                 Physico- 
               
               
                 No. 
                 Het a)   
                 R1 
                 R2 
                 W 4 —W 3 —W 2 —W 1   
                 A 
                 X 
                 chemical data b)   
               
               
                   
               
               
                 E2.1 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 —CH 2 —CH 2 — 
                 N 
                 Br 
                 r.t. = 0.85 min* )  m/z = 315.8 
               
               
                   
               
               
                 E2.2 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 —CH 2 —CH 2 —CH 2 — 
                 N 
                 Br 
                 r.t. = 0.90 min* )  m/z = 329.9 
               
               
                   
               
               
                 E2.3 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 —C(CH 3 )═CH— 
                 N 
                 Br 
                 r.t. = 0.98 min* )  m/z = 327.9 
               
               
                   
               
               
                 E2.4 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 —CH 2 —CH 2 —CH 2 — 
                 N 
                 CN 
                 r.t. = 1.18 min* )  m/z = 274.9 
               
               
                   
               
               
                 E2.5 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 —CH 2 —CH 2 —CH 2 — 
                 N 
                 CN 
                 r.t. = 2.18 min m/z = 266.1 
               
               
                   
               
               
                 E2.6 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 —CH 2 —CH 2 —CH 2 — 
                 N 
                 H 
                 r.t. = 2.04 min m/z = 250.1 
               
               
                   
               
               
                 E2.7 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 —CH 2 —CH 2 — 
                 N 
                 CN 
                 r.t. = 2.21 min m/z = 261.0 
               
               
                   
               
               
                 E2.8 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 —CH═CH—C(O)— 
                 N 
                 SCH 3   
                 r.t. = 2.21 min m/z = 261.0 
               
               
                   
               
               
                 E2.9 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 —CH 2 —CH 2 —CH 2 — 
                 N 
                 NO 2   
                 r.t. = 0.92 min* )  m/z = 301.2 
               
               
                   
               
               
                 E2.10 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 —CH 2 —CH 2 —CH 2 — 
                 N 
                 NO 2   
                 r.t. = 0.86 min* )  m/z = 295.1 
               
               
                   
               
               
                 E2.11 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 —CH 2 —CH 2 —CH 2 — 
                 N 
                 CF 3   
                 r.t. = 1.02 min* )  m/z = 318.0 
               
               
                   
               
               
                 E2.12 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 —C(CH 3 )═CH— 
                 N 
                 NO 2   
                 r.t. = 0.94 min* )  m/z = 311.0 
               
               
                   
               
               
                 E2.13 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 —C(CH 3 )═CH— 
                 N 
                 NO 2   
                 r.t. = 0.89 min* )  m/z = 293.2 
               
               
                   
               
               
                 E2.14 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 —C(CH 3 )═CH— 
                 N 
                 NO 2   
                 r.t. = 0.73 min* )  m/z = 254.1 
               
               
                   
               
               
                 E2.15 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 —CH 2 —CH 2 —CH 2 — 
                 N 
                 NO 2   
                 r.t. = 0.95 min* )  m/z = 313.2 
               
               
                   
               
               
                 E2.16 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 —C(CH 3 )═CH— 
                 N 
                 CF 3   
                 r.t. = 1.01 min* )  m/z = 316.3 
               
               
                   
               
               
                 E2.17 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 —C(CH 3 )═CH— 
                 N 
                 CF 3   
                 r.t. = 1.05 min* )  m/z = 322.2 
               
               
                   
               
               
                 E2.18 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 —C(CH 3 )═CH— 
                 N 
                 NO 2   
                 r.t. = 0.91 min* )  m/z = 298.9 
               
               
                   
               
               
                 E2.19 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 —C(CH 3 )═CH— 
                 N 
                 Cl 
                 r.t. = 0.92 min* )  m/z = 288.1 
               
               
                   
               
               
                 E2.20 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 —C(CH 3 )═CH— 
                 N 
                 Cl 
                 r.t. = 0.90 min* )  m/z = 282.2 
               
               
                   
               
               
                 E2.21 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 H 
                 H 
                 —C(CH 3 )═CH— 
                 N 
                 CF 3   
                 r.t. = 1.09 min* )  m/z = 350.2 
               
               
                   
               
               
                 E2.22 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 H 
                 —C(CH 3 )═CH— 
                 N 
                 CF 3   
                 r.t. = 1.13 min* )  m/z = 364.1 
               
               
                   
               
               
                 E2.23 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 H 
                 —C(CH 3 )═CH— 
                 N 
                 F 
                 r.t. = 1.01 min* )  m/z = 314.1 
               
               
                   
               
               
                 E2.24 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 H 
                 —C(CH 3 )═CH— 
                 N 
                 Br 
                 r.t. = 1.04 min* )  m/z = 376.0 
               
               
                   
               
               
                 E2.25 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 CH 3   
                 H 
                 —C(CH 3 )═CH— 
                 N 
                 Cl 
                 r.t. = 1.03 min* )  m/z = 330.1 
               
               
                   
               
               
                   a) # denotes the attachment point to the remainder of the molecule; 
               
               
                   b) r.t. = HPLC retention time; m/z of the [M + H] + , [M + Na] +  or [M + K] +  peaks. 
               
               
                 * ) analytical UPLC column 
               
            
           
         
       
     
     B. Biological Examples 
     The biological activity of the compounds of formula I of the present invention can or could be demonstrated and evaluated in biological tests as described in the following. 
     General Conditions 
     If not otherwise specified, most test solutions are prepared as follows: 
     The active compound is dissolved at the desired concentration in a mixture of 1:1 (vol:vol) distilled water:acteon. The test solutions are prepared at the day of use (and, if not otherwised specified, in general at concentrations wt/vol). 
     B.1 Green Peach Aphid ( Myzus persicae ) 
     The active compounds were formulated in cyclohexanone as a 10,000 ppm solution supplied in tubes. The tubes were inserted into an automated electrostatic sprayer equipped with an atomizing nozzle and they served as stock solutions for which lower dilutions were made in 50% acetone:50% water (v/v). A nonionic surfactant (Kinetic®) was included in the solution at a volume of 0.01% (v/v). 
     Bell pepper plants at the first true-leaf stage were infested prior to treatment by placing heavily infested leaves from the main colony on top of the treatment plants. Aphids were allowed to transfer overnight to accomplish an infestation of 30-50 aphids per plant and the host leaves were removed. The infested plants were then sprayed by an automated electrostatic plant sprayer equipped with an atomizing spray nozzle. The plants were dried in the sprayer fume hood, removed, and then maintained in a growth room under fluorescent lighting in a 24-hr photoperiod at about 25° C. and about 20-40% relative humidity. Aphid mortality on the treated plants, relative to mortality on untreated control plants, was determined after 5 days. 
     In this test, compounds E1.2, E1.8, E1.16, E1.17, E1.18, E1.39, E1.40, E1.46, E1.47, E1.48, and E2.4, at 300 ppm showed at least 75% mortality in comparison with untreated controls. 
     B.2 Cotton Aphid ( Aphis gossypii ) 
     The active compounds were formulated in 50:50 (vol:vol) acetone:water and 100 ppm Kinetica™ surfactant. 
     Cotton plants at the cotyledon stage (one plant per pot) were infested by placing a heavily infested leaf from the main colony on top of each cotyledon. The aphids were allowed to transfer to the host plant overnight, and the leaf used to transfer the aphids was removed. The cotyledons were dipped in the test solution and allowed to dry. After 5 days, mortality counts were made. 
     In this test, compounds E1.2, E1.8, E1.15, E1.18, E1.39, and E1.48 at 300 ppm showed at least 75% mortality in comparison with untreated controls. 
     B.3 Cowpea Aphid ( Aphis craccivora ) 
     The active compound is dissolved at the desired concentration in a mixture of 1:1 (vol:vol) distilled water:acetone. The test solution is prepared at the day of use. 
     Potted cowpea plants colonized with approximately 100-150 aphids of various stages were sprayed after the pest population has been recorded. Population reduction was assessed after 24, 72, and 120 hours. 
     In this test, compounds E1.1, E1.2, E1.3, E1.4, E1.7, E1.8, E1.9, E1.14, E1.15, E1.16, E1.18, E1.19, E1.21, E1.25, E1.27, E1.32, E1.33, E1.35, E1.36, E1.37, E1.40, E1.42, E1.44, E1.45, E1.46, E1.48, E2.1, E2.2, E2.3, E2.4, E2.7, E2.12, E2.14, E2.15, E2.16 and E2.17 at 500 ppm showed at least 75% mortality in comparison with untreated controls. 
     B.4 Vetch Aphid ( Megoura viciae ) 
     For evaluating control of vetch aphid ( Megoura viciae ) through contact or systemic means the test unit consisted of 24-well-microtiter plates containing broad bean leaf disks. 
     The compounds were formulated using a solution containing 75% v/v water and 25% v/v DMSO. Different concentrations of formulated compounds were sprayed onto the leaf disks at 2.5 μl, using a custom built micro atomizer, at two replications. 
     After application, the leaf disks were air-dried and 5-8 adult aphids placed on the leaf disks inside the microtiter plate wells. The aphids were then allowed to suck on the treated leaf disks and incubated at about 23±1° C. and about 50±5% relative humidity for 5 days. Aphid mortality and fecundity was then visually assessed. 
     In this test, compounds E1.2, E1.4, E1.8, E1.9, E1.13, E1.14, E1.15, E1.16, E1.17, E1.18, E1.19, E1.27, E1.30, E1.32, E1.37, E1.44, E1.46, E1.47, E1.48, E2.3, E2.6, E2.11, E2.16, and E2.23 at 800 ppm showed at least 75% mortality in comparison with untreated controls. 
     B.5 Silverleaf Whitefly ( bemisia argentifolii ) 
     The active compounds were formulated in cyclohexanone as a 10,000 ppm solution supplied in tubes. The tubes were inserted into an automated electrostatic sprayer equipped with an atomizing nozzle and they served as stock solutions for which lower dilutions were made in 50% acetone:50% water (v/v). A nonionic surfactant (Kinetic®) was included in the solution at a volume of 0.01% (v/v). 
     Cotton plants at the cotyledon stage (one plant per pot) were sprayed by an automated electrostatic plant sprayer equipped with an atomizing spray nozzle. The plants were dried in the sprayer fume hood and then removed from the sprayer. Each pot was placed into a plastic cup and about 10 to 12 whitefly adults (approximately 3-5 days old) were introduced. The insects were collected using an aspirator and a nontoxic Tygon® tubing connected to a barrier pipette tip. The tip, containing the collected insects, was then gently inserted into the soil containing the treated plant, allowing insects to crawl out of the tip to reach the foliage for feeding. Cups were covered with a reusable screened lid. Test plants were maintained in a growth room at about 25° C. and about 20-40% relative humidity for 3 days, avoiding direct exposure to fluorescent light (24 hour photoperiod) to prevent trapping of heat inside the cup. Mortality was assessed 3 days after treatment, compared to untreated control plants. 
     In this test, compounds E1.2, E1.8, E1.15, E1.17, E1.18, E1.27, E1.32, and E1.37 at 500 ppm showed at least 75% mortality in comparison with untreated controls. 
     B.6 Boll Weevil ( Anthonomus grandis ) 
     For evaluating control of boll weevil ( Anthonomus grandis ) the test unit consisted of 24-well-microtiter plates containing an insect diet and 20-30  A. grandis  eggs. 
     The compounds were formulated using a solution containing 75% v/v water and 25% v/v DMSO. Different concentrations of formulated compounds were sprayed onto the insect diet at 20 μl, using a custom built micro atomizer, at two replications. 
     After application, microtiter plates were incubated at about 23±1° C. and about 50±5% relative humidity for 5 days. Egg and larval mortality was then visually assessed. 
     In this test, E1.8, E1.32, E1.48, E2.3, E2.6, E2.10, E2.12, E2.13, and E2.22 at 2500 ppm showed over 75% mortality in comparison with untreated controls. 
     B.7 Orchid Thrips ( dichromothrips corbetti ) 
       Dichromothrips corbetti  adults used for bioassay were obtained from a colony maintained continuously under laboratory conditions. For testing purposes, the test compound is diluted in a 1:1 mixture of acetone:water (vol:vol), plus 0.01% vol/vol Alkamuls® EL 620 surfactant. 
     Thrips potency of each compound was evaluated by using a floral-immersion technique. Plastic petri dishes were used as test arenas. All petals of individual, intact orchid flowers were dipped into treatment solution and allowed to dry. Treated flowers were placed into individual petri dishes along with about 20 adult thrips. The petri dishes were then covered with lids. All test arenas were held under continuous light and a temperature of about 28° C. for duration of the assay. After 3 days, the numbers of live thrips were counted on each flower, and along inner walls of each petri dish. The percentmortality was recorded 72 hours after treatment. 
     In this test, compounds E1.2, E1.8, E1.15, E1.18, E1.19, E1.27, E1.32, E1.33, E1.35, E1.37, E1.40, E1.45, E1.48, E2.1, E2.2, E2.3, E2.4, E2.10, and E2.23 at 500 ppm showed at least 75% mortality in comparison with untreated controls. 
     B.8 Rice Green Leafhopper ( Nephotettix virescens ) 
     Rice seedlings were cleaned and washed 24 hours before spraying. The active compounds were formulated in 50:50 acetone:water (vol:vol), and 0.1% vol/vol surfactant (EL 620) was added. Potted rice seedlings were sprayed with 5 ml test solution, air dried, placed in cages and inoculated with 10 adults. Treated rice plants were kept at about 28-29° C. and relative humidity of about 50-60%. Percent mortality was recorded after 72 hours. 
     In this test, compounds E1.2, E1.8, E1.15, E1.18, E1.19, E1.27, E1.32, E1.36, E1.37, E1.39, E1.40, E1.45, E1.48, E2.2, E2.3 and E2.16 at 500 ppm showed at least 75% mortality in comparison with untreated controls. 
     B.9 Rice Brown Plant Hopper ( Nilaparvata lugens ) 
     Rice seedlings were cleaned and washed 24 hours before spraying. The active compounds were formulated in 50:50 acetone:water (vol:vol) and 0.1% vol/vol surfactant (EL 620) was added. Potted rice seedlings were sprayed with 5 ml test solution, air dried, placed in cages and inoculated with 10 adults. Treated rice plants were kept at about 28-29° C. and relative humidity of about 50-60%. Percent mortality was recorded after 72 hours. 
     In this test, compounds E1.2, E1.8, E1.15, E1.18, E1.19, E1.25, E1.27, E1.32, E1.36, E1.37, E1.40, E1.45, E1.48 and E2.16 at 500 ppm showed at least 75% mortality in comparison with untreated controls. 
     B.10 Mediterranean Fruitfly ( Ceratitis capitata ) 
     For evaluating control of Mediterranean fruitfly ( Ceratitis capitata ) the test unit consisted of microtiter plates containing an insect diet and 50-80  C. capitata  eggs. 
     The compounds were formulated using a solution containing 75% v/v water and 25% v/v DMSO. Different concentrations of formulated compounds were sprayed onto the insect diet at 5 μl, using a custom built micro atomizer, at two replications. 
     After application, microtiter plates were incubated at about 28±1° C. and about 80±5% relative humidity for 5 days. Egg and larval mortality was then visually assessed. 
     In this test, compounds E1.19, E2.3 and E2.6 at 800 ppm showed over 75% mortality in comparison with untreated controls.